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Abstract 
Low anaerobic threshold, a marker of decreased exercise capacity, is associated with poorer outcomes 
following surgery. In this thesis I demonstrate a relationship between low preoperative anaerobic 
threshold and preoperative lymphopenia (low lymphocyte count). I subsequently demonstrate that 
preoperative lymphopenia is associated with prolonged hospitalisation and increased postoperative 
complications using 2 surgical cohorts (n=240 and n=881).  
 
Significant metabolic (bioenergetic) and functional changes occur in lymphocytes postoperatively, which 
may contribute to increased morbidity and mortality. Lymphocytes demonstrate a postoperative 
decrease in glycolysis and oxidative phosphorylation. Altered postoperative bioenergetic function are 
accompanied by an increase in mitochondrial reactive oxygen species production and a reduction in 
lymphocyte mitochondrial membrane potential, which are known to be associated with apoptosis or cell 
death. Increased apoptosis of lymphocytes following surgery is the likely mechanism for acquired 
lymphopenia postoperatively (reduction in lymphocyte count which occurs postoperatively). 
 
A decrease in glycolysis is accompanied by increased CD8(+) lymphocyte cytokine production. 
Postoperative inflammasome activation as demonstrated by increased caspase-1 activity, appears to 
occur secondary to glucocorticoid release associated with the stress response to surgery. Caspase-1 is 
associated with glycolysis inhibition (decreased glycolysis postoperatively) and increased apoptosis 
(reduced lymphocyte count postoperatively). Increased Interleukin-1-beta expression, which is 
associated with activation of the inflammasome and increased cytokine production, is demonstrated 
following incubation of lymphocytes with glucocorticoid.  
 
I hypothesise that postoperative changes in lymphocyte function occur secondary to increased 
glucocorticoid levels activating the inflammasome pathway during the stress response to surgery. 
This thesis provides translational data introducing the concept that lymphocyte metabolic 
abnormalities underlie the postoperative immune phenotype.  
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Chapter 1  
Introduction  
 
Lymphocytes are essential for effective innate and adaptive responses to trauma and 
inflammation.(Kim, Zhao et al. 2007, Palm and Medzhitov 2007) Preoperative lymphocyte function 
together with perioperative changes may play a vital role in the development of postoperative 
morbidity.  
 
In this thesis I explore the relationship between aerobic capacity and lymphopenia and hypothesise that 
this contributes to the development of postoperative morbidity. I also explore the perioperative changes 
in human peripheral lymphocyte bioenergetics and functionality and elucidate potential mechanisms for 
the findings demonstrated. 
 
1.1 Surgery and morbidity 
An estimated 234 million major surgical procedures are performed world-wide per year.(Weiser, 
Regenbogen et al. 2008) Surgery is associated with significant patient morbidity and mortality. A 7-day 
European cohort study demonstrated a 4% in-hospital mortality rate within the United Kingdom (UK) 
following adult non-cardiac surgery.(Pearse, Moreno et al. 2012)  
 
Postoperative complications are significant, impacting not only on recovery time but health-care 
expenditure and the subsequent risk of death. Prospectively collected data over 8 years in 105,000 
patients has demonstrated that development of postoperative complications is a reliable predictor of 
long term survival.(Khuri, Henderson et al. 2005) Even apparently minor postoperative morbidity such as 
wound complications significantly increases the risk of mortality up to 8 years following surgery.  
 
Mechanisms involved in the development of postoperative morbidity are poorly understood. 
Identification of the specific pathophysiological changes responsible for the development of 
postoperative morbidity may help to identify new targets for risk stratification and therapeutic 
manipulation.   
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1.2 Sepsis and surgery 
Surgical patients account for up to 30% of patients with sepsis.(Angus, Linde-Zwirble et al. 2001) In the 
United States (US) alone, of the 40 million surgical operations performed annually, approximately 2 
million operations are complicated by surgical site infection.(Vogel, Dombrovskiy et al. 2009) Surgical 
patients are therefore a high-risk group for developing sepsis. The immune system in the postoperative 
period may be transformed by multiple factors including: metabolic and haematological changes, 
bacterial infection, blood transfusion and anaesthesia, which all contribute to the development of 
sepsis.(Windsor, Klava et al. 1995, Desborough 2000, Angele and Chaudry 2005) 
 
Most of the mechanistic research in patients with established sepsis lack robust control populations. 
Confounding factors such as age, gender, ethnicity and comorbidity together with therapeutic agents 
used in the treatment of sepsis alter physiology, therefore making interpretation of experiments and 
generalizability of findings difficult.(Cain, Gutierrez del Arroyo et al. 2015) Utilising endotoxin infusion in 
healthy volunteers as the control population for critical illness studies has been shown to mimic aspects 
of the systemic inflammatory response.(Andreasen, Krabbe et al. 2008) However this model has its 
limitations since, for obvious ethical reasons, this population cannot receive endotoxin at high enough 
doses to trigger end organ dysfunction. Furthermore endotoxin utilised in this study may result in 
differing immune response due to activation of non-infectious (damage associated molecular patterns-
DAMPs) rather than infectious (pathogen associated molecular patterns-PAMPs) inflammatory 
response. 
 
Major elective surgery offers a model for exploring mechanisms underlying sepsis.(Cain, Gutierrez del 
Arroyo et al. 2015) The inflammatory response to tissue trauma occurring during surgery is reproducible 
and surgery has a similar inflammatory effect as that caused by infection. Furthermore, surgical patients 
undergo extensive phenotyping allowing characterisation of baseline organ function, which can act as an 
individual’s own control data. 
 
1.3 The effect of surgery on immune response 
Sterile inflammation is a process in which inflammation occurs in the absence of pathogen, for example 
inflammation associated with a burn.(Chen and Nunez 2010) The mechanisms by which tissue injury 
induces inflammation are less clear. It is believed that necrotic cells release endogenous danger signals 
known as alarmins, which act on innate immune cells to activate similar receptors and signalling 
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pathways to those used by pattern recognition receptors (PRRs) or pathogen-associated molecular 
patterns (PAMPs), leading to cytokine production.(Bianchi 2007, Rosin and Okusa 2011)  
 
Major surgical interventions result in immune cell alterations, including reductions in peripheral T 
lymphocytes, cytotoxic T cells, and natural killer cells.(Slade, Simmons et al. 1975) This surgery-induced 
postoperative inflammatory response characterised by impairment of the cell-mediated immune system 
or short-term immune suppression, has since been demonstrated in several other studies.(Faist, Baue et 
al. 1983, Haupt, Riese et al. 1998)  
 
Surgery is thought to have a greater effect on immune cells than anaesthesia alone. Peripheral 
lymphocyte count and CD3 counts do not significantly change 20 minutes following induction of 
anaesthesia with thiopentone, fentanyl and isoflurane, but do so following surgical incision.(Brand, 
Kirchner et al. 1997) Identifying the precise mechanisms, chronology of the changes, cause and effect 
relationships between molecular pathways demonstrated and evaluating in-vivo function however still 
remains a challenge. 
 
While the precise mechanisms explaining how postoperative complications often occur in systems 
distant to the operative site are not fully understood, the immune system has been implicated as a 
significant contributor to such morbidity.(Bennett-Guerrero, Welsby et al. 1999) The sepsis literature 
may help identify potential mechanisms of complication development in the postoperative phase. 
Deficiencies in proinflammatory responses for example may be harmful in patients with sepsis. This 
deficient inflammatory response may be mediated by polymorphisms in the genes responsible for 
cytokine production such as TNF-α promoter,(O'Dwyer, Mankan et al. 2008) IL-23 and IL-27 gene 
expression.(O'Dwyer, Mankan et al. 2008) This suggests that a cytokine-based immune response is 
beneficial in sepsis. 
 
Prolonged visceral ischemia during major surgery results in an increase in levels of certain cytokines 
including tumour necrosis factor-alpha, (TNF-α), IL-6, IL-8 and IL-10.(Wakefield, Carey et al. 1993) The 
degree of cytokine production appears to correlate with the frequency and magnitude of postoperative 
organ dysfunction.(Wakefield, Carey et al. 1993, Poeze, Ramsay et al. 2002) For example, cytokine gene 
expression (reduced interferon gamma mRNA) is altered immediately following surgery in patients with 
postoperative pneumonia.(White, Martin-Loeches et al. 2011) Genes encoding the cytokine interleukin-
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6 (IL-6) also become activated during aortic surgery and the resultant systemic inflammatory reaction 
has been associated with subsequent impaired pulmonary function.(Adembri, Kastamoniti et al. 2004) 
 
1.4 Effect of surgery on lymphocytes  
An increase in peripheral leukocyte count, a decrease in lymphocyte count and increase in neutrophil to 
lymphocyte ratio (NLR) occurs postoperatively.(Hamid, Bancewicz et al. 1984, Lennard, Shenton et al. 
1985, Yamauchi, Kobayashi et al. 1998) Studies examining postoperative trends in lymphocyte numbers 
have involved relatively small numbers (Table1.1; n=20-35), and few studies have explored trends in NLR 
perioperatively.  
 
The decreases in lymphocyte count seen postoperatively in the general surgical and maxillofacial 
populations of these studies return to preoperative baseline levels by day 3-7 following surgery in 
patients not receiving perioperative steroid therapy.(Hamid, Bancewicz et al. 1984, Lennard, Shenton et 
al. 1985, Dietz, Heimlich et al. 2000) 
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Table 1.1. A summary of the prospective studies exploring postoperative trends in lymphocyte count  
Author Year Cohort Type of 
study 
Number Time points of 
sampling 
Method Decrease in lymphocyte 
count 
Time to 
recovery to 
preoperative 
level 
Hamid et 
al.(Hamid
, 
Bancewic
z et al. 
1984) 
1984 Major elective 
general 
surgery 
 
Prospective 20 D-3 
2 hrs 
postoperative 
D2, D4, D7, D29 
Coulter 
Counter 
(Model ZF) 
Lowest lymphocyte count on 
D2 (median value one-third 
of preoperative value) 
D4 
 
Lennard 
et 
al.(Lenna
rd, 
Shenton 
et al. 
1985) 
 
 
1985 
 
Elective minor 
and major* 
 
Prospective 
 
35 
 
D0, D1, D3, D7, 
D14, D21 
 
Coulter 
Counter 
 
Minor - Lowest count D1 
Major - lowest count D3 
 
*Minor - D3 
*Major - D7 
Dietz et 
al.(Dietz, 
Heimlich 
et al. 
2000) 
2000 Primary head 
and neck SCC 
Prospective 33 D-1 
D1, D7, D21-28 
(all patients 
received steroids 
either on D0 (n=8) 
or for 3 days 
postoperatively 
(n=25) 
Not 
documented 
Lowest count D1 Mean count 
recovered by 
D28 
         
* Minor (general and vascular) and Major (general vascular, gynaecology and renal); SCC = squamous cell carcinoma; D-1 = 1 day before surgery; 
D0 = Day of surgery; D1 = 1 day following surgery etc.; No studies accounted for withdrawals or missed samples.
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The cause for postoperative decrease in lymphocyte count is unknown. Redistribution to 
lymphoreticular structures(Westermann and Bode 1999) or lymphatic tissues(Toft, Lillevang et al. 1993, 
Toft, Svendsen et al. 1993) may play a role in development of postoperative lymphopenia, together with 
the extent of tissue trauma, volume of blood loss,(Cullen and van Belle 1975, Dietz, Heimlich et al. 2000) 
and neurohumoral and hormonal changes, which may also affect lymphocyte mobilization. 
Redistribution has previously been hypothesised to occur with cortisol release during the stress 
response to surgery,(Hamid, Bancewicz et al. 1984)  however evidence supporting this hypothesis and 
mechanisms by which this occurs are lacking. 
 
Immunosuppressive factors such as inflammatory cytokines,(van der Poll and Lowry 1995, Biffl, Moore 
et al. 1996) prostaglandin E2(Grbic, Mannick et al. 1991) and nitric oxide(Jacob, Ochoa et al. 1993) 
adversely affect lymphocyte function which may be reflected in the decrease in numbers seen following 
major surgery. Following tissue trauma and injury, lymphocyte numbers and subset population 
alterations have been described in different lymphoid compartments but the mechanisms responsible 
for this remain unknown. The stress response to surgery which includes an increase in catecholamines 
and corticosteroid levels has been well described.(Desborough 2000) Cortisol results in a known shift in 
the leukocyte differential to a lower percentage of lymphocytes.(Thomson, McMahon et al. 1980) Since 
the adrenal axis is a sensitive feedback system for adverse physiological conditions, including post-
surgical response, changes in the relative lymphocyte count may be a simple, early marker of 
neurohumoral activation. Utilizing a large animal model, Yamada et al. associated plasma cortisol levels 
and lymphocyte apoptosis with surgical trauma in dogs undergoing anaesthesia alone versus 
anaesthesia and laparotomy. The development of lymphopenia was hypothesised to be secondary to 
cortisol induced apoptosis occurring following surgical trauma.(Yamada, Tsuchida et al. 2002)  
 
1.5 Causes of lymphopenia 
The total human T-lymphocyte pool size is approximately 3 x 1011 cells with an approximate turnover of 
3 x 109 cells per day.(Hellerstein, Hanley et al. 1999, Neese, Misell et al. 2002) Peripheral T cell 
populations are maintained by naïve T cells produced in the thymus, cellular self-renewal (or 
homeostatic proliferation) and clonal expansion of activated cells. Various experimental techniques 
have attempted to quantify the relative contributions of these processes, however interpretation of 
such data in terms of the underlying rates of T cell production, division, and death has proven to be 
notoriously difficult and involves mathematical modelling.(De Boer and Perelson 2013) By utilizing 
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deuterium (2H2O) in healthy human adults, the expected life span of naïve T cells have been estimated 
to be almost a decade,(Vrisekoop, den Braber et al. 2008) and are largely maintained by peripheral 
renewal, leaving a fairly minimal role of thymic production.(Bains, Antia et al. 2009, den Braber, 
Mugwagwa et al. 2012) Total memory T cell populations (CD45RO+) tend to be stable, but turnover 
much more rapidly than naïve T cell populations (CD45RO-CD27+), with expected life spans of 30 to 52 
weeks in humans.(Vrisekoop, den Braber et al. 2008) During normal homeostasis CD4+ T cells tend to be 
turning over more rapidly than CD8+ T cells, as demonstrated by the increased half-life of CD8+ 
cells.(Vrisekoop, den Braber et al. 2008, den Braber, Mugwagwa et al. 2012) The reason for the 
difference in turnover rates is unknown but is thought to be partly mediated by homeostatic cytokines, 
such as IL-7.(Puel, Ziegler et al. 1998) 
 
Lymphopenia has been defined as an absolute lymphocyte count more than two standard deviations 
below the mean for a healthy age and sex-matched population. The absolute and relative (percentage of 
total white cell count) lymphocyte counts which constitute lymphopenia vary between laboratories 
based on local populations but usually lie between 1.0-1.5 x 109/L and 15-22% respectively in most 
institutions.(Cancer Research UK website. 2015) Consequently the cut-off values used to define 
lymphopenia in most contemporary studies are usually found within this range.  
 
Established causes of lymphopenia (in the peripheral circulation) are summarised in Table 1.2. Absolute 
lymphocyte numbers within the circulation decrease following surgery, traumatic injury,(O'Mahony, 
Palder et al. 1984) acute illness requiring ICU admission(Feeney, Bryzman et al. 1995) and burns(Zapata-
Sirvent and Hansbrough 1993) Normal CD4:CD8 ratio is quoted between 0.9–1.9. These conditions are 
associated with a greater decrease in proportion of CD4+ lymphocytes compared to CD8+ lymphocytes, 
resulting in an overall decrease in CD4+: CD8+ ratio. While lymphopenia has been related to mortality as 
demonstrated in Table 1.3, correlation between lymphocyte function and postoperative outcome / 
phenotype in humans is lacking. 
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Table 1.2. Recognised causes of lymphopenia 
Cause of lymphopenia Examples 
Reduced production Infection (HTLV-1); bone marrow defects (idiopathic CD4 
lymphopenia) 
 
Increased apoptosis Surgery; infection (Mycobacteria, HIV); autoimmune (SLE – anti 
T-cell antibodies,); drugs (corticosteroids, chemotherapy, 
immunosuppressants; catecholamines); sepsis; cardiac failure; 
radiation  
 
Redistribution to lymphoid 
organs 
Catecholamines (surgery, sepsis, exercise)  
 
 
Failed homeostasis Infection (Influenza - T-reg suppression); autoimmune (RA) 
 
Idiopathic Autoimmune (Sjogren’s syndrome); non-Hodgkin’s lymphoma 
 
Exhaustion (reduced 
function) 
Infection (CMV, EBV); age 
 
HTLV = human T-lymphotropic virus; HIV = human immunodeficiency virus; SLE = systemic lupus 
erythematosus; T-reg = T regulatory cell; RA = rheumatoid arthritis; CMV=cytomegalovirus; EBV=Epstein 
Barr virus; *Malignancy can cause reduced production (if bone marrow infiltration occurs), 
redistribution and exhaustion  
 
1.6 Association between lymphopenia and mortality 
Lymphopenia is associated with increased mortality in patients with trauma,(Cheadle, Pemberton et al. 
1993) cancer,(Fogar, Sperti et al. 2006, Ray-Coquard, Cropet et al. 2009, Vicente Conesa, Garcia-
Martinez et al. 2012, Zhang, Huang et al. 2013) and sepsis.(Boomer, To et al. 2011) Failure to normalise 
lymphopenia has also been associated with increased mortality following trauma.(Heffernan, Monaghan 
et al. 2012) Lymphopenia, utilising a cut-off absolute lymphocyte count value ranging from 1.0-1.5 x 
109/L,(Fogar, Sperti et al. 2006, Clark, Connor et al. 2007{Kozak, 2015 #1656, Bhatti, Peacock et al. 2010, 
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Ozturk, Ozkan et al. 2010, Bhaskar and Parker 2011, Lomivorotov, Efremov et al. 2011, Laulund, 
Lauritzen et al. 2012, Vicente Conesa, Garcia-Martinez et al. 2012)} has also been associated with 
increased postoperative mortality following cancer and non-cancer surgery (Table 1.3).  
 
1.7 Association between lymphopenia and morbidity 
Lymphopenia is a common finding within the hospital environment. A prospective study involving over 
1000 patients over a 3 month period within a single Australian institution identified that lymphopenia in 
hospital patients was most frequently reversible, and due to acute illness, notably surgery, sepsis and 
trauma. Malignancy, with or without chemotherapy, and steroid use were also found to be common 
causes.(Castelino, McNair et al. 1997) This study must be interpreted with caution however as it utilised 
an extremely low lymphocyte cut-off value of <0.6 x 109/L to define lymphopenia, which was not 
referenced in their study. The authors state that this value was used due to the practical reason that a 
very large number of patients had absolute lymphocyte counts either less than the more commonly 
quoted “normal” lymphocyte values between 1.0 x 109/L to 1.5 x 109/L. 
 
Although lymphopenia has been associated with delayed wound healing following hip surgery,(Pacheco-
Haro and Chavez-Cadena 2012) few human studies thus far have prospectively examined the association 
between lymphopenia and postoperative morbidity or postoperative length of hospital stay. 
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Table 1.3. Summary of studies demonstrating worse survival with preoperative lymphopenia 
 
Author, 
Year 
Study design Surgery N Lymphopenia 
definition 
(x 109/L) 
Association with lymphopenia 
Laulund 
2012 
Pooled data  
(3 observational 
studies) 
Hip fracture 1689 <1.4 (Bhaskar) 
<1.5 (Koval) 
<1.0 (Ho) 
Increased mortality OR 2.60 (95% CI = 1.61-4.20) 
 
Lomivorotov 
2011 
 
Retrospective 
observational 
 
Adult cardiac 
 
1368 
 
<1.5 
 
Increased mortality (univariate OR, 3.53; CI, 1.98-6.28; multivariate OR, 2.06; 
CI, 1.02-4.15) 
 
Bhaskar 
2011 
Prospective 
observational 
 
Hip fracture 791 ≤1.1 Increased 1 year mortality; 142/428 (33.2%) vs. 67/363 (18.5%); OR 1.79 
 
Ozturk 
2010 
Prospective 
observational 
 
Hip fracture 74 <1.5 Increased 1 year mortality; multivariate analysis*  
Bhatti 
2010 
Retrospective 
observational 
Pancreatic 
cancer 
 
84 N/A Lymphocyte count was a prognostic covariate; hazard ratio 1.56 (95% 
CI=1.02–2.39) 
Kozak 
2015 
Retrospective Colorectal 
cancer 
129 <1.0 Worse overall survival (date of surgery to the date of death from any cause; 
multivariate analysis; HR, 0.34; 95% CI, 0.162-0.724) 
 
Clark 
2007 
Retrospective 
observational 
Pancreatic 
cancer 
44 <1.5 Worse survival; 8.8 [5.3–13.3] months versus 15.0 [10.0–28.3] months and 
multivariate analysis 
* multivariate analysis also demonstrated that ASA score (III or IV), female gender and low haemoglobin levels on admission remained independent and 
significant risk factors associated with one-year mortality.
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1.8 Lymphopenia - A mediator rather than a marker of increased mortality?  
Inhibition of lymphocyte apoptosis utilizing a caspase-3-inhibitor has been shown to improve mortality 
in mice with sepsis.(Hotchkiss, Chang et al. 2000) The findings from this study highlight a potential 
mechanistic role for lymphocytes contributing to mortality secondary to infection. This therefore 
introduces the potential significance of lymphocytes in the development of postoperative morbidity and 
mortality. Other mutant lymphocyte models have also been explored which further support the concept 
of lymphocytes mediating survival outcomes. 
 
Rag-1 (-/-) mice, which are completely deficient of mature B and T lymphocytes, demonstrate a 5-fold 
augmentation in gut epithelial apoptosis following caecal ligation and puncture (CLP) compared to WT 
mice. Reconstitution of lymphocytes in Rag-1 (-/-) mice via adoptive transfer also decreases intestinal 
apoptosis to levels similar to those seen in WT animals. Subset analysis indicates that CD4(+) but not 
CD8(+), are responsible for the anti-apoptotic effect of lymphocytes on the gut epithelium. Gut-specific 
overexpression of Bcl-2 in transgenic mice decreases mortality following CLP. This survival benefit is 
lymphocyte dependent since gut-specific overexpression of Bcl-2 fails to alter survival when the 
transgene is overexpressed in Rag-1(-/-) mice. Further, adoptively transferring lymphocytes to Rag-1(-/-) 
mice that simultaneously overexpress gut-specific Bcl-2 results in improved mortality following sepsis. 
Thus, sepsis appears to unmask CD4(+) lymphocyte control of gut apoptosis that is not present under 
homeostatic conditions, which acts as a key determinant of both cellular survival and host 
mortality.(Stromberg, Woolsey et al. 2009) 
 
Results from murine studies must however be interpreted with some caution. Mice are considered to be 
the experimental tool of choice for many immunologists. Study of their immune responses has yielded 
great insight into the human immune system function, however fundamental differences exist between 
murine and human immune systems. Known discrepancies between humans and mice have been 
described in innate and adaptive immunity, including: leukocyte subset balance, Toll like receptors (TLR), 
inducible nitric oxide (NO) synthase, B cell and T cell signalling pathway components, cytokines and 
cytokine receptors, Th1/Th2 differentiation (the two functionally distinct subsets of mature T-helper 
cells), co-stimulatory molecule expression and function, and chemokine and chemokine receptor 
expression.(Mestas and Hughes 2004) The acute inflammatory stresses from different aetiologies may 
result in highly similar genomic responses in humans, however the responses in corresponding mouse 
models correlate poorly with human conditions and also, one another.(Seok, Warren et al. 2013) 
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Whether findings from Hotchkiss et al. reflect the importance of human lymphocyte number and 
function in preventing postoperative, or sepsis related morbidity and mortality, remains unclear. Altered 
cell surface expression of splenic CD4+ and CD8+ cells in patients dying from sepsis (Boomer, To et al. 
2011) together with altered cytokine production in this population provide further supporting evidence 
to the hypothesis that lymphocytes play an important role in human sepsis and development of multiple 
organ failure. However it is difficult to ascertain from studies whether they are markers or mediators of 
poor outcomes in humans.   
 
1.9 Neutrophil to lymphocyte ratio (NLR) and survival outcomes 
High neutrophil to lymphocyte ratio (NLR)(Gibson, Croal et al. 2007, Bhutta, Agha et al. 2011, Kao, Klebe 
et al. 2011, Chen, Lin et al. 2012, Tomita, Shimizu et al. 2012, Vaughan-Shaw, Rees et al. 2012, Azab, 
Shah et al. 2013) has been described as a biological marker of subclinical inflammation associated with 
increased postoperative mortality. Raised serum NLR also predicts overall survival in patients with 
cancer.(Walsh, Cook et al. 2005, Gomez, Farid et al. 2008, Halazun, Aldoori et al. 2008, Sarraf, Belcher et 
al. 2009, Bhatti, Peacock et al. 2010, Shimada, Takiguchi et al. 2010, Dan, Zhang et al. 2013, Krane, 
Richards et al. 2013) Significantly higher NLR has also been associated with stage of colorectal 
cancer.(Satomi, Murakami et al. 1995) The majority of studies tend to utilise NLR > 5 as a cut-off value to 
define raised NLR(Walsh, Cook et al. 2005, Gomez, Farid et al. 2008, Halazun, Aldoori et al. 2008, Bhutta, 
Agha et al. 2011, Ayca, Akin et al. 2014) since this provides an index of normal laboratory values of 
neutrophil and lymphocyte counts as originally proposed by Zahorec et al.(Zahorec 2001) 
 
1.10 Cardiovascular disease and the immune system 
Chronic inflammation is a basic pathological mechanism that underlies various diseases including cardiac 
failure. The contribution of lymphocytes has been reported in this process.(Fujiu and Nagai 2013)  
 
Relative lymphopenia is an independent risk factor for development of coronary artery disease in 
asymptomatic patients.(Sweetnam, Thomas et al. 1997) Even after correction for New York Heart 
Association (NYHA) class and peak oxygen consumption, relative lymphopenia (low lymphocyte 
percentage as a proportion of total leukocyte count) is an independent predictor of one and 4 year 
survival rates in patients with advanced heart failure.(Ommen, Hodge et al. 1998) Similarly, relative 
lymphopenia has been associated with worse survival in patients with chronic coronary artery 
disease,(Ommen, Gibbons et al. 1997) acute heart failure(Rudiger, Burckhardt et al. 2006) and elderly 
patients with congestive cardiac failure.(Acanfora, Gheorghiade et al. 2001) Cardiac failure is strongly 
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associated with increased postoperative mortality in patients undergoing major non-cardiac 
surgery.(Hernandez, Whellan et al. 2004)  
 
NLR has also been reported as an independent predictor of outcome in stable coronary artery disease, 
as well as a predictor of short- and long-term mortality in patients with acute coronary 
syndromes.(Tamhane, Aneja et al. 2008, Ayca, Akin et al. 2014) It is linked with increased risk of 
ventricular arrhythmias during percutaneous coronary intervention (PCI) and higher long-term mortality 
in patients undergoing PCI irrespective of indication for procedure.(Bhat, Teli et al. 2013) NLR has also 
been reported as a prognostic marker for outcome following coronary artery bypass grafting(Gibson, 
Croal et al. 2007) and post coronary artery bypass graft associated atrial fibrillation.(Bhat, Teli et al. 
2013) Additionally, NLR may be used as a simple and easy-to-measure marker for prediction of short-
term prognosis and in-hospital mortality in patients with ischaemic and haemorrhagic stroke.(Gokhan, 
Ozhasenekler et al. 2013) In patients admitted with advanced heart failure, a high NLR is associated with 
greater inpatient mortality(Bhat, Teli et al. 2013) and NLR has also been associated with the severity of 
chronic heart failure.(Avci, Alizade et al. 2014) The relationship between NLR and cardiac failure, as 
defined by low anaerobic threshold determined by cardiopulmonary exercise testing, has not been 
previously explored as a potential mechanism for poorer outcomes in this population.   
 
1.11 Association between lymphopenia and heart failure 
Epidemiological studies demonstrate that occult heart failure (Hernandez, Whellan et al. 2004, Hammill, 
Curtis et al. 2008) and low anaerobic threshold (AT) measured by cardiopulmonary exercise testing 
(CPET) which is consistent with sub-clinical heart failure,(Older, Smith et al. 1993, Wilson, Davies et al. 
2010) contribute to morbidity and mortality following non-cardiac surgery. Since original work 
undertaken by Older et al. poor exercise capacity in surgical patients, as measured objectively by 
preoperative CPET,(Lee, Chaloner et al. 2006, Murray, Whiting et al. 2007, Ausania, Snowden et al. 2012, 
Colson, Baglin et al. 2012, Hartley, Pichel et al. 2012, Junejo, Mason et al. 2012, Swart and Carlisle 2012) 
has repeatedly been associated with poorer postoperative outcomes, including infection, following 
surgery.(Wilson, Davies et al. 2010) 
 
While immune cells can have protective effects to compensate for and overcome mechanical stressors 
(such as volume / pressure overload), hypoxia, and neurohumoral stimulation, they also contribute to 
sustained inflammation and development of cardiac failure and poor aerobic capacity.(Topkara, Evans et 
al. 2011) Cardiac failure is now being associated with neurohormonal activation and chronic systemic 
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inflammation.(Topkara, Evans et al. 2011) These are characterised by alterations in numbers, and 
function, of polymorphonuclear monocytes and T-cells.(Topkara, Evans et al. 2011) The immune 
component of heart failure is also demonstrated when innate immune signalling genes are analysed by a 
complex statistical analysis known as principal component analysis (PCA). The profiles differ depending 
on the nature of the pathological tissue injury pattern. For example there are distinct genetic expression 
profiles for innate immune genes in failing and non-failing hearts.(Mann, Topkara et al. 2010). Increasing 
severity of heart failure is associated with increased levels of circulating cytokine,(Rauchhaus, Koloczek 
et al. 2000) protein,(Frantz, Fraccarollo et al. 2003) endotoxin,(Niebauer, Volk et al. 1999), and 
lymphopenia.(von Haehling, Schefold et al. 2009, Nunez, Minana et al. 2011, Vaduganathan, Ambrosy et 
al. 2012)  
 
The relationship between inflammation and postoperative outcome has been described previously. For 
example, patients with reduced levels of antibodies to endotoxin preoperatively, exhibit higher levels of 
proinflammatory cytokines and more perioperative morbidity.(Bennett-Guerrero, Ayuso et al. 1997, 
Bennett-Guerrero, Panah et al. 2001) The relationship between cardiomyocytes and inflammatory cells 
residing in or recruited to the heart,(LaFramboise, Scalise et al. 2007, Pedrotty, Klinger et al. 2009) and 
immune function is becoming an increasingly important target by researchers attempting to reduce 
mortality from cardiac failure.  
 
While many patients with low AT demonstrate physiological parameters consistent with heart failure, 
few of these patients have a formal diagnosis of cardiac failure prior to surgery. (Weber, Kinasewitz et al. 
1982, Weber, Janicki et al. 1987, Sullivan and Cobb 1990, Gitt, Wasserman et al. 2002)  Mechanisms 
exploring why patients with heart failure have poorer postoperative outcomes are underexplored. 
Cardiac failure(Torre-Amione 2005) and malignancy(Proctor, McMillan et al. 2012) are associated with 
immunosuppression and chronic low-grade systemic inflammation, as indicated by readily available 
biomarkers such as lymphopenia and raised NLR. These inflammatory biomarkers appear to robustly 
predict an increased risk of morbidity following colorectal surgery.(Richards, Roxburgh et al. 2012) As 
previously highlighted preoperative NLR, in addition to absolute and relative lymphopenia have been 
independently associated with the development of complications following major surgery.(Proctor, 
McMillan et al. 2012) Thus, understanding the mechanisms that contribute to established preoperative 
inflammation may identify modifiable factors that enable reductions in postoperative 
morbidity(Davenport, Henderson et al. 2005) and hence improve longer-term outcomes.(Longo, Virgo et 
al. 2000, Khuri, Henderson et al. 2005) Accumulating evidence suggests that the cardiovascular and 
   
32 
 
immune systems work synergistically together with other organ systems. Chronic inflammation may 
result in impaired immune and cardiac function, thus increasing susceptibility to infection, 
complications, morbidity and mortality postoperatively. 
 
For purposes of this thesis, sub-clinical heart failure is defined either as an asymptomatic patient with 
AT<11mL/kg/min or a patient with AT <11mL/kg/min without a formal diagnosis of heart failure. The 
high-risk preoperative patient is routinely phenotyped through routine investigations including full blood 
count, (identifying lymphopenia and high NLR); and in some centres, CPET (identifying low AT). The link 
between lymphopenia and low AT has not previously been explored. Worse outcomes in patients with 
low AT may be associated with presence of lymphopenia. The fact that lymphopenic, or “high risk” 
patients demonstrate worse survival following cancer and non-cancer surgery (Table 1.3) may be related 
to a greater prevalence of heart failure (low AT) in this patient cohort.  
 
1.12. Bioenergetic function in lymphocytes - murine / cell line studies 
Bioenergetics refers to metabolic processes resulting in production and utilization of ATP (adenosine 
triphosphate). T cell metabolism is intimately linked to T cell survival, function and 
differentiation.(Gerriets and Rathmell 2012) Cells generate ATP by glycolysis and by oxidative 
phosphorylation.(Jones and Thompson 2007, Vander Heiden, Cantley et al. 2009) Impaired 
mitochondrial function, reduced ATP production, increased oxidative stress and T cell necrosis have 
been identified as key contributors to the development of inflammation in patients diagnosed with 
systemic lupus erythematosus.(Gergely, Grossman et al. 2002, Doherty, Oaks et al. 2014) Morbidity 
secondary to sepsis and trauma has a bioenergetic component. Whether a similar inflammatory pattern 
occurs postoperatively resulting in lymphocyte bioenergetic dysfunction, apoptosis and patient 
morbidity remains unclear.  
 
Buttgereit et al. described a hierarchy of energy-consuming processes within activated rat thymocytes 
which become affected in the face of impaired energy production.(Buttgereit, Burmester et al. 2000) 
The largest consumer of energy is calcium transport followed by Na+K+ATPase pump (sodium active 
transport) and macromolecule synthesis including proteins and DNA / RNA. Key functions that are 
adversely affected by inadequate energy production by lymphocytes are summarised in table 1.4. 
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Table 1.4. Key lymphocyte functions requiring ATP 
 
 Functions requiring ATP in lymphocytes 
Cytokine production Antigen processing 
Cell motility Lymphocyte activation 
Cell division Antibody production 
Antigen presentation Cytotoxicity 
 
Unlike tumours, T cells rapidly transition between resting catabolic states (naïve and memory T cells) to 
one of growth and proliferation (effector T cells) as part of normal development. In addition, as T cells 
differentiate during an immune response they also move from what are presumably nutrient-replete 
lymphoid organs to sites of cancer or infection, where oxygen, nutrients, and growth factors may 
become limiting.(Pearce, Poffenberger et al. 2013) Changes in peripheral T cell function are not only 
supported by but are dependent on metabolic reprogramming, and specific effector functions are 
dependent upon adoption of the correct metabolism.(Pearce, Poffenberger et al. 2013) During each 
stage of a T cell's life, whether it is naïve, activated, antigen-experienced, or anergic, for optimal 
function, metabolism must match the function of that particular T cell.  
 
Mitochondrial ATP production is fuelled in murine naïve and memory (quiescent) lymphocytes by 
external glucose, amino acids and lipids or breakdown from intracellular components during 
autophagy.(Pearce 2010). In quiescent lymphocytes ATP is mainly used to drive protein synthesis and 
cation transport.  
 
1.13 T cell activation and metabolism 
In the two-signal model(Baxter and Hodgkin 2002), full T cell activation occurs when there is: 
1) Binding of MHC-II associated antigen on antigen presenting cells (APCs) to the T-cell receptor (TCR) - 
CD3 complex.  
2) A co-stimulatory signal provided by B7-1 (CD80) or B7-2 (CD86) binding on APC to the T-cell CD28 
receptor, or by Interleukin-2 (IL-2) ligation.(Zheng, Delgoffe et al. 2009)   
 
The T cell receptor (TCR, molecule found on the surface of T lymphocytes that is responsible for 
recognising antigens bound to major histocompatibility complex (MHC) molecules) signal is amplified 
through a protein tyrosine kinase cascade, involving a rise in intracellular calcium and activation of 
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protein kinase C (PKC). The subsequent activation of transcription factors leads to phospholipid 
turnover, ionic signals, alteration in cytoskeleton, gene transcription and the final increase of 
macromolecule synthesis. These processes result in cytokine synthesis and movement of the cell from 
G0 to G1 in the cell cycle. These processes require a rapid increase in cellular metabolism. Increased 
metabolism is a critical part of activation because if T cells fail to increase glucose metabolism due to 
inadequate nutrients or direct metabolic inhibition, activation and proliferation are suppressed.(Cham 
and Gajewski 2005, Jacobs, Herman et al. 2008, Shi, Wang et al. 2011) Furthermore increased glucose 
uptake can enhance T cell activation and proliferation.(Jacobs, Herman et al. 2008)  
 
Most cells metabolise glucose to pyruvate via glycolysis and then oxidize pyruvate to carbon dioxide 
(CO2) in the mitochondria, generating the large majority of their ATP through oxidative phosphorylation. 
To fuel the energetic and biosynthetic demands of rapid clonal expansion, activated T cells, even in the 
presence of adequate oxygen, generate a significant proportion of ATP by upregulation of glucose 
uptake and glycolysis.(Fox, Hammerman et al. 2005, Jones and Thompson 2007, Maciver, Jacobs et al. 
2008) Lymphocytes activated in vitro preferentially convert pyruvate into lactate that is secreted from 
the cells rather than oxidize pyruvate in the mitochondria.(Vander Heiden, Cantley et al. 2009) This 
process, known as aerobic glycolysis, yields only 2 ATP per molecule of glucose, compared to a maximum 
of 36 ATP when glycolysis is coupled to oxidative phosphorylation (Figures 1.1 and 1.2 summarise ATP 
production and oxidative phosphorylation).  
 
While it seems counterintuitive for cells to employ a low-efficiency pathway to produce ATP under 
conditions of high energy demand, it has been proposed that proliferating and rapidly growing cells 
preferentially utilise aerobic glycolysis to optimise ribose-5-phosphate and NADPH, needed for the 
synthesis of macromolecules during cell division, and the reducing equivalents needed to protect 
dividing cells from oxidative damage.(Brand and Hermfisse 1997, Vaughn and Deshmukh 2008, Vander 
Heiden, Cantley et al. 2009)  
 
Individual complexes within the electron transport chain (ETC) can be inhibited in order to identify and 
compare changes in oxygen consumption rate (OCR- a marker of oxidative phosphorylation) and 
extracellular acidification rate (ECAR - a marker of glycolysis). By interrogating perioperative changes in 
lymphocyte metabolic profiles using extracellular flux analysis, the presence of ETC dysfunction (and 
individual ETC complex dysfunction) may be identified, which may account for perioperative 
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lymphopenia and ultimately postoperative morbidity. Detailed methodology of this technique, including 
the drugs utilised to inhibit ETC complexes, are summarised in Chapter 2.6. 
 
1.14 Lymphocyte bioenergetic function and postoperative morbidity 
Postoperative metabolic impairment may predispose lymphocytes to apoptosis, which may result in the 
acquired lymphopenia / decrease in lymphocyte count demonstrated following surgery (Table 1.1). Since 
lymphocytes play a vital role in defence against infection,(Hotchkiss, Chang et al. 2000) postoperative 
reduction in lymphocyte count secondary to metabolic impairment and apoptosis, may contribute to the 
increased risk of infectious complications which is known to occur following surgery. 
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Figure 1.1 ATP production in relation to glycolysis, Krebs cycle and oxidative phosphorylation 
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Figure 1.2 ATP production by oxidative phosphorylation within the electron transport chain 
 
 
Electron transport depicted by red line.  
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1.15 Anergy 
Anergy can be defined as unresponsiveness to antigenic stimulation leading to decreased 
cytokine production, glycolytic and mitochondrial ATP production and proliferation. If the TCR 
signal is received without CD28 co-stimulation, the T-cell becomes anergic, with a reduction in 
glucose metabolism.(Zheng, Delgoffe et al. 2009) This may be due to a lack of B7-CD28 binding 
(e.g. due to anti-B7 antibody), or to binding of B7 to inhibitory receptors such as cytotoxic T-
lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PCD 1) or B and T lymphocyte 
attenuator (BTLA). (Chen 2004)  
 
Although anergic lymphocytes are maintained in vivo, their precise role remains 
unclear.(Walker and Abbas 2002) Postoperative anergy has previously been described in 
peripheral blood mononuclear cells,(Faist, Baue et al. 1983, Haupt, Riese et al. 1998) and an 
excess of anergic T-cells seen in situations of physiological stress such as trauma has been 
associated with poorer outcomes.(Bandyopadhyay, De et al. 2007)  
 
Defects in cellular energy production of alloreactive T cells have been shown to both reduce 
lymphocyte function and induce apoptosis resulting in lymphopenia.(Gatza, Wahl et al. 2011) 
Lymphocytes from lymphopenic patients have an increased propensity to apoptosis and 
reduced ATP content. Little is however known about the metabolic adaptations that occur in 
vivo to meet the increased demand for ATP in activated and proliferating lymphocytes in the 
postoperative state. Bioenergetic changes following anaesthesia and surgery, preceding 
exposure to various T-cell stimuli, may therefore be a cause of postoperative lymphocyte 
dysfunction, apoptosis and subsequent increased hospital length of stay. Study of 
perioperative changes in lymphocyte bioenergetic function may help to explain why 
lymphocyte counts drop following surgery. 
 
1.16 Cytokine production by lymphocytes  
Cytokines are low molecular weight proteins (<80kDa), which play a central role in the 
homeostasis of the immune system. Cytokine secretion and receptor expression on cellular 
membranes or in soluble forms, coordinate the immune response by inducing activation 
and/or inhibition of naive, memory and effector cells. Lymphocytes are an important source of 
cytokines (lymphokines) and play a significant role in mediating immunity and inflammation 
following tissue injury.(Sheeran and Hall 1997) Cytokines generally only require picomolar 
concentrations that act on target cell surface receptors and ultimately influence protein 
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synthesis within the cell. Most cytokines are synthesised as they are required and not stored. 
Some cytokines are however pre-synthesised and stored in cytoplasmic granules.(Gordon and 
Galli 1991)  
 
1.17 Classification of lymphokines 
According to the profile of cytokine synthesis, T cells can be subdivided into two functionally 
distinct subsets of mature TH cells: TH1 and TH2. TH1 cells are characterised by their regulation 
of cell-mediated immunity and the secretion of interleukin-2 (IL-2), interferon gamma (IFN-γ) 
and tumour necrosis factor-alpha (TNF-α). These cytokines are microbicidal and act on 
intracellular pathogens. In contrast, the TH2 subset is important for humoral immunity, B-cell 
proliferation and the production of most antibodies through IL-4-6, IL-I0, and IL- 13.(Mosmann 
and Coffman 1989) TH2 cell cytokines mainly act extracellularly, and suppress the TH1 
response. Table 1.5 summarises TH1 cytokine function. 
 
Table 1.5 Summary of TH1 cytokine function 
Lymphokine Cellular effects 
Interleukin-2 
(IL-2) 
The major pleiotropic cytokine produced by stimulated CD4+ T cells. 
Stimulates T cell growth, promotes T helper cell activity, NK cytolytic activity, 
augments cytotoxicity. Stimulates B cell and T reg differentiation by activating 
STAT proteins through phosphorylation of JAK1 and JAK3, depending on the 
cytokine milieu after antigen stimulation. Mediates activation induced cell death.  
Modulates expression of key cytokine receptors controlling responsiveness to a 
range of cytokines following antigen encounter.  
 
TNF-Alpha 
(TNF-α) 
Found within endosomes and lysosomes and protects against organisms that 
infect macrophages. Can also be stored as membrane proteins, which provides an 
immediate cytokine source during tissue injury. (Massague and Pandiella 1993) 
Stimulates neutrophil and macrophage activity, inhibits collagen synthesis by 
fibroblasts, inhibits endothelial cell proliferation, stimulates fibroblast 
proliferation. Cytotoxic for tumour cells and is inhibited by IL-10. 
 
Interferon-
Gamma 
(IFN-γ) 
Stimulates macrophage activity and B cell differentiation, stimulates and inhibits 
fibroblast proliferation, inhibits collagen production and collagen cross-linking, 
inhibits endothelial cell proliferation, increases endothelial cell adhesiveness for 
lymphocytes. Defence against microorganisms that establish intracellular 
infections including listeria, monocytogenes, leishmania, viruses and pathogenic 
inflammatory diseases. IFN-γ limits outgrowth of IL-4 producing T cells. 
JAK = Janus kinase pathways; STAT = Signal Transducers and Activators of Transcription 
Perioperative changes in cytokine expression and intracellular expression within lymphocytes 
may help further our understanding of cytokine production in sepsis.  
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1.18 Cytokine production in sepsis and surgery 
Perioperative patterns of cytokine production may provide valuable insight into lymphokine 
production associated with sepsis. The importance of cytokine detection method and cytokine 
production site interrogated is demonstrated in the sepsis literature. While IFN-γ and TNF-α 
production have been shown to decrease in splenocytes when stimulated in vitro from 
patients who die from sepsis,(Boomer, To et al. 2011) higher serum TNF-α,(Calandra, 
Baumgartner et al. 1990, Kothari, Bogra et al. 2013) and IL-2,(Balc, Sungurtekin et al. 2003) 
cytokine levels have been associated with increased severity of sepsis. Furthermore the 
severity of sepsis or stage of illness may have profound effects on levels of cytokine 
production, however conflicting evidence exists. For example, Boomer et al. described a 
decrease in TNF-α production from splenocytes stimulated in vitro in patients who died from 
sepsis,(Boomer, To et al. 2011) however preserved secretion of TNF-α was described in acutely 
septic patients.(Boomer, Shuherk-Shaffer et al. 2012) Authors attributed these differences to 
demographic heterogeneity between the studies. Hence a standardised surgical model 
inducing lymphopenia, could aid our understanding of lymphokine production by potentially 
offering mechanistic insight and addressing the discrepancies seen in many sepsis studies. 
 
1.19 Hypotheses 
In this thesis, I hypothesise that: 
1) Preoperative lymphopenia is associated with increased postoperative morbidity and  
and reduced exercise capacity. 
2) Lymphocytes have impaired metabolism and functionality postoperatively (increased  
oxidative stress and altered cytokine production) resulting in increased apoptosis, and  
reduced lymphocyte count. 
3) Postoperative changes in lymphocyte metabolism are driven by activation of the  
inflammasome (Chapter 7), secondary to increased glucocorticoid levels released  
during the stress response to surgery.  
A summary of the hypotheses explored in this thesis is presented in Figure 1.3. 
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1.20 Aims 
I aim to demonstrate the association between lymphopenia and postoperative morbidity. I also 
aim to demonstrate that the postoperative decrease in lymphocyte count occurs secondary to 
altered metabolic function and apoptosis, predisposing patients to infectious complications. 
 
Ultimately this work will contribute further to our understanding of how surgery affects 
lymphocytes, immunity and patient outcomes.    
 
1.21 Objectives 
1) The association between impaired exercise capacity and lymphopenia will be explored 
by utilising preoperative cardiopulmonary exercise and leucocyte data in patients undergoing 
major colorectal surgery.  
2) The relationship between preoperative lymphopenia and postoperative morbidity will 
be explored in 2 separate patient cohorts: major colorectal and mixed adult surgical 
population. Morbidity will be assessed utilising hospital length of stay in both cohorts, a 
validated postoperative morbidity scoring tool in the mixed adult surgical population and 
diagnosis of sepsis (≥2 systemic inflammatory response syndrome criteria and presence of 
positive culture) in the colorectal cohort. 
3) The effects of surgery on metabolic function of lymphocytes will be assessed pre- and 
postoperatively using paired patient samples (pre vs. postoperative) of isolated lymphocytes 
interrogated with extracellular flux analysis. 
4) The effects of surgery on lymphocyte function will be assessed in paired (pre vs. 
postoperative) patient samples using flow cytometry assays exploring mitochondrial function 
(reactive oxygen species production and mitochondrial membrane potential) and lymphocyte 
cytokine production. 
5) Whether postoperative activation of an inflammatory pathway (inflammasome) occurs 
secondary to glucocorticoid, which account for postoperative changes seen in lymphocytes will 
be explored utilising flow cytometry and western blot analysis. Activated caspase 1 and 
Interleukin-1-beta expression (demonstrating inflammasome activation) will be assessed in 
lymphocytes incubated with a physiological concentration of glucocorticoid. 
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Figure 1.3. Summary of thesis hypothesis 
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Chapter 2   
General Methods  
2.1 Study Cohorts 
The different studies utilised for clinical data analysis and blood sampling for laboratory experiments in 
this thesis are outlined in Table 2.1.  
 
Table 2.1 Clinical studies utilised to obtain samples in this thesis 
 Lymphopenia and AT 
length of stay. 
Perioperative changes 
in lymphocyte count 
(Chapter 3) 
Perioperative 
changes in 
bioenergetic 
function 
(Chapter 4) 
Lymphopenia and length of 
stay and complications 
(Chapter 3). Perioperative 
changes in mitochondrial 
membrane potential, mROS 
production and cytokine 
production, (Chapters 5 and 6) 
Study Name COMPETE-C 
 
POM-E VISION-UK 
 
Ethics 
Reference 
 
MREC 08/H0203/159 
 ISRCTN 14680495 
 
 
MREC 09-H0805-59 
ISRCT N90019424 
 
MREC 10/WNo03/25 
ISCTN NCT00512109 
 
Study site 
 
Derriford Hospital, 
Plymouth 
 
 
University College 
Hospital, London 
 
Multi-centre (University College 
Hospital, London) 
 
Study date 
 
03/2009 – 04/2010 
 
 
04/2010 – 08/2014 
 
09/2011 – 08/2013 
 
Study cohort 
 
Elective major 
colorectal  
 
Elective hip and 
knee arthroplasty 
aged > 50 years old 
 
 
Elective non-cardiac surgery. 
Overnight stay >45 years old 
 
COMPETE-C = Cardiac Output Monitoring & Preoperative Exercise TEsting for Colorectal surgery; POM-
E = Post-Operative Morbidity Exercise; AT = anaerobic threshold; VISION-UK = Vascular events In non-
cardiac Surgery patIents cOhort evaluation; mROS = mitochondrial reactive oxygen species.  
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Two studies were utilised to analyse perioperative morbidity data (COMPETE-C and VISION-UK), 1 
study was utilised to analyse perioperative trends in lymphocyte count (COMPETE-C) and 2 clinical 
studies were utilised to obtain blood samples for laboratory experiments (COMPETE-C and VISION-UK).  
 
2.2 Summary of study cohorts used in thesis 
a) Cardiac Output Monitoring & Pre-operative Exercise TEsting for Colorectal surgery (COMPETE-C) 
(Challand, Struthers et al. 2012)    
 
Study type: Double-blind stratified randomised controlled trial 
 
Ethics: This was approved by the Cornwall and Plymouth Research Ethics Committee (Ref: 
08/H0203/159) and conducted at Derriford Hospital, Plymouth, UK, between March 2009 and April 
2010 (UK NIHR CRN 7285, ISRCTN 14680495). Patients were provided with written information at the 
time of CPET and invited to consider their participation. Written informed consent was obtained from 
all participants before randomization. Serious adverse events were reported to the Ethical Committee. 
 
Inclusion criteria: All adult patients undergoing major colorectal surgery at Derriford Hospital 
 
Exclusion criteria: Individuals whose oxygen consumption at anaerobic threshold (AT) was 
undetectable or measured <8.0 mL/kg/min (considered too unfit to randomise) were excluded, as 
were those where cardiopulmonary exercise testing (CPET) was not performed. 
 
Methods: This study aimed to compare intra-operative goal directed fluid therapy (GDT) to standard of 
care and determine the effects of GDT on length of stay, critical care admission, mortality, and hospital 
readmission rates.  
 
Patients attended preoperative clinic for assessment. Demographics and Revised Cardiac Risk Index 
(RCRI) scores were recorded. In brief this scoring tool awards 1 mark for each of the following: high risk 
surgery; history of ischaemic heart disease; history of congestive cardiac failure; history of 
cerebrovascular disease; preoperative insulin requirement; serum creatinine >177mmol/l).(Lee, 
Marcantonio et al. 1999) A score ≥ 3 is considered high risk of perioperative cardiac event. Blood tests 
were taken in all patients preoperatively and depending on clinical need postoperatively. 
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Patients completed symptom-limited maximal CPET as part of their routine preoperative assessment 
on a stationary ergometer (Zan, nSpire, Colorado, USA). AT, measured in oxygen consumption relative 
to body mass (mL/kg/min) was used as the marker of aerobic fitness and determined according to 
published guidelines.(2003) 
 
The majority of patients were admitted to hospital on the day of surgery. Bowel preparation was 
discouraged; those patients receiving bowel preparation were admitted for an intravenous (iv) infusion 
of 1–2 litres of Hartmann’s solution in the 12 hours preceding their arrival in the operating theatre, 
according to the hospital protocol.(Sanders, Mercer et al. 2001) All patients received general 
anaesthesia, the conduct of which was left to the discretion of the consultant anaesthetist. 
Supplementary thoracic epidural anaesthesia was generally used for open procedures and intrathecal 
diamorphine with local anaesthetic or local anaesthetic field blocks were used for laparoscopic 
procedures. Intraoperative crystalloid, colloid, blood products, and inotropes/vasopressors were 
administered by the anaesthetist based on estimated maintenance fluid requirements, intraoperative 
losses, and the measurement of standard haemodynamic variables—aiming for a maintenance rate of 
10 mL/kg/hr Hartmann’s solution. Invasive arterial and central venous pressure monitoring was 
undertaken in selected patients. 
 
Patients were risk-stratified as aerobically unfit (anaerobic threshold 8.0 – 10.9 mL/kg/min) or 
aerobically fit (AT ≥ 11.0 mL/kg/min) and within these strata were allocated to the intervention, goal 
directed therapy or standard fluid management (control) groups by random block allocation using 
sequentially numbered opaque sealed envelopes. The investigator had no involvement in perioperative 
decision-making or postoperative care. A researcher blinded to group allocation recorded 
postoperative outcomes. Adverse events were monitored by the local Research and Development 
service. A medically qualified investigator inserted an oesophageal doppler probe (CardioQTM, Deltex 
Medical, Chichester, UK) immediately after induction of anaesthesia and recorded haemodynamic 
variables every 15 minutes until the end of surgery. Patients allocated to GDT received supplementary 
colloid (VoluvenTM; Fresenius Kabi Ltd, Cheshire, UK) given by the investigator. 
 
Standardised postoperative care was provided on a dedicated colorectal surgery ward. Admission to 
the critical care unit was at the discretion of the surgeon and anaesthetist. All patients were allowed 
free fluids, light diet, or both on the evening of surgery if tolerated. There was no formal protocol for 
postoperative fluid administration though local guidelines recommend a daily fluid intake of 2 litres. 
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Early mobilisation was encouraged, epidurals were discontinued at 48–72 h, and pain managed with 
oral analgesics at the earliest opportunity. 
 
COMPETE-C study data used in thesis: The COMPETE-C study data is used in Chapter 3 to explore the 
relationship between: 
I. Lymphocyte count and anaerobic threshold 
II. Preoperative lymphopenia and postoperative length of hospital stay 
III. Preoperative lymphopenia and postoperative incidence of sepsis 
IV. Perioperative trends in leukocyte parameters (lymphocyte count, percentage and NLR 
 
b) Post-Operative Morbidity-Exercise: preoperative exercise biology and postoperative outcomes 
(POM-E) 
 
Study type: Observational cohort study 
 
Ethics: This study was approved by the South-East London REC office (Ref: 09-H0805-59) and 
conducted at UCLH between April 2010 and August 2014  (ISRCTN 90019424). Informed written 
consent was obtained prior to elective major surgery at UCLH in patients who underwent CPET. 
Consent was obtained for perioperative morbidity data collection combined with blood sampling. 
Adverse events were monitored by the local Research and Development service. Serious adverse 
events were additionally reported to the Ethical Committee. 
 
Inclusion criteria: Patients undergoing major elective major surgical procedures that are associated 
with a high incidence of postoperative morbidity (abdominal/oesophageal/hepatic 
resection/gynaecology/urological reconstructive surgery) and who meet the following criteria: 
1. American Society of Anesthesiologists (ASA) risk grade 3 - 4 
2. Aged greater than 50 years, either sex 
 
Exclusion criteria: Patients were excluded if they: had evidence of acute myocardial ischaemia 
(contraindication for inotropic support); acute arrhythmias (contraindication for inotropic support); 
pregnancy (lithium-based cardiac output monitoring device); or if patients were receiving palliative 
treatment only. 
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Methods: This Observational cohort study of response to cardiopulmonary exercise testing in healthy 
volunteers and non-cardiac surgical patients, blood samples, microvascular and cardiopulmonary data 
were collected prior to and 60 minutes following exercise. Postoperatively, blood samples, 
microvascular and cardiopulmonary data were also collected. A researcher who was blinded to the 
CPET and blood test results, collected morbidity outcomes. The aim of the study was to determine 
immune, bioenergetic and microcirculatory responses to CPET in healthy volunteers and non-cardiac 
surgical patients. As part of this study venepuncture was performed preoperatively and on day 3 
postoperatively. 
 
The same team performed surgery and anaesthesia and standardised care was delivered according to 
local protocols. Low molecular weight heparin was administered routinely for thromboprophylaxis. 
Where performed, epidural analgesia was discontinued within 36 hours postoperatively to enable 
mobilisation and physiotherapy. Patient-controlled morphine analgesia was administered to patients 
who had undergone procedures under spinal anaesthesia. Resumption of oral fluid and solid intake 
was encouraged on the day of surgery. 
 
POM-E study data used in thesis: Patient blood samples from POM-E study participants were utilised 
for: 
I. Perioperative lymphocyte bioenergetic experiments performed in Chapter 4.  
 
c) The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION-UK) 
Study Type: Prospective cohort study 
 
Ethics: This study was approved by the London REC office (MREC Ref: 10/WNo03/25) and national 
ethical approval was obtained (clinicaltrials.gov, identifier NCT 00512109). The multi-site study 
included UCLH recruitment where informed verbal and written consent were obtained prior to surgery 
at UCLH. Consent was obtained for perioperative morbidity data collection combined with blood 
sampling. Adverse events were monitored by the local Research and Development service. Serious 
adverse events were additionally reported to the Ethical Committee. 
 
Inclusion criteria: Eligible patients for the VISION study had elective non-cardiac surgery during a 
weekday, were aged 45 years or older, received general or regional anesthesia, and underwent 
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elective or urgent/emergency surgery during the day or at night, during a weekday or the weekend 
requiring overnight hospital stay. 
 
Exclusion criteria: Patients were excluded who were <45 years old, did not require an overnight 
hospital admission after surgery, who were previously enrolled in the VISION Study, or who declined 
informed consent. 
 
Methods: The VISION study is a large, international, multi-centre, prospective cohort study evaluating 
complications after non-cardiac surgery in over 15,000 patients. The aim of the study was to establish 
diagnostic criteria, characteristics, predictors, and 30-day outcomes of myocardial injury after non-
cardiac surgery. In patients undergoing non-cardiac surgery, troponin T was measured during the first 3 
postoperative days. Patients therefore underwent venepuncture preoperatively and daily for the first 3 
postoperative days. The primary outcome was 30-day mortality. Eligible patients for the VISION-UK 
study at University College Hospital, London received a general or regional anaesthesia. 
 
An investigator reviewed and approved all data. Research personnel at participating centers submitted 
the case report forms and supporting documentation directly to the data management system 
(iDataFax; coordinating center, McMaster University, Hamilton, Ontario, Canada). Data monitoring in 
VISION consisted of central data consistency checks, statistical monitoring, and on-site monitoring for 
all centers. Postoperative morbidity data was collected in patients recruited into this study on day 3 
and day 7 following surgery. 
 
VISION-UK study data used in thesis: VISION-UK data is used throughout this thesis to explore: 
I. Relationship between preoperative lymphopenia and postoperative length of hospital 
stay (Chapter 3) 
II. Preoperative lymphopenia and postoperative morbidity (Chapter 3) 
III. Postoperative changes in mitochondrial reactive oxygen species production and 
mitochondrial membrane potential within lymphocytes (Chapter 5) 
IV. Postoperative changes in intracellular cytokine production within lymphocytes 
(Chapter 6) 
V. Effect of glucocorticoids on lymphocyte reactive oxygen species production, and 
inflammasome activation (activated caspase 1 and interleukin 1-beta expression; 
Chapter 7) 
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2.3 Statistical analyses and power calculations 
The analyses and power calculations for studies and experiments in chapters 3 to 7 are outlined within 
the relevant chapters.  
 
2.4 Sample processing – Lymphocyte Isolation 
Lymphocytes were obtained preoperatively from 20 mL of heparinised (final concentration 50 iu/mL) 
peripheral venous blood placed on ice and, within 1 hour, diluted 1:1 in phosphate-buffered saline 
(PBS) before undergoing density gradient centrifugation with Ficoll Plus (Amersham Biosciences, 
Chalfont St Giles, Beds, UK). This was centrifuged at 400 x g for 30 minutes at 20˚C with no centrifuge 
brake. The resulting plasma layer was carefully aspirated using a sterile Pasteur pipette. The layer 
containing lymphocytes and monocytes (mononuclear layer) was then aspirated and washed with PBS 
at 4˚C, centrifuged at 300g for 8 minutes and then washed again and centrifuged for 6 minutes. After a 
further wash with phosphate-buffered saline (BD Biosciences, Amersham, UK) to remove platelets, 
isolated PBMCs were resuspended at 1x106 cells / mL in Dulbecco's Modified Eagle's Medium (DMEM) 
and placed in a plastic culture dish for 2 hours to allow monocytes to adhere to the plastic. Non-
adherent lymphocytes were then gently resuspended using a pipette, counted again and resuspended 
in DMEM 4.5 g/L glucose. Cell count and cell viability was established by the Trypan Blue dye exclusion 
test. (De Luca 1965) A Neubauer-improved haemocytometer was used for manual cell counting.  
 
Lymphocytes of purity > 98% were isolated following removal of monocytes (Figure 2.1). CD14 is 
expressed by macrophages, neutrophils, dendritic cells and monocytes. Following the cell isolation 
method described above, lymphocytes and monocytes are initially isolated. The supernatant remaining 
following monocyte adherence to culture dish consists of >95% CD4(+) and CD8(+) lymphocytes. Total 
numbers of isolated lymphocytes from each sample depended on volume of blood taken during 
venepuncture and absolute lymphocyte count of patient.  The reagents, antibodies and equipment 
utilised for experiments in this thesis are summarised at the end of this chapter (Tables 2.3–2.5).
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Figure 2.1 Flow cytometry plot demonstrating proportion of CD14(+) monocytes (APC) and CD3(+) T lymphocytes (FITC) in supernatant following 
lymphocyte isolation technique (monocyte adherence) (>99% viability demonstrated by Trypan blue haemocytometry)  
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2.5 Extracellular Flux Analysis 
The Seahorse Bioscience XF24 extracellular flux analyser can be utilised to determine 
distinct bioenergetic profiles for human lymphocytes.(Chacko, Kramer et al. 2013) This 
system allows for real-time, non-invasive measurements of oxygen consumption rate 
(OCR) extracellular acidification rate (ECAR) / proton production rate (PPR), which can be 
correlated to mitochondrial function and glycolysis, respectively.(Dranka, Benavides et al. 
2011)  
 
Mitochondrial OCR (a measure of oxidative phosphorylation) and ECAR (a measure of 
glycolytic lactate production (Brand and Nicholls 2011)) were measured (Seahorse XF 
System, North Billerica, MA, USA) in freshly isolated lymphocytes from pre- and 
postoperative patients under identical experimental conditions, 3 days apart with at least 
5 measures per patient sample, lymphocyte yield permitting. The technique is 
summarised in Table 2.2.  
 
Table 2.2. Overview of extracellular flux analyzer (seahorse XF24) technique 
Day before assay Day of assay 
Hydrate cartridge and store 
overnight at 37OC 
Load cartridge, calibrate and add stress 
test compounds 
Prepare assay medium stock Change to assay medium and pre-
incubate Run experiment and analyse 
data 
Seed cells in XF microplate 
 
Isolated lymphocytes were stored at a concentration of 1million cells per mL in 4.5 g/L 
DMEM (Invitrogen, Paisley) in a humidified incubator at 37˚C with 5% CO2, 21% O2 and 
74% N2. This provides conditions ideal for tissue and cell culture due to the slightly acidic 
environment, which is designed to mimic the cell’s natural conditions and maintain a 
constant pH 7.2-7.5. Lymphocytes were subsequently re-suspended for one hour prior to 
seeding in assay plate wells, to a concentration of 10 million cells per mL (1 million cells in 
0.1 mL) and 25 μg/mL concanavalin A in unbuffered DMEM (without sodium bicarbonate 
or phenol red, supplemented with 5.6 mM glucose, 5 mM pyruvate and 2 mM L-
glutamine). Sodium bicarbonate buffer has the ability to neutralise pH associated with H+ 
ion production. Unbuffered solution (without sodium bicarbonate) is therefore utilised in 
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order for any changes in pH to be detectable to assess ECAR, a surrogate marker of 
glycolysis. The unbuffered solution allows for customization of the media for XF 
experimental design, permits greater control over substrates and enables the flux analyser 
to accurately measure ECAR and PPR. 
 
Cell-Tak™ (BD Biosciences) is an extracellular matrix protein preparation isolated from the 
marine mussel Mytilus edulis. It is used to adhere cells to the plate well that do not 
naturally settle to the bottom in a microplate under gravity. The wells had been previously 
prepared with Cell-Tak. Lymphocytes were left to adhere for 90 minutes at 37ºC in 
humidified air before commencement of the assay.  
  
By means of a mechanical piston, the device creates a sealed transient micro-chamber of 
7 µl volume above the lymphocyte monolayer.  Oxygen and H+ concentration in this 
microenvironment change according to cell metabolism. After a pre-determined period of 
time (90 seconds for these experiments) the piston rises and the media (0.6 to 1.0 mL) re-
equilibrates with the ambient air. Two sets of analyte specific sensors are attached to the 
tip of the piston and lie 200 µm above the cells when the measurements are made. The 
sensors contain fluorescent particles embedded in a polymeric substrate that allows for 
selective diffusion of the specific analyte to contact with the fluorophores. Light-Emitting 
Diodes (LEDs) provide monochromatic light via fiber optic bundles to excite the sensors 
(λ=530 and λ=470 nm for oxygen and H+, respectively). The fluorophores are quenched by 
oxygen and H+ and the light emitted is correlated with the concentration of the analyte in 
the media. Each sensor is connected via the fiber optic bundle to a photodiode that 
converts the emitted light signal into current. The XF24 is a plate-based assay where up to 
20 concomitant of these systems can be studied. 4 wells are not plated with cells and 
constitute controls for the assay conditions, namely temperature and media 
characteristics. Maintenance of the XF24 was undertaken in accordance with 
manufacturer guidelines by UCL Biomedical Sciences department. This involved daily 
calibration of sensors and LEDs to ensure reliable, accurate and consistent results 
between samples taken on different days.  
 
The assay cartridge is first placed into the XF Analyzer to allow automatic calibration of 
optical sensors. Next, the cell culture plate is inserted into the instrument. The injection 
ports attached to the wells allow for injection of inhibitors of mitochondrial respiratory 
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chain to determine the defects in individual cellular respiration pathways or enzymes 
(Figure 2.2 and 2.3). Following baseline readings, four compounds were added in 3 
separate injections with three further OCR and ECAR measurements after each compound 
(Figures 2.4 and 2.5). Experiments for isolated lymphocytes have previously determined 
that the optimal cell number required for accurate measurements of OCR is 1 million (100 
μL of a 10 million/mL concentration).(Wang, Dillon et al. 2011) The optimum 
concentration of the inhibitors and activators to be used for the assessment of 
mitochondrial function were determined by titrating the individual compounds in 
separate experiments against the cell number determined. These concentrations were 
consistent with those recommended by the manufacturer.  
 
The mean basal respiration is determined by taking 3 OCR measurements before the 
addition of the inhibitors or activators. These 3 baseline readings taken 10 minutes apart 
are to demonstrate that the sensors within the machine read consistently and any 
subsequent changes occurring in OCR and ECAR occur secondary to drugs added (Drugs 
explained in section 2.6). Mitochondrial basal respiration, proton leak, and the maximal 
respiration were calculated after correcting for the non-mitochondrial OCR for each assay. 
Cells were allowed to attach to the XF24 plate for 45 minutes before measurement of 
mitochondrial function. Under these conditions, viability was over 90% for cells.  
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Figure 2.2 Diagram representing 4 injection ports in relation to each seahorse plate well 
 
Measurements of OCR and ECAR taken every 10 minutes; injections A, B, C added to well after 30, 60 and 90 minutes respectively  
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Figure 2.3 Mitochondrial drugs utilised during extracellular flux analysis
 
 
= inhibitor (e.g. rotenone inhibits complex 1). Figure depicts site of action of each mitochondrial drug within the ETC. 
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2.6 Pharmacological interrogation of mitochondrial complex activity 
(a) ATP synthase (Complex V) inhibitor - Oligomycin 0.25μM (0.2μg.mL-1)(Sigma Aldrich, Dorset, UK) 
Dose titrations for oligomycin were carried out in order to induce a maximal change in respiration 
without signs of cell death measured by Trypan blue haemocytometry.(Zaobornyj and Valdez 2005, 
2013 ) Lymphocyte cell death was not affected with concentrations up to 0.25µM left for 60 minutes. 
ATP-linked OCR and proton leak were determined by adding oligomycin. The fall in OCR following 
oligomycin injection is the rate of oxygen consumption that corresponds to ATP synthesis, and the 
oligomycin- insensitive rate is considered as proton leak across the inner mitochondrial membrane. 
Oligomycin causes a reduction in ATP production by inhibiting the proton channel of the Fo portion of 
ATP synthase. With state 3 phosphorylation inhibited, remaining oxygen consumption is not coupled to 
ATP production, therefore oxygen consumption contributing to ATP synthesis can be distinguished 
from that being used to overcome the inner mitochondrial membrane proton leak. Blocking 
mitochondrial ATP production increases glycolysis in an effort to maintain overall cellular ATP 
production and the resultant increase in ECAR gives an indication of the glycolytic capacity of a cell 
(Figure 2.5).  
 
(b) Electron transport chain coupling - Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) 
2μM (Sigma Aldrich, Dorset, UK): ionophore.(Hoth, Fanger et al. 1997) 
FCCP, an uncoupler of the electron transport chain, was used to determine the maximal respiration 
rate. This rate gives the theoretical maximum oxygen consumption that can take place at cytochrome c 
oxidase whether limited by availability of substrate or activity of the electron transport chain. The 
difference between the basal rate and this FCCP stimulated rate is termed the spare respiratory 
capacity of the mitochondrion, which is a measure of the maximal potential respiratory capacity the 
cell can utilise under conditions of stress and/or increased energetic demands e.g. occurring during 
activation and proliferation (Figure 2.4). This compound transports protons across the mitochondrial 
membrane. This results in a loss of electrical gradient across the membrane, which subsequently 
stimulates maximal electron transport chain (ETC) activity. This effort to regain the mitochondrial 
membrane results in an increase in oxygen consumption. This uncouples ETC activity from ATP 
production and gives an indication of the maximal respiratory capacity of the ETC, assuming substrate 
delivery is adequate (Figure 2.4). Prior administration of oligomycin ensures that the proton gradient 
cannot be regained by the reverse action of ATP synthase. As with oligomycin, glycolysis and 
consequently ECAR will further increase in an effort to maintain cellular ATP levels. 
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(c) Complex 1 activity - Rotenone (1μM) (Zaobornyj and Valdez 2005, 2013 , Lu, Wu et al. 2015) with 
antimycin A (1μM)(Vives-Bauza, Zhou et al. 2010{Garedew, 2010 #1703)}(Sigma Aldrich, Dorset, UK): 
ETC complex inhibitors.  
Rotenone inhibits Complex I by preventing the transfer of electrons from the Fe-S centre in Complex I 
to ubiquinone (Coenzyme Q). Antimycin A, an inhibitor of Complex III, was used to completely inhibit 
mitochondrial electron transport. The OCR determined after antimycin A injection is attributable to 
non-mitochondrial oxygen consumption. Antimycin A inhibits Complex III by binding the Qi site of 
cytochrome c reductase, preventing the oxidation of ubiquinol. Stopping mitochondrial respiration in 
this way allows the contribution of non-mitochondrial processes (substrate oxidation and cell surface 
oxygen consumption) to be quantified and subtracted from basal and maximal OCR figures in order to 
express pure mitochondrial oxygen consumption.(Wu, Neilson et al. 2007) 
 
(d) Glycolytic capacity - 2 Deoxy-Glucose (100mM administered as third injection for glycolysis 
experiments; see Figure 2.5)(2013 )  
To determine the extent to which ECAR represents glycolysis in this system, (rather than other cellular 
sources of acid), lymphocyte function was also assessed following 2-deoxyglucose (2-DG) 100nM 
administration.(2013 ) 2DG is a glucose analogue with the 2-hydroxyl group replaced by hydrogen. Due 
to its structural similarity to glucose it is transported into the cell by glucose transporters. It becomes 
bound to glucose hexokinase, but cannot be phosphorylated by this enzyme, and glycolysis is therefore 
competitively inhibited. The resultant decrease in basal ECAR demonstrates the proportion of baseline 
ECAR that is due to glycolysis.  
 
2.7 Spare respiratory capacity 
The term reserve respiratory capacity or spare respiratory capacity (Figure 2.4 OCR following FCCP – 
baseline OCR) is used to describe the amount of extra ATP that can be produced by oxidative 
phosphorylation in case of a sudden increase in energy demand. Depletion of the reserve respiratory 
capacity has been related to a range of pathologies affecting high energy requiring tissues. During 
aging of an organism, and as a result of mitochondrial dysfunctions, the efficiency of oxidative 
phosphorylation declines. Postoperatively, lymphocytes may require a sudden burst of additional 
cellular energy in response to stress or increased workload for many reasons (Table 1.4). If the spare 
respiratory capacity of the cells is not sufficient to provide the required ATP, affected cells may be 
driven into senescence or cell death.(Desler, Hansen et al. 2012) Exhaustion of the reserve respiratory 
capacity has been correlated with a variety of pathologies including heart disease,(Sansbury, Jones et 
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al. 2011) neurodegenerative disorders,(Nicholls 2008) and cell death in smooth muscle.(Hill, Higdon et 
al. 2010) Changes in SRC in the postoperative phase may therefore be a contributing factor to 
development of postoperative morbidity and sepsis. 
 
Glycolytic reserve and spare respiratory capacity reflect a cell’s ability to respond to environmental 
perturbation. Some cell types operate closely to their maximum metabolic potential and are therefore 
less likely to survive a significant increase in metabolic demand or a decrease in substrate availability. 
For example, glioma stem cells have higher spare respiratory capacity than their progeny and this 
increase positively correlates with the ability to survive stressors like radiation.(Vlashi, Lagadec et al. 
2011)
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Figure 2.4 An example of oxygen consumption rate plot with labelled respiration parameters and drug administration points 
 
(pMoles/min) 
OCR measured in pMoles/min, measured at 3 time 
points at 10 minute intervals before and after injection:  
1= Oligomycin; 2= FCCP; 3= Rotenone and Antimycin A; 
A= Basal respiration; B= ATP turnover (coupling 
efficiency=Basal respiration – Respiration following 
oligomycin); C= H+ leak; D= Spare respiratory 
capacity=ETC Accelerator Response - Basal Respiration; 
E= Respiratory capacity; F= Non-mitochondrial 
respiration; Basal Response = 3rd basal measurement 
i.e. measurement before oligomycin 
ETC Accelerator Response = Maximum rate after FCCP; 
ATP Coupler Response = Minimum rate after oligomycin 
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Figure 2.5 An example of extracellular acidification rate measurement plot demonstrating altered mitochondrial metabolism following injections of 1) 
oligomycin, 2) FCCP, and 3) 2-DG         
 
1=oligomycin; 2= FCCP; 3= 2 Deoxyglucose; SGC = Spare 
glycolytic capacity (ECAR following oligomycin – Baseline 
ECAR); GC = Glycolytic capacity; GR = Glycolytic reserve; 
NGA = Non-glycolytic acidification 
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2.8 Measurement of mitochondrial membrane potential using a tetramethylrhodamine methyl ester 
(TMRM) whole blood assay  
(a) Cell preparation for TMRM assay 
Blood samples were processed on the same day as venepuncture. Mitochondrial membrane potential 
was measured using the following TMRM assay methodology.  
 
TMRM is a cell-permeant, cationic, red-orange fluorescent dye that is readily sequestered by active 
mitochondria. It has been used to detect mitochondrial permeability and membrane depolarisation in 
lymphocytes.(Rasola and Geuna 2001) Preoperative CD4(+) and CD8(+) T cell populations were gated 
and analysed with and without an optimised concentration of FCCP. 2 µM concentration was found to 
reduce the mitochondrial membrane potential while ensuring that sufficient cells remained viable for 
flow cytometry analysis within 30 minutes of administration. FCCP was utilised as a positive control 
because it uncouples the ETC and therefore decreases mitochondrial membrane potential of 
lymphocytes. Providing patients were still hospitalised and consented to postoperative venepuncture, a 
further patient matched blood sample was taken on day 2 post surgery. 
 
(b) Measurement of membrane potential using the TMRM assay 
T-cell subsets (CD4 and CD8 cells) and their mitochondrial membrane potential were analysed by 
multiparametric flow cytometry. 100 µL of each heparinised blood sample was incubated with optimal 
concentrations of a APC conjugated CD4 antibody and vioblue conjugated CD8 antibody (Mylteni Biotec, 
Auburn) diluted in PBS with 0.2% bovine serum albumin for 30 min at 4oC in the dark. The blood sample 
was then stimulated for 15 min at 37°C with or without 2 µM FCCP (Sigma Aldrich). After incubation with 
FCCP, 200 µM TMRM (made up in JC-1 buffer solution freshly prepared from a stock solution 2 mM in 
DMSO) was added and samples left for further 15-minute incubation. The JC-1 dye is used to determine 
to monitor mitochondrial membrane potential. It is predominantly a monomer that yields green 
fluorescence with emission of 530±15 nm. At high concentrations (due to higher mitochondrial 
membrane potentials) the dye aggregates yielding a red to orange coloured emission (590±17.5 nm). 
Consequently, mitochondrial depolarisation is indicated by a decrease in the red/green fluorescence 
intensity ratio and an increase in the aggregate fluorescent count is indicative of hyperpolarization. The 
potential-sensitive colour shift is due to concentration-dependent formation of red fluorescent J-
aggregates. Treating cells with FCCP eliminates mitochondrial membrane potential and JC1 staining. JC1 
is suitable for the labelling of mitochondria in live cells and is not compatible with fixation. 
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The samples subsequently underwent erythrocyte lysis with blood lysis buffer (Sigma Aldrich) for 15 min 
at room temperature. The cells were finally washed and centrifuged twice in PBS (Invitrogen) and re-
suspended in 500µL PBS ready for flow cytometry. Isotype-matched mouse immunoglobulins were used 
as controls for CD4 and CD8 in each experiment. No isotype control was used for TMRM. Samples were 
immediately measured using a Cyan cytometer (BD Biosciences). The data were analysed using summit 
software (BD Biosciences). After the standard calibration of the flow cytometer, data were recorded 
until 10000 CD4+ T-cells were acquired or the cell suspension was exhausted. 
 
2.9 Measurement of mitochondrial reactive oxygen species (ROS) production using a MitoSox assay 
on isolated lymphocytes 
  
(a) Cell preparation for MitoSox assay 
100,000 Isolated lymphocytes from patients were incubated with staurosporine (a proapoptotic 
microbial alkaloid) and mitochondrial ETC inhibitors (myxothiazol, rotenone and FCCP) for 30 minutes to 
increase mROS production by lymphocytes. Following incubation the MitoSox assay described below 
was performed in order to elucidate percentage of lymphocytes expressing mitochondrial ROS. Pre- and 
postoperative lymphocyte samples were also interrogated for presence of mitochondrial ROS at 
baseline (control) and following FCCP stimulation.    
 
Staurosporine is a non-selective protein kinase inhibitor, which induces mitochondrial apoptosis through 
caspase dependent and independent pathways.(Zhang, Gillespie et al. 2004) Myxothiazol is an inhibitor 
of the mitochondrial cytochrome bc1 complex. It is a competitive inhibitor of ubiquinol, and binds at the 
quinol oxidation site of the bc1 complex, blocking electron transfer within the ETC of mitochondria.  
 
(b) Measurement of mitochondrial ROS using MitoSox assay in isolated lymphocytes 
The FlowCellect™ MitoStress Kit (Millipore, MA, USA) allows for the measurement of mitochondrial 
superoxide generation, which is detected by membrane permanent dye MitoSox Red using a single 
cellular sample.(Mukhopadhyay, Rajesh et al. 2007) Multiparametric evaluation of this marker allows 
the analysis of oxidative stress.(Aronis, Melendez et al. 2003) 
 
The assay was performed as per manufacturer recommendations.  100,000 isolated lymphocytes (purity 
>99%) in 100 μL were added with and without 2 μL MitoSox Red working solution. Cells were incubated 
for 15 minutes in a 37°C CO2 incubator and subsequently centrifuged at 300 x g for 5 minutes at room 
temperature. After aspirating off supernatant, one further wash was performed with 200 μL of 1x Assay 
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Buffer per well and cells were centrifuged at 300 x g for 5 minutes at room temperature, before being 
re-suspended with 200 μL of 1x Assay Buffer. Cells were analysed immediately on a flow cytometer 
equipped with blue and red lasers. 
 
MitoSox Red is a fluorogenic dye that is live-cell permanent, and is selectively targeted to the 
mitochondria where it reacts with superoxide radicals and fluoresces yellow/red. MitoSox Red is 
excitable by a 488nm laser and fluoresces maximally at 580 nm (yellow fluorescence on the guava 
easyCyte 8HT). 
 
2.10 Cell preparation of cells for intracellular cytokine assay 
T-cell subsets and their intracellular cytokine production were analysed by multiparametric flow 
cytometry. 1 mL of a heparinised whole blood sample was stimulated for 16 hours at 37°C in RPMI 
medium (Gibco, New York, USA) at a ratio of 2:1 (RPMI : blood) with 10 µg/mL brefeldin A(Levings, 
Sangregorio et al. 2001{Gorden, 2005 #1705)} (control sample) (Sigma Chemical) with or without 100 
ηM PMA (Tsukahara, Gordienko et al. 1993)(Sigma Chemical, Dorset, UK) and ionomycin (750mg/mL, 
Sigma Chemical, Dorset, UK).(Foster, Prussin et al. 2007) RPMI 1640 is a liquid medium utilizing a 
bicarbonate buffering system with amino acids and vitamins providing effective culture of lymphocytes. 
Brefeldin disaggregates the Golgi complex and enables the intracellular cytokine accumulation of 
proteins.(Pala, Hussell et al. 2000) PMA stimulates protein kinase C directly, the theta isoform of which 
is essential for T-cell activation.(Isakov and Altman 2002) Ionomycin is an ionophore produced by the 
bacterium Streptomyces conglobatus. It is used to raise the intracellular level of calcium (Ca2+) and 
stimulate intracellular cytokine production in conjunction with PMA. After incubation, 100 µL of each 
blood sample was incubated with optimal concentrations of a FITC conjugated CD4(+) antibody and 
vioblue conjugated CD8(+) antibody (Mylteni Biotec, Auburn, California) diluted in PBS with 0.2% bovine 
serum albumin for 30 minutes at 4oC in the dark. The samples were subsequently fixed and 
permeabilised with 200µL Cytofix/Cytoperm (BD Biosciences, San Diego) for 20 minutes at room 
temperature and then 1mL of BD Perm/Wash (BD Biosciences, San Diego) was added prior to 
centrifugation at 1500 rpm for 5 min and removal of the supernatant. Following centrifugation 4µL of 
APC conjugated cytokine (Miltenyi Biotec Ltd, Surrey) (IL-2, TNF-α or IFN-γ) were added to the cells and 
incubated at 4oC in the dark for 30 minutes. 
 
The cells were then fixed with 100 µL 2% PFA and erythrocyte lysis (Sigma Aldrich, Dorset, UK) was 
performed with blood lysis buffer for 15 minutes. The cells were finally washed and centrifuged twice in 
PBS and resuspended in 500 µL PBS ready for flow cytometry. This whole blood cytokine assay was 
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developed to optimise intracellular cytokine detection using flow cytometry. Isotype-matched mouse 
immunoglobulins were used as controls for each experiment.  
 
Samples were immediately measured using a Cyan cytometer (BD Biosciences). After the standard 
calibration of the flow cytometer, data were recorded until 10000 CD4(+) T-cells were acquired or the 
cell suspension was exhausted. 
 
2.11 Flow cytometry assays  
(a) Preparation of cells for measurement in flow cytometer 
Flow cytometry methodology for analysis of mitochondrial membrane potential, mitochondrial reactive 
oxygen species production and intracellular cytokine production by lymphocytes are described in the 
methods sections of the relevant chapters (Chapters 5 and 6).  
 
For all experiments, the cytometer was maintained and calibrated on a daily basis using calibrant 
samples to ensure the laser transmitters and detectors produced consistent and reliable frequency and 
intensity readings. All flow cytometry data were analysed using summit software (BD Biosciences). 
 
(b) Control Samples utilised in flow cytometry experiments 
The following control samples were prepared for the flow cytometry experiments performed within this 
thesis, as recommended by Tung et al.(Tung, Heydari et al. 2007) 
 
I. Unstained control 
Unstained cells were utilised as control samples due to autofluorescence, a phenomenon which is 
dependent on multiple factors including: incubation medium used, activation status of cells and laser 
channel utilised.    
 
II. Isotype control 
The reagents utilised to identify cell types in this thesis rely on reagent binding to antigen binding sites 
containing variable regions (within Fab portion of antibody). Binding of reagents can however also occur 
to constant regions (within Fc portion of antibodies). Isotype controls elucidate the binding occurring to 
constant regions / Fc portions of antibodies, therefore allowing subsequent determination of amount of 
fluorescence occurring from variable / Fab regions being studied. 
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III. Fluorescence Minus One (FMO) 
For all flow cytometry experiments performed in this thesis utilising greater than one fluorophore, a 
FMO sample was utilised as a control in order to determine the effect that each channel had on 
fluorescence. Since the compensation corrections differ according the amounts of the various reagents 
present on cells in different subsets, it is important to independently determine the boundary between 
positive and negative cells for each subset. This is done by including FMO controls for all fluorescence 
channels within this boundary. The FMO control samples were treated with the same medium and 
protocol as other samples, but were stained with one less reagent in the stain set. This aided 
discrimination between poorly defined cell populations and increased accuracy of results. 
 
Furthermore in all flow cytometry experiments, data was always collected prior to application of 
fluorescence compensation correction. 
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Table 2.3. Chemicals and reagents used in thesis experiments 
Lot and batch numbers provided where available 
  
Reagent Supplier Address Batch No. Lot No. 
Dulbeccos’s Phosphate-
Buffered Saline (Calcium 
and Magnesium-free) 
(PBS) 
Invitrogen Ltd Paisley, UK 14190-094 1250143 
Ficoll-Paque PLUS (Ficoll 
sodium diatrizoate) 
GE Healthcare Buckinghamshire, 
UK 
17-1440-03 10115414 
Dulbecco’s Modified Eagle 
Medium with GlutaMAX, 
Sodium Pyruvate and 1g/L 
or 4.5 g/L D-glucose 
(DMEM) 
Invitrogen Ltd Paisley, UK 21885-025 1038505 
Blood Lysis Buffer: 
0.84 g NaHCO3 
7.7g NH4CL 
1000 mL distilled water 
Chemicals from 
Sigma Aldrich 
Dorset, UK   
Paraformaldehyde 
(diluted to 2% 
concentration in PBS) 
    
Dexamethasone     
Trypan Blue solution Sigma Aldrich Dorset, UK   
Heparin sodium 1000 
iu/mL 
Leo Laboratories 
Ltd 
Buckinghamshire, 
UK 
  
Concanavalin A, from 
Canavalia ensiformis (Jack 
bean), Type IV 097K670 
Sigma Aldrich Dorset, UK   
Oligomycin Sigma Aldrich Dorset, UK   
FCCP Sigma Aldrich Dorset, UK   
Rotenone Sigma Aldrich Dorset, UK   
Antimycin A Sigma Aldrich Dorset, UK   
2-deoxyglucose (2-DG) Sigma Aldrich Dorset, UK   
MitoStress kit Millipore Hayward, CA, USA FCCH100109 12-0525 
Dimethyl Sulfoxide Sigma Aldrich  03363MD 200-664-3 
Bovine Serum Albumin 
(diluted to required 
concentration in PBS then 
sterile filtered) 
Sigma Aldrich Dorset, UK   
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Table 2.4. Monoclonal antibodies and isotype controls used in thesis experiments 
Antibody- 
fluorochrme 
Isotype Clone Supplier Utility Batch No.  Lot No. 
CD3-APC 
CD3-FITC 
Mouse 
IgG2a 
BW264/56 1 T-lymphocytes   
CD4-FITC Mouse 
IgG1 
M-T466 1 T helper 
lymphocytes (and at 
lower levels on 
monocytes / 
dendritic cells) 
130-080-
501 
5120321133 
CD8-VioBlue Mouse 
IgG2a 
 1 T cytotoxic 
lymphocytes and NK 
cell subset 
 5130226124 
CD14-APC Mouse 
IgG2a 
TUK4 1 Monocytes / 
macrophages. Low 
level expression on 
neutrophils. 
  
TNF-A- APC Rat Ig2b  1 Cytokine 130-091-
649 
5120725162 
IFN-G- APC Rat Ig2b  1 Cytokine 130-091-
640 
5120614130 
IL-2- APC Rat Ig2b  1 Cytokine 130-091-
644 
5120614131 
 
1. Miltenyi Biotec Ltd, Surrey, UK. 2. Abcam plc, Cambridge, UK 3. Biolegend UK Ltd, Cambridge, UK. 4. 
Cayman Chemical Company, Ann Arbor, USA. Lot and batch numbers provided where available 
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Table 2.5. Scientific machines and disposable equipment utilised 
Equipment Supplier Address Serial No. Lot No. 
Centrifuge: Haraeus 
Megafuge 1.0R 
Kendro Laboratory 
products 
Langenselbold, 
Germany 
232128  
Centrifuge: ALC PK120 ALC Cologno 
Monzese, Italy 
79909574  
Centrifuge: Eppendorf 
5415 C 
Eppendorf Hamburg, 
Germany 
  
Heated water bath Grant 
model JB4 
Grant Instruments Cambridge, UK 629640002  
Vortex – Rotamixer Hook and Tucker 
instruments 
Croyden, UK 7725  
Flow Cytometer: CyAn 
ADP 9 colour with Summit 
4.3.1 software 
Beckman Coulter Inc Fullerton, USA 626  
Scales     
15 mL Falcon 
polypropylene tubes 
BD Biosciences Oxford, UK   
50 mL Falcon 
polypropylene tubes 
BD Biosciences Oxford, UK 8362220 3009676 
10, 200 and 1000 μL 
Diamond sterilised pipette 
tips 
Gilson Inc. Middleton, 
USA 
REFF167101 
REFF167103 
REFF167104 
GCDE0/12314 
UBBF2/52780 
UZBC2/20080 
24-well plates: Costar 24 
well culture cluster 
Corning 
International 
NY, USA   
Flow cytometer test tubes Elkay    
3 mL sterile Pasteur 
pipettes 
Ramboldi Ltd Limassol, 
Cyprus 
  
Cell culture incubator 
Galaxy R 170litre 
RS Biotech 
Laboratory Ltd 
Irving, UK 2154  
Biological safety cabinet 
Class II Holten LaminAir 
Model 1,2 
Thermo Scientific Waltham, USA   
Bench microscope: Zeiss 
Axiovert 25 
Zeiss Oberkochen, 
Germany 
606731 451200 
Neubauer improved 
haemocytometer 
Assistant Germany   
24 Well culture plate: 
Falcon 
Becton Dickinson Franklin Lakes, 
NJ, USA 
353047  
Lot and serial numbers provided where available 
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Chapter 3  
Lymphopenia is associated with lower 
anaerobic threshold and increased 
postoperative morbidity 
3.1 Introduction 
The relationship between lymphopenia and mortality in patients with cardiac failure highlights the need 
to explore preoperative immunological status as a plausible mechanism contributing to patients with 
low AT developing postoperative morbidity and requiring a prolonged hospital stay (Chapters 1.10 and 
1.11).  
 
Exercise data has previously been utilised to distinguish patients with varying severity of heart failure. 
(Hansen, Sun et al. 2012) Hansen et al. demonstrated distinctive patterns for New York Heart 
Association (NYHA) classification, reflecting sequential changes in cardiac output, arterial and mixed 
venous Oxygen (O2) and carbon dioxide (CO2) content differences, and ventilation and developed 
reference formulas (based on oxygen consumption, CO2 production and ventilation) on the basis of 
exercise tests of healthy subjects.  
 
While lymphopenia has been related to cardiac morbidity, the relationship between lymphopenia and 
AT measured by cardiopulmonary exercise testing (CPET) has thus far not been explored. I also 
determine perioperative changes in peripheral lymphocyte count and NLR occurring within the first 5 
days following surgery (and until hospital discharge) using prospectively collected data with large 
patient numbers. 
 
3.2 Hypothesis 
In patients undergoing elective colorectal surgery (COMPETE-C) and mixed surgery (VISION-UK), 
preoperative lymphopenia is associated with impaired aerobic capacity, postoperative morbidity and 
increased length of hospital stay.
   
72 
 
Methods  
3.3 Study populations 
Patients undergoing major colorectal surgery that were screened or recruited to participate in the 
COMPETE-C randomised controlled trial, conducted at Derriford Hospital, Plymouth, UK, between 
March 2009- April 2010 (ISRCTN 14680495), were included in the following analyses: 
1) AT / lymphocyte count analysis  
2) Preoperative lymphopenia and hospital length of stay  
3) Preoperative lymphopenia and incidence of sepsis (≥ 2 SIRS criteria and positive culture) 
4) Differences in preoperative lymphocyte counts in patients diagnosed with postoperative 
sepsis 
5) Postoperative trends in lymphocyte count (absolute and %) and NLR 
 
Absolute lymphocyte count, relative lymphocyte count and NLR were analysed from 7 time points 
during the patients’ hospital stay where available form the COMPETE –C study data. Time points 
analysed included preoperative, day 1-5 post surgery and day of discharge (if > day 5 post surgery). 
Cut-off values for lymphopenia were defined as < 1.2 x 109/L and NLR >5. Justification for utilising these 
values is provided in Chapters 1.5 and 1.6.   
Patients undergoing major elective surgery across all specialties at UCLH recruited into the VISION-UK 
study were included in the following analyses: 
1) Preoperative lymphopenia and hospital length of stay  
2) Preoperative lymphopenia and incidence of postoperative morbidity (POMS scoring) 
3.4 Data collection  
Different team members collected all data in a blinded manner. Those performing surgery and 
investigators were unaware of the hypothesis in question. 
 
COMPETE-C: Cardiopulmonary Exercise Testing. Patients attended preoperative clinic for assessment 
and CPET testing. Patients completed symptom-limited maximal cardiopulmonary exercise testing 
(CPET) as part of their routine preoperative assessment. Following a period of 2min rest and 2 min 
unloaded pedalling, patients began ramped, continuous incremental, and symptom limited exercise on 
a stationary ergometer (Zan, nSpire, CO, USA), with a ramp gradient 15–20 W/minute. CPET was 
   
73 
 
stopped as determined by the patients’ tolerance. Ventilation and gas exchange variables were 
measured using a metabolic cart (Zan, nSpire, CO, USA). 12-lead electrocardiogram, non-invasive blood 
pressure, and pulse oximetry were monitored throughout the test period. Anaerobic threshold (AT) 
was used as the marker of aerobic fitness. AT was determined by two independent assessors according 
to the published guidelines using V-slope and confirmed by ventilatory equivalents.(Pina, Balady et al. 
1995) 
 
VISION-UK: Postoperative morbidity survey (POMS) scoring. All patients recruited in to the VISION-UK 
study at University College London Hospital were followed up by research nurses blinded to the 
morbidity scores and blood test results. Prospective POMS scoring,(Bennett-Guerrero, Welsby et al. 
1999, Sanders, Keogh et al. 2012) a validated tool used to assess development of postoperative 
morbidity (complications) was performed on day 3 and day 7 postoperatively by performing chart and 
patient review where indicated. The categories and definitions of morbidity information collected 
using this survey are outlined below: 
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Table 3.1 POMS Survey – performed on day 3 and day 7 following surgery in VISION-UK patients 
 
* indicates one point, maximum possible score = 20  
 
 
 
Morbidity 
type 
Criteria 
Pulmonary 
 
The patient has developed a new requirement for oxygen* or 
respiratory support* 
Infectious 
 
Currently on antibiotics* and/or has had a temperature of >38°C in the 
last 24 h* 
Renal 
 
 
Presence of oliguria <500 mL/24 h*, increased serum creatinine (>30% 
from preoperative level)*; urinary catheter in situ for nonsurgical 
reason* 
Gastrointestinal 
 
Unable to tolerate an enteral diet for any reason*, nausea and vomiting 
or abdominal distension* 
Cardiovascular 
 
 
 
 
Diagnostic tests or therapy within the last 24 h for any of the following: 
(1) new MI or ischemia*, (2) hypotension (requiring fluid therapy 
>200mL/h or pharmacological therapy*, (3) atrial or ventricular 
arrhythmias*, (4) cardiogenic pulmonary edema and thrombotic event 
(requiring anticoagulation)*. 
 
Neurological 
 
New focal neurological deficit*, confusion or delirium* 
 
Hematological 
 
 
Requirement for any of the following within the last 24 h: packed 
erythrocytes, platelets, fresh-frozen plasma, or cryoprecipitate* 
Wound 
 
Wound dehiscence requiring surgical exploration or drainage of pus 
from the operation wound with or without isolation of organisms* 
Pain 
 
New postoperative pain significant enough to require parenteral opioids 
or regional analgesia* 
 
Mobility 
 
Unable to mobilise in same manner as preoperatively* 
 
Drain 
 
In situ* 
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3.5 Study Outcomes 
Full details of the COMPETE-C (Challand, Struthers et al. 2012) and VISION-UK (Botto, Alonso-Coello et 
al. 2014) protocols have previously been published. 
 
Outcomes for this chapter are as follows: 
Primary outcome – Demonstrate relationship between AT <11 mL/kg/min and lymphopenia relative to 
AT >11mL/kg/min (COMPETE-C).  
 
Secondary outcomes - Demonstrate relationship between lymphocyte count and development of 
postoperative sepsis (COMPETE-C cohort: defined by ≥ 2 of the following: temperature < 36oC / >38oC; 
heart rate >90/min; respiratory rate >20/min or PaCO2 <4.3KPa; White cell count <4 or >12 x 109/L and 
a positive culture) and postoperative morbidity (VISION-UK cohort: POMS criteria) and the association 
between lymphopenia (<1.2 x 109/L) and length of hospital length of stay (COMPETE-C and VISION-UK 
cohorts). I also explore the impact of age, gender and co-morbidity (RCRI ≥ 3, AT< 11mL/kg/min) on 
LOS and the postoperative recovery of lymphocyte count (and NLR) until day of hospital discharge 
(COMPETE-C cohort). 
 
3.6 Sample size and statistical analysis 
I powered the primary outcome on the basis that approximately 30% colorectal patients with low AT 
(<11mL/kg/min)(Wilson, Davies et al. 2010) would exhibit a prognostically significant difference in 
lymphocyte count <1.2 x 109/L,(Halazun, Aldoori et al. 2008, Ding, An et al. 2010, Proctor, McMillan et 
al. 2012) with an anticipated standard deviation of 1.0.Thus, ≥185 patients with AT > 11mL/kg/min, 
would be required compared with ≥ 56 patients with low AT (alpha = 0.05; power = 90%). Kolmogorov–
Smirnov was used to test continuous data for normality of distribution. Mean values between AT 
groups were analysed using independent samples t-test. One way MANOVA (multivariate) analysis was 
used to determine NLR and lymphopenia in low and normal AT groups adjusted for age and malignancy 
(known causes of lymphopenia(Peron, Cropet et al. 2013, Brass, McKay et al. 2014) and reduced 
AT(Matsumura, Nishijima et al. 1983, Williams, Nyasavajjala et al. 2014)) Length of stay analyses 
between normal and lymphopenic patients, high and low AT and high and low NLR were performed 
using log rank analysis and cox regression analysis was utilised to determine the effect of lymphopenia 
(<1.2 x 109 cells/L) and other potential confounding variables, once again corrected for age and 
malignancy. Related samples Friedman’s two-way analysis of variance by ranks was used to compare 
whether differences existed between non-parametric data at different perioperative time points. Post-
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hoc analysis was performed with Friedman pairwise test. All statistical analyses were performed using 
IBM SPSS Version 20 (IBM Corporation, Somers, New York, USA).  
   
77 
 
Results 
3.7 Demographics 
Demographics, and associated cardiopulmonary test parameters, of patients undergoing preoperative 
CPET are shown in Table 3.2. 
 
Table 3.2. CPET demographics in COMPETE-C colorectal surgery cohort, stratified according to the 
prognostically relevant anaerobic threshold of 11mL kg-1min-1  
 AT <11mL/kg/min AT>11mL/kg/min P-value 
Number 79 161  
Age (Years) 71 (69-73) 63 (61-66) 0.0001 
Male : Female 1.05 1.47 0.3 
Cancer n(%) 66 (86)            114 (72) 0.02 
Chemotherapy (n,%) 21 (13) 11 (14) 0.82 
Body mass index (kg/m2) 29.6 (28.5-30.6) 27.4 (26.7-28.0) 0.0004 
AT (mL/kg/min) 9.4 (8.23-10.33) 13.75 (12.2-15.78) <0.001 
VE/VCO2 30.3 (28.9-31.7) 27.8 (27.2-28.5) 0.0004 
Peak VO2 (mL/kg/min) 14.8 (13.9-15.6) 22.5 (21.5-23.4) <0.0001 
Data are presented as mean (95% confidence intervals), unless stated otherwise.  
 
Patients included in the analysis for this study were randomised to receive either goal directed colloid 
therapy or standard of care fluid therapy. There was no difference in mean AT (mean AT in both groups 
>11mL/kg/min; p = 0.589), preoperative lymphocyte count  (SD) (1.75 (0.67) vs. 1.80 (0.80) x 109/L; 
p=0.657) or preoperative relative lymphocyte count (24.6 (8.7) vs. 24.5 (8.7) %; p=0.96) between the 
randomised and non-randomised groups. Length of stay was also similar between groups (p=0.07). 
  
3.8 CPET physiological characteristics and leukocyte subsets 
69 % of patients exhibited an AT associated with New York Heart Association class 1-4 heart 
failure,(Lang, Karlin et al. 2009, Hansen, Sun et al. 2012)(Figure 3.1), with the majority of anaerobic 
threshold values consistent with Normal and NYHA Class 1-2.  
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Figure 3.1 Histogram showing numbers of patients (n=240) stratified by AT-defined NYHA class  
 
Cut-off values for AT estimated from recent 
published series (Normal >14 mL/kg/min; NYHA 1 = 
12.1-14 mL/kg/min; NYHA 2 = 10.1-12 mL/kg/min; 
NYHA 3 = 7.6-10 mL/kg/min; NYHA 4 = <7.5 
mL/kg/min).(Lang, Karlin et al. 2009, Hansen, Sun 
et al. 2012). Numbers of patients in each category 
shown in each bar. 
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3.9 Anaerobic threshold and leukocyte subsets (COMEPETE-C) 
Unadjusted, the AT cut-off value <11mL/kg/min was associated with absolute and relative lymphopenia and 
higher NLR, (Table 3.3). Adjusted for the presence of malignancy and age, impaired cardiovascular performance 
was also associated independently with higher NLR (p=0.022), absolute (p=0.001) and relative lymphopenia 
(p=0.001). Controlling for age and the presence of malignancy (present in 77% of colorectal surgical patients), no 
significant interaction was observed between malignancy and AT <11mL/kg/min (P=0.29). Multiple regression 
analysis identified AT as the sole factor associated with higher NLR (P=0.033). 
 
Table 3.3 Leukocyte subsets according to low or normal AT groups 
 ≥ 11mL/kg/min 
(n=159) 
< 11mL/kg/min 
(n=77) 
P-value 
WCC (x 109/L) 7.39 (2.09) 7.99 (2.20) 0.043* 
NLR 3.05 (1.55) 3.59 (1.65) 0.017* 
Neutrophil count 4.90 (1.85) 5.23 (1.73) 0.208 
Lymphocyte count  
(x 109/L) 
1.83 (0.76) 1.63 (0.55) 0.043* 
Monocyte count % 0.57 (0.21) 0.63(0.27) 0.07 
Lymphocyte % 25.74 (9.02) 22.32 (7.31) 0.005* 
Neutrophil % 66.31 (9.36) 69.25 (7.72) 0.02* 
Monocyte % 7.95 (2.51) 8.43 (3.04) 0.209 
 
All data represented mean (SD); n=236 patients. * = p<0.05; Missing AT data from 4 patients and missing 
preoperative leucocyte data from 11 patients. 
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3.10 Sepsis Outcomes related to lymphopenia (COMEPETE-C) 
Patients that developed postoperative sepsis in the colorectal population had lower preoperative lymphocyte 
counts compared to patients who did not develop sepsis (n=30 vs. 142; 1.61(0.45) vs. 1.85(0.77) x 109/L 
respectively; p=0.022; independent t-test). Preoperative lymphopenia was not associated with increased sepsis 
(4/15 in lymphopenic group vs. 26/157 in normal lymphocyte group; p=0.324; Chi-squared test). 
 
3.11 Postoperative development of morbidity (VISION-UK) 
In the VISION-UK patients recruited at UCLH undergoing surgery from a variety of surgical specialties, 
preoperative lymphopenia (patients with preoperative lymphocyte count <1.2 x 109/L; mean count (SD) = 1.00 
(0.46) x 109/L in lymphopenic group and 2.14 (0.81) x 109/L in normal count group) was associated with 
increased postoperative morbidity at Day 3 (antibiotic requirement, catheter requirement, no enteral feeding, 
blood transfusion requirement and pain), and at Day 7 postoperatively (pulmonary, antibiotic requirement, no 
enteral feeding, wound complications and pain; Table 3.4).  
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Table 3.4 Incidence of POMS defined complications stratified to preoperative lymphopenia  (VISION-UK) 
 
*= Demonstrates increased incidence of morbidity in lymphopenic group; AKI=acute kidney injury; N+V=nausea 
and vomiting; ACS=acute coronary syndrome 
  n Normal  
(n=773) 
Lymphopenia 
(n=96) 
Relative Risk  
[95% CI] 
P-value 
DAY 3 
POMS  
Pulmonary 161 137 24 1.41[0.97-2.06] 0.075 
Antibiotics 89 72 17 1.90 [1.17-3.09] 0.009* 
Fever 19 15 4 2.15[0.73-6.34] 0.17 
AKI 8 7 1 1.15[0.14-9.25] 0.90 
Oliguria 3 3 0 1.14[0.06-21.90] 0.087 
Catheter 68 55 13 1.90[1.08-3.35] 0.03* 
No Enteral feed 69 27 42 12.53[8.11-19.34] <0.0001* 
N+V / distension 120 103 17 1.33[0.84-2.13] 0.23 
Hypotension 5 5 0 0.73[0.04-13.02] 0.83 
ACS 3 3 0 1.14[0.06-21.90] 0.93 
Anticoagulation 3 3 0 1.14[0.06-21.90] 0.93 
Arrhythmia 4 4 0 0.89[0.05-16.34] 0.94 
Confusion 4 3 1 2.01[0.23-17.83] 0.53 
Focal neurological 
deficit 
1 1 0 2.66[011-64.84] 0.55 
Wound 39 31 8 2.08[0.98-4.39] 0.06 
Blood 27 19 8 3.39[1.53-7.53] 0.003* 
Pain 153 129 24 1.50[1.02-2.19] 0.04* 
Drain 24 19 5 2.11[0.81-5.55] 0.13 
   N=771 N=96   
DAY 7 
POMS 
Pulmonary 41 31 10 2.59[1.31-5.12] 0.006* 
Fever 5 4 1 2.01[0.23-17.78] 0.53 
Antibiotics 49 38 11 2.32[1.23-4.39] 0.009* 
AKI 4 3 1 2.68[0.28-25.48] 0.39 
Oliguria 6 4 2 4.02[0.75-12.63] 0.11 
Catheter 71 59 12 1.63[0.91-2.93] 0.10 
No Enteral feed 32 23 9 3.14[1.50-6.60] 0.002* 
N+V / distension 37 30 7 1.87[0.85-4.15] 0.12 
Hypotension 2 1 1 8.03[0.51-127.37] 0.14 
ACS 1 1 0 2.65[0.11-64.67] 0.55 
Anticoagulation 4 4 0 0.88[0.05-16.30] 0.93 
Arrhythmia 1 0 1 23.88[0.98-582.06] 0.05 
Confusion 2 1 1 8.03[0.51-127.37] 0.14 
Focal neurological 
deficit 
2 1 1 8.03[0.51-127.37] 0.14 
Wound 20 13 7 4.32[1.77-10.57] 0.001* 
Blood 7 5 2 3.18[0.63-16.17] 0.16 
Pain 27 20 7 2.81[1.22-6.47] 0.02* 
Drain 10 8 2 2.01[0.43-9.32] 0.37 
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3.12 Lymphopenia and Hospital Length of stay  
The absolute lymphocyte count, <1.2 x 109/L (COMPETE-C; n= 228; p=0.035-Figure 3.2), but not relative 
lymphocyte count <15% (p=0.243) nor NLR>5 (p=0.193), was associated with increased hospital length of stay.  
Preoperative lymphopenia was also associated with prolonged hospital length of stay in the VISION-UK patients 
(n=881; Figure 3.3).  
 
Cox regression (or proportional hazards regression) is a method for investigating the effect of several variables 
upon the time a specified event such as hospital discharge takes to happen. Cox regression analysis was 
performed on the clinical and demographic data available from the COMPETE-C data set in order to determine 
which factors influenced LOS. Results from this analysis are summarised in Table 3.5. 
 
Table 3.5 Cox regression model showing the effect of variables on length of stay  
 
Variable Co-efficient 
(B) 
Standard 
Error 
Wald (X2) P-Value Risk [95%CI] 
Age -0.015 0.007 0.504 0.478 0.995 [0.981, 1.009] 
Cancer diagnosis 0.012 0.192 0.004 0.950 1.012 [0.694, 1.475] 
RCRI score -0.156 0.094 2.759 0.097 0.856 [0.712, 1.028] 
AT 0.041 0.019 4.995 0.025* 1.042 [1.005, 1.081] 
Lymphopenia -0.479 0.204 5.526 0.019* 0.620 [0.416, 0.924] 
*= p<0.05 
 
The association between absolute lymphocyte count < 1.2 x 109/L and LOS in the COMEPETE-C cohort was found 
to be independent of age, RCRI score and diagnosis of cancer. Absolute lymphocyte count also did not 
independently predict LOS > 7 days (ROC analysis; p = 0.367) therefore indicating that alone it is not a reliable 
predictor of prolonged length of hospital stay in this patient population.  
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Figure 3.2 Kaplan Meier Plot demonstrating length of stay and preoperative lymphopenia (COMPETE—C; n=240; <1.2 x 109/L; log rank test)  
   
84 
 
Figure 3.3 Kaplan Meier plot demonstrating length of stay and preoperative lymphopenia (VISION-UK; n=881; log-rank test; p<0.001) 
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3.13 Perioperative trends in lymphocyte count and NLR (COMPETE-C) 
Day 1 to 5 postoperative counts are summarised in Figures 3.4-3.6. Absolute count, but not 
relative lymphocyte count or NLR, recovered to preoperative level by day of hospital discharge 
(p=0.082, p<0.001, p<0.001 respectively). Median length of stay (LOS) was 8 (IQR 5-13) days. 
 
Figure 3.4 Median lymphocyte count (x 109/L) in the perioperative period 
 
Numbers above x-axis demonstrate number of patients with lymphocyte counts performed. 
Proportion of patients remaining in hospital: Day 1 = 100% (n=239); Day 2 100% (n=239); Day 3 
93% (n=222); Day 4 83% (n=198); Day 5 72% (n=172). Significant difference between groups 
evaluated with related samples Friedman’s two-way analysis of variance by ranks (p<0.001; 
n=28) and post-hoc analysis performed with Friedman pairwise test.  
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Figure 3.5 Perioperative relative lymphocyte count (COMPETE-C) 
 
 
Numbers above x-axis demonstrate number of patients with lymphocyte counts performed. 
Differences between groups evaluated with related samples Friedman’s two-way analysis of 
variance by ranks (n=28; p<0.001) and post-hoc analysis with Friedman pairwise test. No 
differences were demonstrable between Day 1-Day 5 and discharge counts.  
 
 
 
 
  
# < Preoperative value, p<0.001 
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Figure 3.6 Perioperative changes in NLR (COMPETE-C) 
  
Preoperative n= 229; D1 n=208 and discharge n=163 
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Discussion  
 
3.14 Anaerobic threshold and leukocyte subsets 
The relationship between immune response and exercise capacity has previously been 
described.(Mathur and Pedersen 2008) Habitual exercise for example, is associated with 
improved immune responses to vaccination(Pascoe, Fiatarone Singh et al. 2014) and outcomes 
following viral infections(Simpson 2011) and malignancy.(Ballard-Barbash, Friedenreich et al. 
2012)  
 
These data show that cardiac failure, stratified by AT (<11mL/kg/min measured by CPET), is 
associated with lymphopenia and raised NLR. These biomarkers have emerged as robust 
prognostic indicators of colorectal surgical outcome.(Satomi, Murakami et al. 1995, Walsh, 
Cook et al. 2005, Chu-Yuan, Jing et al. 2013, Kozak, von Eyben et al. 2015) Though many studies 
have reported the association between preoperative NLR and postoperative complications 
(Cook, Walsh et al. 2007, Halazun, Aldoori et al. 2008, Ding, An et al. 2010, Proctor, McMillan 
et al. 2012, Jankova, Dent et al. 2013) and low AT and postoperative complications,(Lee, 
Chaloner et al. 2006, Murray, Whiting et al. 2007, Ausania, Snowden et al. 2012, Colson, Baglin 
et al. 2012, Hartley, Pichel et al. 2012, Junejo, Mason et al. 2012, Swart and Carlisle 2012) none 
have thus far linked lymphopenia (or NLR) to aerobic performance.  
 
These findings suggest that low preoperative AT, often found in patients who have not 
received a formal diagnosis of heart failure, is associated with lymphopenia which is indicative 
of a chronic inflammatory immune state. This pre-existing immune state appears to be 
associated with subsequent development of complications from all body systems resulting in 
prolonged hospital length of stay. Prolonged hospital stay in patients with preoperative 
lymphopenia has been demonstrated in two separate cohorts (colorectal and different types of 
non-cardiac surgery). This suggests that this is a phenomenon, which is consistently seen in 
lymphopenic patients undergoing major elective surgery. Since the presence of overt cardiac 
failure is an important prognostic factor in determining postoperative outcome,(Hernandez, 
Whellan et al. 2004, Hammill, Curtis et al. 2008) this data suggests that dysregulation of 
inflammatory control may play a contributory role in developing postoperative morbidity.  
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Cardiac failure is associated with neurohormonal activation and chronic systemic 
inflammation,(Topkara, Evans et al. 2011) characterised by marked alteration in absolute 
numbers, and function, of polymorphonuclear, monocytes and T-cells.(Topkara, Evans et al. 
2011) More severe heart failure is associated with higher levels of circulating 
endotoxin(Niebauer, Volk et al. 1999), cytokines(Rauchhaus, Koloczek et al. 2000) and 
lymphopenia.(von Haehling, Schefold et al. 2009, Nunez, Minana et al. 2011, Vaduganathan, 
Ambrosy et al. 2012) Immune dysregulation has been traditionally thought to be a marker of 
cardiac disease progression. However recent evidence suggests that cardiac failure and poor 
aerobic capacity are in fact caused by immune dysfunction.(Topkara, Evans et al. 2011) There is 
also evidence demonstrating patients with preoperative depletion of antibodies to endotoxin 
exhibit higher levels of proinflammatory cytokines and sustaining more perioperative 
morbidity.(Bennett-Guerrero, Ayuso et al. 1997, Bennett-Guerrero, Panah et al. 2001)  
 
Whether lymphopenia is a mediator, or a marker, of poorer perioperative outcomes requires 
further research. Data in this chapter demonstrates a significantly lower preoperative 
lymphocyte count in patients who subsequently develop sepsis, which supports previous 
studies highlighting the important role of lymphocytes in murine(Hotchkiss, Tinsley et al. 1999) 
and human(Heffernan, Monaghan et al. 2012) models of injury/critical illness. A substantial 
proportion of patients exhibit lymphopenia preceding surgery, which suggests the presence of 
an “at risk” population of patients susceptible to developing postoperative morbidity. This is 
also consistent with recent data showing increased mortality in patients failing to reverse 
lymphopenia during critical illness.(Heffernan, Monaghan et al. 2012) 
 
There are several limitations of this exploratory study. Matching NYHA class to CPET variables 
may be inaccurate given the fact that inter-observer variability exists among clinicians grading 
severity of cardiac failure according to clinical symptoms using the NYHA system.(Raphael, 
Briscoe et al. 2007) Validation of these cut-off values analysing lymphocyte functionality and 
AT may be warranted together with measurement of endotoxin levels. The association 
between NLR and coronary artery disease (Demir 2013, Fowler and Agha 2013) may reveal 
mechanistic links to perioperative outcomes, including myocardial injury. Ultimately, detailed 
outcome data- including propensity to infectious complications- would test the hypothesis 
further that low AT may be associated with defective innate and/or adaptive immune 
functionality. 
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In summary, lymphopenia is associated with impaired cardiorespiratory reserve. These 
observations suggest that preoperative inflammation, associated with impaired 
cardiorespiratory performance, may contribute a pathophysiological role in determining 
postoperative outcome. 
 
3.15 Lymphopenia and length of stay 
This data demonstrates an association between lymphopenia (<1.2 x 109/L) and prolonged 
length of hospital stay following elective colorectal surgery. This cut-off value of lymphopenia 
has also previously been related to worse survival in patients with pancreatic cancer.(Fogar, 
Sperti et al. 2006) The effect of lymphopenia on LOS in this cohort was found to be 
independent of age, RCRI and diagnosis of cancer. Assessing hospital stay in this cohort reflects 
the acquisition of postoperative morbidity, and thus serves a useful time-dependent measure 
enabling the most robust statistical assessment – Kaplan-Meier/log-rank tests- to interrogate 
the data, as previously reported.(Visser, Keegan et al. 2009) Development of sepsis in this 
cohort was also associated with a lower preoperative lymphocyte count. It should be noted 
that while the Compete-C trial was a study demonstrating no differences in outcome between 
goal-directed therapy and control groups,(Challand, Struthers et al. 2012) there are clear 
differences between lymphopenic and normal lymphocyte groups with regards to length of 
stay.   
 
Consistent with findings from previous studies, this study demonstrates that there is a 
significant decrease in absolute and relative lymphocyte counts and a rise in NLR seen 
postoperatively. Previous studies have reported normalisation of lymphocyte count by the 4th-
7th day following major general surgery.(Hamid, Bancewicz et al. 1984, Lennard, Shenton et al. 
1985) This data is consistent with previously published data since absolute lymphocyte counts 
did not return to preoperative levels by the 5th postoperative day, but did so by the day of 
hospital discharge (median LOS [IQR] = 8 [8] days).   
 
Further work is required to elucidate the factors, which influence recovery of leukocyte 
numbers. This data has not determined the individual or combined effects of anaesthesia and 
surgery upon leukocyte subset values. The advantage of using a homogenous tissue injury 
model such as colorectal surgery in a single institution was the limitation of a number of 
potential confounding factors including: pre-existing surgical comorbidity, surgical type,  
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operator, anaesthesia provider care and postoperative care received. The reproduction of 
results in other surgical specialties validates these findings.  
 
In summary, preoperative lymphocyte count has emerged as a robust prognostic marker of 
surgical outcome, which raises the clinically relevant possibility that preoperative immune 
characteristics contribute to the pathophysiological mechanisms determining postoperative 
outcome. Furthermore even at the time of hospital discharge NLR and relative lymphocyte 
levels do not return to pre-surgery level, which implies that immunological recovery from 
surgery may take longer than previously appreciated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
92 
 
 
 
 
 
CHAPTER 4 
Postoperative lymphopenia is 
associated with a hypometabolic 
phenotype  
 
 
 
 
 
   
93 
 
Chapter 4 
Postoperative lymphopenia is associated 
with a hypometabolic phenotype  
4.1 Heart failure and lymphocyte bioenergetic function 
Mitochondrial physiology of lymphocytes has previously been associated with metabolism 
of other cells including cardiomyocytes in murine studies.(Cortez, Neves et al. 2012) This 
concept is supported by studies demonstrating increased apoptosis of peripheral 
lymphocytes following myocardial infarction,(Konstantinova, Khomyakova et al. 2011) and 
myocardial mitochondrial dysfunction being demonstrated as a major contributing factor 
to cardiac failure.(Rosca, Minkler et al. 2011) Consequently lymphopenia may result in 
reduced AT as described in Chapter 3. Development of pre or postoperative lymphopenia 
may be secondary to impaired metabolic function.  
 
Most studies thus far exploring lymphocyte metabolism have been either murine studies 
or experiments performed on human leukaemic cell lines. In this chapter I explore the 
bioenergetic changes associated with postoperative lymphopenia, (which has been 
unequivocally demonstrated to occur in Chapter 3).  
 
4.2 Surgery and bioenergetic function of lymphocytes 
Decreased lymphocyte proliferation in response to mitogenic stimulation occurs after 
tissue trauma,(Faist, Schinkel et al. 1993) which can last for days.(Horgan, Mendez et al. 
1994) Impaired T cell proliferation is associated with increased susceptibility to infection 
and death.(Keane, Birmingham et al. 1983) Bioenergetic changes inducing lymphocyte 
apoptosis following anaesthesia and surgery may be a possible cause of postoperative 
immune dysfunction and increased morbidity. There is thus far no published human data 
describing the effect of surgery on bioenergetic function of lymphocytes. 
 
Despite the importance of having sufficient ATP available for the energy-dependent 
processes involved in immune activation, little is known about the metabolic adaptations 
that occur in vivo to meet the increased ATP requirements during activation of 
lymphocytes in the postoperative state and in the presence of other pathologies including 
heart failure.(Gatza, Wahl et al. 2011)  
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Lymphocyte functions required for a successful response to antigenic stimulation are 
dependent on an increase in ATP via glycolysis.(Jones and Thompson 2007) Defects in 
cellular energy production can lead to both reduced lymphocyte function, and apoptosis 
with consequent lymphopenia. Bioenergetic failure is therefore a potential unifying defect 
consistent with both postoperative lymphopenia and a failure to respond appropriately to 
lymphocyte activation induced by the range of perioperative insults encountered. 
Postoperative tendency of lymphocytes to undergo apoptosis may also be secondary to 
bioenergetic dysfunction. 
 
4.3 Hypothesis 
Metabolic dysfunction develops in lymphocytes postoperatively.  
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Methods 
4.4 Patients 
For study, I selected a stable, well-defined population of patients free of pathologies 
associated with lymphopenia, undergoing scheduled, standardised tissue trauma (elective 
joint replacement surgery),(Bennett-Guerrero, Welsby et al. 1999, Ghaferi, Birkmeyer et 
al. 2009, Kirksey, Chiu et al. 2012) and characterised metabolic changes in lymphocytes 
postoperatively. 
 
Orthopaedic patients undergoing elective hip and knee arthroplasty for degenerative 
arthropathy were recruited into the single-centre POM-E study at University College 
London Hospital. The same teams performed surgery and anaesthesia, and standardised 
care was delivered according to local protocols. Patient recruitment and protocol is 
summarised in Chapter 2.2. 
 
4.5 Extracellular flux analyzer (Seahorse XF24) technique 
Methods of cell separation and bioenergetic analysis of lymphocytes is summarised in 
Chapter 2. 
 
4.6 Statistical Analysis 
Data were analysed by descriptive and comparative approaches. All experiments were 
performed in replicates of 4-5 (lymphocyte yield permitting). Laboratory studies were 
powered on the basis that previous work has reported that ≥30% fall in ATP production 
result in altered cellular function.(Leist, Single et al. 1997) Given that normal ATP content 
in lymphocytes is approximately 3 nmol per million cells(Karlsson, DePierre et al. 1997, 
Gergely, Grossman et al. 2002) an anticipated difference in ATP content of 1±0.5 nmol 
(mean±SD) between lymphocyte groups would require at least 7 pre- and postoperative 
matched patient samples per experiment or lymphocyte count group (α=0.05; β=0.8).  
Therefore to account for approximately 45% dropout or withdrawal from the study or 
discharge before day 3 postoperatively a sample size of 13 would be needed. All results 
are expressed as absolute numbers and percentages (means ±SD). Fisher’s exact test was 
used to compare categorical data distributions, and Kolmogorov–Smirnov to test 
continuous data for normality of distribution of continuous data. Parametric methods and 
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tests were used as indicated to analyse normally distributed data, and two-group non-
parametric Wilcoxon signed-rank and Mann–Whitney U tests to analyse data deviating 
from a normal distribution. Statistical analyses were undertaken with IBM SPSS Version 20 
(IBM Corporation, Somers, New York, USA). Reported P values are two-sided, and a p 
value ≤0.05 was considered to indicate statistical significance.  
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Results 
4.7 Demographics 
13 patients undergoing elective orthopaedic surgery (POME-E) were recruited into this 
study. Patient characteristics are summarised in Table 4.1. Perioperative changes in 
lymphocyte count are shown in Figure 4.1. 
 
Table 4.1 Pre vs. postoperative (paired sample) orthopaedic patient characteristics 
 
 
 
 
 
 
Values presented as mean (95%CI) 
 
 
 
 
 
  
 Patient Cohort (n=13)  
Age (years) 74 (69 - 78) 
Preoperative lymphocyte count (x 109/L) 1.77 (1.30-2.23) 
Preoperative relative lymphocyte count (%) 26.85 (20.45 – 33.25) 
Postoperative lymphocyte count  (x 109/L) 1.38 (0.95-1.81) 
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Figure 4.1 Perioperative changes in lymphocyte count in patients recruited for 
bioenergetic analysis 
   
n=13; p<0.0001; Wilcoxen signed rank test 
 
4.8 Oxygen consumption rate 
Figure 4.2 demonstrates the postoperative median (IQR) reduction in oxygen 
consumption of number matched lymphocytes taken preoperatively and day 3 
postoperatively. ETC accelerator response (defined as maximum response following FCCP 
– non-mitochondrial baseline oxygen consumption; see Figure 2.4) decreased 
postoperatively (383.44 (147.77-619.10) vs. 142.28 (107.62-176.93) pMoles/min; 
p=0.038). This rate is indicates the maximal oxygen consumption by mitochondria (the 
difference between baseline oxygen consumption from non-mitochondrial sources and 
maximal consumption following FCCP). It gives an indication of the oxygen consumption 
that can take place at complex IV, whether limited by availability of substrate or activity of 
the electron transport chain. This is a measure of the maximal potential respiratory 
capacity the cell can utilise under conditions of stress and/or increased energetic demands 
e.g. occurring during activation and proliferation 
 
Median coupling efficiency (OCR basal – OCR Oligomycin;  (IQR; indicating the amount of 
cellular oxygen consumption coupled to ATP synthesis) decreased postoperatively (126.61 
(72.54 – 180.68) vs. 50.33 (36.72 – 63.95) pMoles/min; p=0.005), spare respiratory 
capacity (maximal potential respiratory capacity the cell can utilise under conditions of 
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increased energetic demands) decreased postoperatively (OCR FCCP – OCR basal; 235.77 
(63.81 – 407.74) vs. 80.57 (58.33 – 102.82) pMoles/min; p=0.007; IQR; Related samples 
Wilcoxen signed rank test). 
 
4.9 Extracellular acidification rate 
The effect of 2 deoxyglucose on ECAR in shown in Figure 4.3. The changes in extracellular 
acidification rate are summarised in Table 4.2. There was a decrease in postoperative 
ECAR values at baseline and following administration of each drug. Mean glycolytic 
reserve (FCCP ECAR - 2DG ECAR; 95% CI) decreased postoperatively (106.61 (73.52 -
139.70) vs. 75.38 (56.03 – 94.73); p=0.016).  
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Figure 4.2 Median oxygen consumption rate of lymphocytes preoperatively and day 3 
postoperatively 
A) Baseline OCR (n=13; p=0.002) 
 
B) OCR following oligomycin (n=13; p=0.016) 
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C) OCR following FCCP (n=13; p=0.004) 
 
D) OCR following rotenone and antimycin-A (n=13; p=0.039) 
 
 
 
All paired values analysed using related samples Wilcoxen Signed rank test 
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Figure 4.3 Effect of 2DG (2 deoxyglucose) on oxygen consumption rate in the 
perioperative period (n=7; p=0.028)  
 
 
 
 
All paired values analysed using related samples Wilcoxen Signed rank test 
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Table 4.2 Perioperative extracellular acidification rate values 
Treatment Preoperative ECAR 
mpH/min (95% CI) 
Postoperative ECAR 
mpH/min (95% CI) 
p-value 
Basal  60.10 (30.88-89.32) 37.41 (22.28-52.54) 0.0029* 
Oligomycin  103.96 (51.95-155.96) 73.12 (47.33-98.91) 0.0236* 
FCCP 132.94 (70.24-195.64) 92.11 (60.49-123.74) 0.0225* 
Rotenone / Anti-A  106.56 (56.74-156.37) 72.15 (48.27-96.02) 0.0260* 
2DG  17.16 (12.78-21.54) 12.12 (5.92-18.33) 0.1075 
 
* Represents p value < 0.05. Values presented as mean (95%CI) 
 
4.10 Glucose uptake 2-NBDG  
I next aimed to demonstrate that mitochondrial inhibitors increased glucose uptake, and 
addition of concanavalin did not affect glucose uptake, implying cell viability was not 
affected. Mitochondrial inhibitors utilised were: oligomycin (0.25 µM) and FCCP (2 µM); in 
medium containing physiologically normal concentrations of glucose to mimic 
normoglycaemia (6 mmol/L). Isolated lymphocytes obtained from 3 non-diabetic 
preoperative patients. Uptake of 2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-
2-Deoxyglucose), a fluorescent glucose analogue was measured using flow cytometry, 
following activation of lymphocytes with concanavalin-A for 2 hrs to monitor glucose 
uptake in live cells, as an indicator of cell viability. Glucose uptake occurred following 
administration of concanavalin-A, oligomycin and FCCP, indicating cell viability in the 
methodology used in this study (Figure 4.4). 
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Figure 4.4 Effect of Concanavalin A and mitochondrial inhibitors on glucose uptake (2NBDG) 
  
CTRL = Control 
CON A = Concanavalin A 
OLIGO = Oligomycin 
Cell viability confirmed by the uptake of 2-NDBG in 
lymphocytes treated with Con-A, oligomycin and 
FCCP. Addition of Concanavalin A did not affect 
glucose uptake in control sample (p=0.285), 
Oligomycin (p=1.00), or FCCP (p=1.00).  
No significant difference in 2-NDBG uptake with 
addition of oligomycin or FCCP. 
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Discussion  
4.11 Discussion 
This study demonstrates that there is a postoperative decrease in oxygen consumption in 
lymphocytes following brief activation with concanavalin A. Concanavalin stimulation was 
limited to 1 hour as further stimulation has been associated with cell apoptosis.(Barbosa, 
Arruda et al. 2001) Cell viability was confirmed in this study with positive uptake of 
glucose in the presence of concanavalin A and mitochondrial inhibitors. The decrease in 
lymphocyte cell metabolic function on day 3 following surgery corresponds with the 
ongoing presence of postoperative lymphopenia (both absolute and relative) seen in 
these patients.  
 
Bioenergetic failure is a core feature of failure to recover from critical illness.(Brealey, 
Brand et al. 2002, Carre, Orban et al. 2010, Boomer, To et al. 2011, Pan, Yamada et al. 
2011, Kubota, Chida et al. 2012) This data demonstrates that lymphocytes taken from 
patients postoperatively exhibit a distinct bioenergetic profile characterised by low 
metabolic capacity. The maximum OCR achieved following FCCP (ETC accelerator 
response) injection and spare respiratory capacity (indicator of maximal respiratory 
capacity of the lymphocyte under conditions of increased energetic demand e.g. antigen 
stimulation, cytokine / antibody production, proliferation Table 1.4), were lower 
postoperatively suggesting that there may be an inability for lymphocytes to meet the 
demand of energy production via oxidative phosphorylation required for immune 
activation and proliferation in the postoperative period.  
 
Lymphocytes activated in vitro preferentially convert pyruvate into lactate that is secreted 
from the cells rather than oxidize pyruvate in the mitochondria, a process known as 
aerobic glycolysis.(Vander Heiden, Cantley et al. 2009) The decrease in ECAR at baseline 
following surgery and after administration of each mitochondrial inhibitor also shows that 
there is a decrease in lymphocyte glycolysis postoperatively. Regulatory genetic variants 
involving key mediators of gene networks have been implicated in the switch to glycolysis 
that occurs in sepsis, including HIF1α and mTOR, and mediators of endotoxin tolerance, T-
cell activation, and viral defence.(Davenport, Burnham et al. 2016) Furthermore 
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transcriptome data in a study by van Vught et al. suggests a role for impaired glycolysis in 
immune suppression in patients with sepsis and susceptibility for ICU-acquired 
infections.(van Vught, Klein Klouwenberg et al. 2016) Genetic variants may be important 
in postoperative lymphocyte metabolic function and patient outcome and therefore 
warrants further exploration. The rate of change in pH in tissue culture extracellular fluid 
is a function of the cell concentration and rate of proton excretion per cell. Therefore 
inhibition of ECAR may have been related to the number of viable cells from cellular 
damage during the experiments. Cell viability was assessed prior to commencing 
experiments and was found to be >90% in all cases. Addition of Cell Tak and plating did 
not affect viability.(Edwards 2012) Loss of cell viability during extracellular flux analysis 
may have occurred but would be in keeping with the hypothesis of increased apoptosis of 
postoperative lymphocytes resulting from impaired bioenergetic function causing 
lymphopenia. Other causes for reduced ECAR include reduced lactate production 
secondary to inhibition of pyruvate to lactate conversion.  
 
This study demonstrates postoperative global mitochondrial impairment and impaired 
glycolysis. Increased metabolism is a critical part of activation because if T cells fail to 
increase glucose metabolism due to inadequate nutrients or direct metabolic inhibition, 
activation and proliferation are suppressed.(Cham and Gajewski 2005, Jacobs, Herman et 
al. 2008, Shi, Wang et al. 2011). Since lymphocyte metabolism is closely related to 
survival, function and differentiation, these findings are consistent with the hypothesis 
that decreased lymphocyte proliferation in response to mitogenic stimulation occurs after 
tissue trauma (surgery),(Faist, Schinkel et al. 1993) which can last for days.(Horgan, 
Mendez et al. 1994) Therefore postoperative bioenergetic dysfunction in lymphocytes 
could be a contributing mechanism leading to increased lymphocyte apoptosis and 
reduced absolute and relative lymphocyte counts that occurs in the postoperative period 
(Chapter 3). Parameters describing cellular function of peripheral blood mononuclear cells 
in bioenergetic terms have been shown to semi-quantitatively correlate with the activity 
of rheumatoid disease and proved useful in assessing the therapeutic effect of the 
disease.(Kuhnke, Burmester et al. 2003, Doherty, Oaks et al. 2014) Mitochondrial 
hyperpolarization and the resultant ATP depletion have been shown to sensitise T cells for 
necrosis in patients with SLE, which may contribute to inflammation in these 
patients.(Gergely, Grossman et al. 2002) ATP depletion has been related to increased 
apoptosis in human T cells.(Leist, Single et al. 1997) The clinical effects of decreasing 
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baseline OCR to one-third (as seen in these patient samples) of preoperative values, 
warrant further investigation. These perioperative bioenergetic changes may however 
contribute to increased susceptibility to infection following surgery (Chapter 3).  
 
Since I controlled for the number of lymphocytes interrogated using the flux analyser 
there is a clear postoperative decline in oxidative phosphorylation and glycolysis of 
lymphocytes. Although this is consistent with the concept of postoperative immune cell 
anergy which has previously been described in T lymphocytes(Maciver, Jacobs et al. 2008) 
and immune regulatory cells,(Faist, Baue et al. 1983, Haupt, Riese et al. 1998) the stage of 
lymphocyte cell cycle was not formally interrogated in this study, which would further 
support this hypothesis . A similar immune phenotype of decreased oxidative 
phosphorylation has been demonstrated in sepsis, (Crouser 2004, Carre and Singer 2008, 
Exline and Crouser 2008) chronic immune states and associated with organ dysfunction 
occurring in critical illness.(Banz, Jakob et al. 2011) Mitochondrial dysfunction in sepsis is 
linked with derangements in energy homeostasis and may involve impairment of electron 
flow through the ETC complexes(Crouser, Julian et al. 2002, Callahan and Supinski 2005, 
Belikova, Lukaszewicz et al. 2007) or increase in the proton conductance through the inner 
mitochondrial membrane.(Crouser, Julian et al. 2002, d'Avila, Santiago et al. 2008) These 
changes can affect mitochondrial oxygen consumption, resulting in bioenergetic failure as 
a consequence of impaired oxidative phosphorylation.(Crouser 2004, Carre and Singer 
2008, Exline and Crouser 2008) Reduced ATP content and complex I activity from skeletal 
muscle have also been associated with increased severity of sepsis,(Brealey, Brand et al. 
2002) compared to asymptomatic surgical patients.(Brealey, Brand et al. 2002, Edwards, 
Sultan et al. 2015) This highlights that a proportion of patients undergoing elective surgery 
may be predisposed to the increased risk of development of postoperative lymphocyte 
apoptosis, subsequent lymphopenia and morbidity.  
 
The post-surgical alteration in oxygen consumption and glycolysis demonstrated in this 
study may be associated with alterations in immune response, including impaired T cell 
proliferation which has previously been associated with increased susceptibility to 
infection.(Keane, Birmingham et al. 1983) Therefore the decreases seen in OCR and ECAR 
postoperatively may result in diminished lymphocytic function dependent on ATP 
production. This may impair host responses to subsequent pathological and inflammatory 
insults and thus impact on multiple organ systems in the postoperative period as 
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described in a two-hit hypothesis. This may explain the increased complication rates and 
resultant prolonged hospital length of stay demonstrated in patients with preoperative 
lymphopenia (Chapter 3).  
 
4.12 Differences in methodology compared to other lymphocyte bioenergetic studies 
Four times the number of lymphocytes were utilised per experiment in this study (1 
million vs. 250,000) compared to in the methodology published by Chacko et al.(Chacko, 
Kramer et al. 2013) and also lymphocytes were stimulated with concanavalin A for 1 hour 
prior to flux analysis. Concanavalin is a commonly utilised T cell mitogen which,(Dwyer 
and Johnson 1981), which was administered to stimulate activation of T cells and thereby 
increase ATP utilisation and production in order to maximise the signal demonstrated 
during bioenergetic profiling, without affecting cell viability. The difference in 
methodology is likely to be related to the effect of phosphate buffered saline (PBS) on 
metabolic function of lymphocytes, as Chacko et al. found increased oxidative 
phosphorylation with the use of RPMI compared to PBS. This may be due to presence of 
glutamine, which is a nutrient known to increases oxidative phosphorylation.(Lanning, 
Looyenga et al. 2014) Murine studies suggest that CD8(+) cells may have increased ability 
compared with CD4(+) cells to oxidise glutamine as an alternative fuel source, (Cao, 
Rathmell et al. 2014) which may alter metabolic profiles and results from lymphocytes 
interrogated. Utilising a greater number of lymphocytes and resuspension with PBS rather 
than RPMI may therefore result in altered metabolic profiles of lymphocytes due to it 
RPMI being a more effective culture medium than PBS.(Chacko, Kramer et al. 2013) 
Additionally I incubated cells with concanavalin A to increase oxygen consumption and 
metabolic activity prior to analysing bioenergetic profile which was not done in the 
Chacko et al. study perhaps because magnetic bead cell separation was used, which itself 
can activate cells.(Onlamoon, Boonchan et al. 2013) Instead I chose to utilise a Ficoll 
separation technique, which resulted in different timings before extracellular flux analysis 
could be commenced. The method utilised to isolate lymphocytes varied. In this study, 
monocytes were separated from mononuclear cells by adherence following isolation after 
Ficoll separation (98% purity), whereas Chacko et al. only obtained >80% purity by utilizing 
bead separation, which is substantially less than the 97% that would usually be expected 
with the use of such a technique.(Semple, Allen et al. 1993) However regardless of 
numbers of cells, and medium utilised to incubate cells, the methodology in this study was 
identical pre- and postoperatively with matched patient samples.  
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4.13 Study strengths 
While surgical studies are often flawed due to presence of heterogeneity and confounding 
factors such as cancer within recruited patients, this study was undertaken on a relatively 
homogenous major surgical population undergoing elective hip and knee arthroplasty 
surgery. I studied orthopaedic patients as they represent the majority of elective surgery 
across different healthcare systems,(Hagen, Vaughan-Sarrazin et al. 2010) involving an 
increasingly aged population (mean age of 74 years in this study) with multiple 
comorbidities. The surgical procedures in this study were also standard models of tissue 
injury and recovery profiles without confounding factors such as sepsis and malignancy. 
Furthermore, a significant burden of clinical morbidity is not uncommon in these patients, 
as demonstrated by hospital readmission rates.(Jencks, Williams et al. 2009) Finally, there 
is an association between anergy, failure of delayed hypersensitivity response, and 
lymphopenia(Gibson, Croal et al. 2007) with adverse outcomes following surgery(Christou, 
Meakins et al. 1995), trauma(Puyana, Pellegrini et al. 1998, Bandyopadhyay, De et al. 
2007) and sepsis.(Venet, Chung et al. 2009) However, the paucity and heterogeneity of 
patient studies, plus the complexity of the surgical procedures (chiefly in patients 
undergoing cancer surgery), limit robust conclusions from being drawn. The serial analysis 
of perioperative samples, enabling each patient to act as their own control, is a robust 
model that circumnavigates the significant challenges of appropriate control samples and 
minimises the potential for confounding factors within the study.  
 
4.14 Study limitations 
Limitations include the limited numbers of cells that could be obtained from 
postoperative and lymphopenic patients, which limited the number of experiments that 
could be performed rather than the validity of findings. The use of isolated lymphocytes 
may be considered a strength of this ex-vivo study, by allowing interrogation of cell 
metabolic profiles. However, since isolated lymphocytes were not in their natural milieu 
found in-vivo, the lymphocytes studied may have demonstrated different metabolic 
profiles in response to cytokines and afferent signals from other cells and neurohumoral 
systems. Also differences in metabolic profiles between different lymphocyte subsets 
were not interrogated as this was limited by lymphocyte yield. Ideally, one would combine 
the information obtained from cellular and in-vivo/ex-vivo studies to obtain a more 
complete characterization of metabolism. This would be extremely difficult to perform in 
practice due to limited lymphocyte yield from human blood sampling and inability to 
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administer mitochondrial complex inhibitors in vivo. Murine studies could be performed, 
however these do not necessarily translate to human responses as discussed in Chapter 
1.8 and serial blood sampling would be difficult to perform.  
 
All patients in this cohort underwent hip or knee arthroplasty under general anaesthesia 
with inhalation agent for maintenance, with or without peripheral nerve blockade. It 
remains unclear whether undergoing surgery utilising a regional technique alone e.g. 
neuraxial anaesthesia would alter postoperative bioenergetic function in any way, 
however when combined with regional the effect on bioenergetic function of lymphocytes 
appeared to be ubiquitous. None of the patients in this cohort underwent surgery under 
regional anaesthesia alone and therefore this question cannot be answered in this study. 
It remains unclear whether the effects demonstrated on lymphocyte metabolic profiles in 
this study are the result of tissue trauma and subsequent neurohumoral responses. 
Therefore further work is needed to elucidate the effect of age, type of surgery, site of 
surgery, postoperative analgesia regimens and postoperative infection on bioenergetic 
function of lymphocytes.  
 
In summary lymphocytes demonstrate a hypometabolic phenotype postoperatively 
(decreased oxidative phosphorylation and glycolysis). Reduced ATP production has 
previously been related to T cell apoptosis, however findings from this study introduce the 
idea of postoperative lymphopenia occurring secondary to ETC dysfunction induced 
apoptosis. To explore this hypothesis further I next interrogate perioperative lymphocytes 
for changes in mitochondrial ROS production and mitochondrial membrane potential. 
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Chapter 5 
Perioperative lymphocyte mitochondrial 
membrane potential and reactive oxygen 
species production 
5.1 Reactive oxygen species and oxidative stress 
Reactive oxygen species (ROS), formed as a natural by-product of oxygen metabolism 
include free radicals, oxygen ions and peroxides. Although ROS plays an important role in 
the immune system and is involved in key signalling events, excess levels can cause 
damage to lipids, DNA and proteins. This phenomenon is known as oxidative stress. 
 
Mitochondria play a critical role in energy balance within cells, regulation of apoptotic 
proteins and are also the main source of reactive oxygen species (ROS). ROS are 
considered pathogenic in many disease states.(Aronis, Melendez et al. 2003) Superoxide 
production occurs during the oxidative phosphorylation process of cellular respiration in 
the process of reduction of molecular oxygen by the ETC.(Lambert and Brand 2009). The 
superoxide produced in turn can initiate a cascade of reactions that produce other ROS 
including peroxynitrite, hydrogen peroxide, and hydroxyl radical. A vicious circle of 
oxidative stress and damage to cellular structures can lead to either cell death by 
apoptosis or to a cellular energetic decline and aging.(Cadenas and Davies 2000) 
Mitochondrial dysfunction caused by oxidative stress has been implicated in numerous 
disease stages including neurodegeneration, cancer, diabetes and aging.(Griendling, 
Sorescu et al. 2000)  
 
5.2 Mitochondrial reactive oxygen species and membrane potential  
Decreased bio-energetic function and altered postoperative ETC function have been 
demonstrated in postoperative patients (Chapter 4). Impaired ETC function can decrease 
mitochondrial membrane potential,(Peng, Yu et al. 2006) and is associated with increased 
mitochondrial ROS (mROS) production (in leukaemic THP-1 cell lines) (Zhou, Yazdi et al. 
2011) and increased apoptosis (in astrocytes).(Jou 2008) While the association between 
impaired ETC and increased mROS has not been reproduced in human lymphocytes, or 
explored in the perioperative period, THP-1 cell line is a human cell line which does 
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provide insight into potential mechanisms of postoperative immune cell dysfunction 
which could explain the ETC dysfunction demonstrated in this thesis. 
 
Results from experiments utilising cell lines must be interpreted with some caution 
however. For example, because the THP-1 cell line was derived from the blood of a 
patient with acute monocytic leukaemia, the extent to which THP-1 cells mimics 
lymphocytes in vivo is not entirely known.(Qin 2012) THP-1 are cancer cells, which 
undergo increased levels of glycolysis(Gatenby and Gillies 2004) and oxidative 
phosphorylation(Zheng 2012) due to their constant proliferative state. In THP-1 cells, 
metabolites in the TCA cycle are not decreased to the same extent by 2-DG, which 
indicates that THP-1 utilises energy sources other than glucose. TCA cycle metabolites in 
THP-1 cells may be derived from acetyl-CoA by fatty acid β-oxidation.(Miwa, Shikami et al. 
2013)  
 
While reduced oxidative phosphorylation can result in reduced ROS production, 
mitochondrial DNA damage can result in a state of increased mROS production, reduced 
ATP production, reduced oxidative phosphorylation and mitochondrial 
dysfunction.(Kirkinezos and Moraes 2001) The relationship between ETC dysfunction, 
mROS production and mitochondrial membrane potential are outlined in Figure 5.1.  
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Figure 5.1 Mechanism by which ETC dysfunction may result in increased mitochondrial ROS, reduced oxidative phosphorylation and reduced membrane 
potential 
 
ETC= electron transport chain; mROS= mitochondrial 
reactive oxygen species; MP= membrane potential; 
mitochondrial oxidative damage can result in release of 
intermembrane space proteins such as cytochrome c (Cyt 
C) to the cytosol by mitochondrial outer membrane 
permeabilisation and thereby activate cell apoptosis. 
mROS also induces mitochondrial permeability transition 
pore (PTP), rendering the inner membrane permeable to 
small molecules during ischaemia / reperfusion injury. 
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In this chapter I aim to demonstrate increased mROS production and reduced 
mitochondrial membrane potential secondary to iatrogenic / induced ETC dysfunction 
mimicking the postoperative phenotype (Figure 5.1). Postoperative reduction in bio-
energetic function may occur due to impairment of the ETC which results in increased 
oxidative stress, increased mROS, reduced mitochondrial membrane potential, ultimately 
increasing propensity for lymphocyte apoptosis. This could provide a unifying mechanism 
for postoperative reduction in oxidative phosphorylation and OCR. 
 
5.3 Hypothesis 
Oxidative stress and decreased mitochondrial membrane potential develops within 
lymphocytes postoperatively.  
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Methods 
5.4 Mitochondrial membrane potential (Tetramethylrhodamine, Methyl Ester; TMRM); 
whole blood assay 
 
(a) Patients 
Patients undergoing general, urological, breast and orthopaedic surgery (VISION-UK) at 
University College London Hospital were recruited into this single centre study. All 
prospectively recruited subjects provided written informed consent for data collection 
combined with blood sampling, following ethical committee approval. Surgery and 
anaesthesia were performed and standardised care was delivered according to study 
protocols outlined in Chapter 2.  
 
Preoperative and day 2 postoperative paired patient blood samples were taken from 
individuals. Day 2 samples were taken to standardise pharmacological interventions 
among the majority of patients and most patients were still in hospital on this day.  
 
(b) Flow cytometry analysis of TMRM assay 
Preparation of cells for the TMRM assay is summarised in the General Methods chapter 
(Chapter 2.8). Mitochondrial membrane potentials (Median FIuorescence Intensity of 
TMRM) of CD4(+) and CD8(+) cells were recorded as demonstrated in Figure 5.2 and 5.3. 
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Figure 5.2 Flow cytometry analysis of lymphocyte mitochondrial membrane potential  
 
Lymphocyte population gated onto scatter plots A 
and C as previously described. CD4(+) cells gated 
onto histograms B and D in order to elucidate MFI. 
FCCP is a positive control (C-D), which decreases 
mitochondrial membrane potential, resulting in a 
decrease in MFI.  
Isotype control sample used to determine CD4(+) 
cells as previously described.  
No isotype control for TMRM.  
Unstained control shown in E. 
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Figure 5.3 Changes in perioperative mitochondrial membrane potential of CD4 cells as demonstrated by PE (TMRM) MFI 
 
Decrease in TMRM MFI demonstrated in CD4(+) cells 
from one patient sample.  Measurements at different 
time points controlled for by utilising same technique, 
sample preparation, reagents and flow cytometry laser 
settings and protocols within the summit programme.  
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5.5 Mitochondrial ROS production in isolated lymphocytes 
(a) Patients  
Patients undergoing general, urological, gynaecological and orthopaedic surgery (VISION-UK) at 
University College London Hospital were recruited into this single centre study. Preoperative and day 2 
postoperative paired patient blood samples were taken from individuals.  
 
(b) Flow cytometry analysis of MitoSox assay 
Preparation of cells for the MitoSox assay is summarised in the General Methods chapter (Chapter 2.9). 
The flow cytometry analysis method is summarised in Figure 5.4. 
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Figure 5.4 Flow Cytometry Analysis of lymphocyte mitochondrial ROS production 
 
 
  
Quadrant position established by using a sample 
containing A) no MitoSox dye (i.e. unstained or 
isolated cells only).B) Control sample with MitoSox 
dye and C) sample with MitoSox dye and FCCP. 
Percentage of cells in right upper and lower 
quadrants represents the percentage of 
lymphocytes expressing MitoSox (mitochondrial 
ROS). Not all cells positive for MitoSox following 
FCCP administration possibly due to: 1) 
inadequate incubation time of cells in FCCP 2) cell 
death 3) Insensitivity of assay. 
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Mitochondrial ROS production was interrogated in preoperative lymphocytes following addition of: 
staurosporine (protein kinase C inhibitor; proapoptotic microbial alkaloid) and mitochondrial ETC 
inhibitors (myxothiazol, rotenone and FCCP) for 30 minutes to increase mROS production by 
lymphocytes.  
 
Pre- and postoperative lymphocyte samples were also interrogated for presence of mitochondrial ROS 
at baseline (control) and following FCCP stimulation. 
 
5.6 Statistical analysis 
The study was powered based on a 25% difference in mitochondrial membrane potential being 
interpreted as clinically significant in patients diagnosed with SLE as mitochondrial membrane potential 
and apoptosis were increased in SLE patients compared to healthy controls.(Gergely, Grossman et al. 
2002) This degree of change in mitochondrial membrane potential impacts on ATP synthesis, T cell 
activation and apoptosis.(Fiers, Beyaert et al. 1999, Skulachev 1999) In order to achieve an alpha error 
of 0.05 and power 0.8, a sample size of 8 paired samples would be required to demonstrate differences 
between pre and postoperative TMRM. In order to account for withdrawals, early hospital discharge 
and difficult venepuncture a sample size of 19 was recruited for analysis.  
 
For the assessment of changes in mROS production, since >10,000 lymphocytes were gated during flow 
cytometry analysis of each sample, in order to achieve an alpha error of 0.05 and power 0.8, patient 
numbers of 3 (matched pre- and postoperative samples) were needed to demonstrate differences in 
MFI (>25% increase considered significant) secondary to FCCP, myxothiazol, rotenone and 
staurosporine.  
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Results 
5.7 Demographics – Membrane potential 
Preoperative samples were taken from 19 patients undergoing general, urological, breast and 
orthopaedic surgery (demographics in Table 5.1). Preoperative CD4 mitochondrial membrane potential 
was interrogated on all of these patients and CD8 mitochondrial membrane potential on 13 of these 
patients. 8 patients were available and also had postoperative samples taken on day 2 following 
surgery (Figure 5.5).    
 
Figure 5.5 Patient samples used in TMRM analysis 
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Table 5.1 Demographics of TMRM study cohorts 
 CD4 TMRM cohort 
(n=19) 
CD8 TMRM cohort 
(n=13) 
Pre vs. Postoperative 
(n=8; matched) 
Age (years)  61 (56 - 67) 61 (53 – 69) 60 (55 – 65) 
Absolute lymphocyte 
count (x 109/L) 
1.87 (1.50 – 2.24) 1.91 (1.45 – 2.37) 2.05 (1.24 – 2.80) 
Relative Lymphocyte 
count (%) 
26.21 (21.31 – 31.10) 26.02 (19.62 – 32.42) 27.96 (18.08 – 37.84) 
Gender n (%) Male 11 (58 ) 
Female 8 (42) 
Male 7 (54) 
Female 6 (46) 
Male 6 (75)  
Female 2 (25) 
Type of surgery n (%) 
General 
Urology 
Breast 
Orthopaedic 
 
11 (58) 
6 (32) 
1 (5) 
1 (5) 
 
 
6 (46) 
5 (38) 
1 (8) 
1 (8) 
 
4 (50) 
3 (38) 
0  
1 (12) 
Numbers unless stated otherwise presented as mean (95% CI) 
 
5.8 FCCP in TMRM Assay 
FCCP decreased the mitochondrial membrane potential in CD4(+) and CD8(+) cells (Table 5.2). 
 
Table 5.2 Mitochondrial membrane potential in preoperative samples 
 TMRM MFI CTRL TMRM MFI FCCP P value 
CD4 (n=19) 157.53 (121.37 – 193.69) 60.59 (48.36 – 72.81)* <0.0001 
CD8 (n=13) 211.93 (161.69 – 262.17) 74.61 (57.45 – 91.78)* <0.0001 
Values presented as mean (95% CI); *P < 0.0001 
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5.9 Perioperative changes in mitochondrial membrane potential 
Changes in CD4(+) (Figure 5.6) and CD8(+) cell mitochondrial membrane potential are shown in table 
5.3. 
Table 5.3 Pre- vs. postoperative mitochondrial membrane potential of CD4 and CD8 cells 
 PREOPERATIVE TMRM MFI POSTOPERATIVE TMRM MFI 
 CTRL FCCP 
 
CTRL    FCCP 
CD4 
(n=8) 
133.70  
(51.3 – 186.48) 
86.36  
(40.56 – 186.48) 
50.24 
(21.43 – 80.55) 
25.47 
(11.25 – 75.26)* 
CD8 
(n=8) 
205.16  
(130.52 – 279.80) 
84.76 
(54.84 – 114.68) 
269.03  
(158.74 – 379.33) 
120.60  
(68.26 – 172.95) 
CD 8 values presented as mean (95%CI) pre vs. postoperative samples analysed with paired t-tests; CD4 
values presented as median (IQR) pre vs. postoperative samples analysed with Related samples 
Wilcoxen signed rank test. * p=0.028 (see Figure 5.6) 
 
Figure 5.6 Change in CD4 mitochondrial membrane potential with FCCP administration 
 
 
There was no difference in control CD4(+) mitochondrial membrane potential postoperatively in the 
control samples (p=0.237), however postoperative membrane potential with FCCP was lower than 
preoperative (p=0.028). There was no decrease in CD8(+) mitochondrial membrane potential (control 
or FCCP) postoperatively.   
Related samples Wilcoxen signed 
rank test; n=8; p=0.028 
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5.10 ROS production with mitochondrial inhibitors 
Preoperative blood samples were taken to investigate the effect of FCCP (n=7), myxothiazol (n=4), 
rotenone and staurosporine (n=3) on lymphocyte mROS production in this separate study. 
Mitochondrial ROS production was interrogated on isolated lymphocyte samples (>99% purity). 
 
5.11 Demographics – ROS production with mitochondrial inhibitors 
7 patients (5 male, 2 female) with a mean age (95% CI) of 48 years (34 – 62) were recruited into this 
study and preoperative samples were interrogated to assess mROS production (MitoSox) following 
FCCP (n=7), myxothiazol (n=4), rotenone (n=3) and staurosporine (n=3). 
 
FCCP increased percentage of lymphocytes expressing mROS (Figure 5.7). Staurosporine, rotenone 
(Figure 5.8) and myxothiazol (Figure 5.9) also increased percentage of lymphocytes expressing mROS. 
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Figure 5.7 Effect of FCCP on mROS production in preoperative lymphocytes  
 
*n=7; p=0.018; Related samples Wilcoxen signed rank test. 
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Figure 5.8 Effect of staurosporine and rotenone on mROS production by lymphocytes 
 
Lymphocyte population gated onto SS vs. PE plots shown above 
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Figure 5.9 Effect of myxothiazol on lymphocyte mROS production 
 
 
 
5.12 Perioperative mitochondrial ROS expression 
Demographics 
9 patients were recruited into this study (6 male, 3 female) with a mean (95% CI) age of 71 (64-78) 
years. 6 patients underwent urology procedures and the remaining 3 patients had general, 
gynaecology and orthopaedic procedures performed.  
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Table 5.4 Perioperative MitoSox expression 
 Median % (IQR) 
Lymphocytes expressing MitoSox 
Preoperative Control  (n=9) 4.90 (2.50 – 7.07) 
Postoperative Control (n=9) 9.45 (3.62 – 24.68) 
Preoperative FCCP (n=6) 8.43 (2.26 – 21.08) 
Postoperative FCCP (n=6) 7.53 (4.50 – 21.50) 
Values analysed using related samples Wilcoxen signed rank test  
 
Percentage of lymphocytes expressing MitoSox postoperatively are summarised in Table 5.4. 
Percentage of lymphocytes expressing mROS increased postoperatively in control samples (p=0.008; 
Figure 5.10) but not following FCCP (p=0.917).   
 
Figure 5.10 Perioperative baseline expression of MitoSox by lymphocytes 
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Discussion 
This study demonstrates perioperative changes in mitochondrial membrane potential (Figure 5.6) and 
mROS production (Figure 5.10) in human lymphocytes. A postoperative decrease in CD4(+) cell 
mitochondrial membrane potential is demonstrated in cells challenged with FCCP. FCCP also impairs 
ATP synthesis by transporting H+ ions through the cell membrane before they can be utilised in 
oxidative phosphorylation, which is related to increased mROS production. This phenotype of 
mitochondrial dysfunction occurs postoperatively in lymphocytes, which demonstrate increased 
baseline mROS production and decreased mitochondrial membrane potential. 
  
There was however no difference in CD8(+) FCCP mitochondrial membrane potential demonstrated 
postoperatively compared to paired preoperative FCCP samples. These findings suggest that there may 
be functional differences in how CD4(+) and CD8(+) cells respond to surgery. The findings of this 
chapter are summarised in Figure 5.11.  
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Figure 5.11 Summary of perioperative TMRM and MitoSox results 
 
mMP= mitochondrial membrane potential; mROS= mitochondrial membrane potential; ETC= electron transport chain; preop=preoperative; 
postop=postoperative 
   
132 
 
5.13 Established metabolic differences between CD4+ and CD8+ cells 
Cao et al. compared activation-induced proliferation and metabolic reprograming of CD4(+) and CD8(+) 
T cells isolated from mice spleen and lymph nodes. Resting CD4(+) and CD8(+) T cells were found to be 
metabolically similar and used a predominantly oxidative metabolism. Following activation CD8(+) T 
cells proliferated more rapidly. Stimulation led both CD4(+) and CD8(+) T cells to sharply increase 
glucose metabolism and adopt aerobic glycolysis as a primary metabolic program. Activated CD4(+) T 
cells, however, remained more oxidative and had greater maximal respiratory capacity than activated 
CD8(+) T cells. CD4(+) T cells were also associated with greater levels of ROS and increased 
mitochondrial content, irrespective of the activation context. CD8(+) cells were better able, however, 
to oxidize glutamine as an alternative fuel source. The more glycolytic metabolism of activated CD8(+) 
T cells correlated with increased capacity for growth and proliferation, along with reduced sensitivity of 
cell growth to metabolic inhibition. These specific metabolic programs may therefore promote greater 
growth and proliferation of CD8(+) T cells and enhance survival in diverse nutrient conditions such as 
the postoperative state.(Cao, Rathmell et al. 2014) The decreased glycolysis seen during extracellular 
flux analysis (Chapter 4) may represent increased susceptibility to lose mitochondrial membrane 
potential resulting in decreased CD4(+) glycolysis. Maintenance of CD8(+) glycolysis postoperatively 
may result in greater CD8 cytokine production postoperatively compared with CD4 cells. These findings 
would also be in keeping with the reduction in CD4:CD8 ratio described in the postoperative phase and 
inflammatory states such as sepsis.(Xia, Liu et al. 2012) 
 
While differences have been shown to remain between CD4(+) and CD8(+) T cells irrespective of 
activation context, ROS production in each population is dependent on both the strength of the 
activating stimuli and cytokine context.(Cao, Rathmell et al. 2014) Metabolic reprogramming is 
therefore partially dictated by the environment and by co-stimulatory signals. This is likely to be 
important in vivo, where T cells are presented with antigens of varied avidity in the presence of varied 
cytokine milieus, oxygen tensions, and nutrient environments. Recent studies using nutrient 
transporter knockout T cells(Sinclair, Rolf et al. 2013, Macintyre, Gerriets et al. 2014, Nakaya, Xiao et al. 
2014) indicate that activation-induced metabolic reprogramming is critical for many inflammatory 
responses in vivo; however, metabolic comparison of in vivo reprogrammed CD4 and CD8 cells has not 
yet been performed. 
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The importance of glycolysis in cytokine production has been demonstrated in murine models.(Chang, 
Curtis et al. 2013) These concepts are summarised in Figure 5.12 and perioperative cytokine 
production is explored further in Chapter 6.  
 
5.14 Study Limitations 
This study has several limitations. The effects of surgery on mROS production by all lymphocytes, 
rather than CD4(+) and CD8(+) cells separately, were explored due to experiments being limited by 
lymphocyte yield. It would be important to co-stain CD4(+), CD8(+) cells and MitoSox following FCCP 
treatment in order to determine whether perioperative differences in mROS production exist between 
these populations. This could be assessed in further detail utilising confocal microscopy, which would 
allow imaging of living cells, with requirement of fewer cells to demonstrate an effect.  
 
There are two outlying results in Figure 5.10 (postoperative expression of MitoSox by isolated 
lymphocytes). Whether this is due to experimental error or true physiological differences in these 
patients in the postoperative period is not clear, however these two results could have skewed the 
results of the mROS production analysis and should therefore be interpreted with some caution. It 
should however be noted that since a significant number of lymphocytes in the postoperative period 
may already have undergone apoptosis (lymphocyte counts hypothesised to drop postoperatively due 
to apoptosis), this may explain why changes in mROS and mMMP, while are significant may not appear 
as great as bioenergetic data in Chapter 4. The lymphocytes that are likely to show the greatest 
differences in the membrane potential and ROS may have already undergone apoptosis in vivo prior to 
performing experiments.  
 
In summary pharmacologically induced mitochondrial dysfunction in lymphocytes results in reduced 
mitochondrial membrane potential and increased mROS production. Surgery results in a similar 
phenotype suggesting that postoperative increase in CD4 lymphocyte mROS production is attributable 
to loss of mitochondrial membrane potential. These findings are consistent with the reduced 
bioenergetic function demonstrated in postoperative lymphocytes (Chapter 4).
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Figure 5.12 Proposed differences in metabolic profiles between CD4 and CD8 cells  
 
ACD4 = activated CD4 cells; ACD8= activated CD8 cells; MRC = maximum respiratory capacity; oxphos= oxidative phosphorylation; based on findings from 
murine study(Cao, Rathmell et al. 2014)
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Chapter 6   
Perioperative Lymphokine 
production 
6.1 Lymphocytes and inflammation 
In addition to their “traditional” roles in the immune system, lymphocytes are becoming increasingly 
recognised as regulators of inflammation. Transgenic models of wound infection demonstrate that 
CD4+ lymphocytes are pivotal in modulating the function of polymorphonuclear cells at Staphylococcus 
Aureus (S. Aureus) infected wound sites.(McLoughlin, Solinga et al. 2006) Compared to wild type (WT) 
mice, alphabeta T cell receptor knockout mice demonstrate significantly lower concentrations of 
polymorphonuclear specific CXC chemokines (a small family of cytokines acting on CXC chemokine 
receptors, which recruit leukocytes) in wound tissue. Severity of wound infection is enhanced by 
administration of a CXC chemokine and abrogated by antibodies that blocked the CXC receptor. These 
data reveal an important and underappreciated role for CD4(+) alphabeta T cells in S. Aureus infection 
in orchestrating immune responses including: controlling local CXC chemokine production; neutrophil 
recruitment to the site of infection and subsequent bacterial replication. Other murine models have 
shown that T-regulatory cells reduce bowel inflammation secondary to innate immune cells via IL-10 
and TGF-β.(Maloy, Salaun et al. 2003) Furthermore in Rag-1-deficient mice, injected CD4 and CD8 cells 
result in tempering of TLR induced cytokine storm in an antigen-independent fashion.(Kim, Zhao et al. 
2007)  
 
6.2 Advances in method of lymphokine detection 
Intracellular cytokine expression within lymphocytes in the perioperative period is thus far an 
unexplored area of research. (Pala, Verhoef et al. 2000) Studies have previously used ELISA to evaluate 
cytokine expression from isolated lymphocytes(Berguer, Bravo et al. 1999, Franke, Lante et al. 2009) 
and supernatant following surgery.(Evans, Galustian et al. 2009) This method does not however 
identify the cellular source of cytokines secreted into plasma and serum. Whole blood assays have the 
advantage of not requiring lymphocyte isolation, requiring less preparation time and manipulation 
(Rodriguez-Caballero, Garcia-Montero et al. 2004) while retaining host lymphocytes in a 
microenvironment more similar to that in vivo.(Prussin 1997, Pala, Hussell et al. 2000) Protein 
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transport inhibitors can also be utilised in conjunction with this method in order to determine which 
cells produce the cytokine.  
 
6.3 Glycolysis and cytokine production 
When activated murine T cells are provided with co-stimulation and growth factors but are blocked 
from engaging glycolysis using galactose, their ability to produce TH1 cytokines (IFN-γ) is markedly 
compromised,(Chang, Curtis et al. 2013) with decreased IFN-γ mRNA in cells utilising oxidative 
phosphorylation. These results demonstrate that the engagement of aerobic glycolysis specifically 
permits the translation of IFN-γ mRNA in activated T cells and thereby regulates the ability of the cells 
to attain full effector status.(Chang, Curtis et al. 2013) A decrease in lymphocyte glycolysis (Chapter 4) 
may therefore be accompanied by a decrease in cytokine production postoperatively in human 
lymphocytes.  
 
6.4 Cytokines and surgery  
Cytokines have local effects of mediating and maintaining the inflammatory response to tissue injury 
and are also responsible for initiating some of the systemic responses, which occur following trauma. 
For example, prolonged visceral ischemia during major surgery has been shown to result in increased 
levels of TNF-α,(Wakefield, Carey et al. 1993) the magnitude of which correlates with the frequency 
and degree of postoperative organ dysfunction.(Wakefield, Carey et al. 1993, Poeze, Ramsay et al. 
2002) It has become clear that an adequate host immune response against infection is largely 
dependent on the activation of TH1 and TH2 cells.(Del Prete, Maggi et al. 1994, Romagnani 1997) Host 
immune responses following major surgical trauma is associated with down-regulation of cellular 
immunity in the early postoperative period,(Salo 1992) which may contribute to infectious 
complications following surgery.(Christou, Meakins et al. 1995)  
 
6.6 Hypothesis 
Reduced glycolysis impairs TH1 cytokine production in T-lymphocytes postoperatively. 
 
   
   
138 
 
Methods 
6.7 Patients 
Patients undergoing general, urology, orthopaedic and gynaecology surgery (VISION-UK) were 
recruited into this study. Blood samples were taken preoperatively on the morning of surgery through 
a 20 G IV cannula. Postoperative samples were taken in a subset of patients on day 3 following surgery.  
 
6.8 Flow cytometry analysis of intracellular cytokine assay 
The proportion of CD4(+) or CD8(+) cells expressing IL-2, TNF-α or IFN-γ was calculated (Figure 6.1) and 
corresponding MFI recorded (Figure 6.2).
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Figure 6.1 Flow cytometry analysis of intracellular cytokine production by lymphocytes  
  
Lymphocytes gated onto density plots. Quadrants set with 
isotype control sample (A). Percentage of CD8+TNFα+ cells 
presented in summit software as percentage of gated 
lymphocyte population. Median Frequency Intensity 
subsequently elucidated by transferring CD8+TNFα+ gated 
population onto histogram (Figure 6.2)  
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Figure 6.2 Method utilised to obtain MFI of CD8(+)TNFα(+) cells 
 
CD8(+)TNFα(+) population gated onto histogram to determine MFI (circled in red)
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In this chapter I explore the effect of: 
1) PMA and ionomycin activation on CD4(+) and CD8(+) cell cytokine production pre-and 
postoperatively 
2) Surgery on cytokine production in unstimulated CD4(+) and CD8(+) cells 
 
6.9 Statistical Analysis 
A 10% difference in median fluorescence intensity (MFI; the median total amount of cytokine present 
in each cell averaged from 10,000 cells analysed using flow cytometry) has previously been described 
between septic and non-septic patients.(Boomer, To et al. 2011) To achieve a power of 0.8 and alpha 
error of 0.05, a sample size of 9 pre- and postoperatively matched patients would be required. 12 
matched samples were obtained to account for a 30% withdrawal rate from the study or early hospital 
discharge. Data were analysed by descriptive and comparative approaches. All results are expressed as 
absolute numbers and percentages (means (95%CI); medians (IQR)).  
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Results 
6.10 Patient cohorts 
20 Patients were recruited into this study from VISION-UK. Of these, 12 patients also had postoperative 
blood samples taken for further evaluation of perioperative changes of lymphokine production in 
unstimulated CD4(+) and CD8(+) cells. 9 patients also had evaluation of lymphokine production from 
CD8 cells activated with PMA and ionomycin. Patient groups recruited and experiments performed are 
outlined in Figure 6.3 below. 
 
Figure 6.3 Patient cohorts recruited for lymphokine study 
 
CTRL = cells + brefeldin A; PMA = cells + brefeldin A + PMA + ionomycin 
 
Results are summarised as follows: 
1) Effect of PMA and ionomycin stimulation on CD4(+) cytokine production 
2) Evaluation of PMA and ionomycin stimulation on CD8(+) cells pre- (n=20) and postoperatively (n=9) 
3) Evaluation of perioperative changes in unstimulated CD4(+) and CD8(+) cells (n=12) 
4) Evaluation of perioperative changes in PMA and ionomycin stimulated CD8(+) cells (n=9)  
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6.11 Effect of PMA and ionomycin stimulation on CD4(+) cytokine production 
PMA and ionomycin caused down-regulation (shedding) of CD4(+) cells. Consequently it was not 
possible to ascertain cytokine production from CD4(+) cells following treatment with PMA. (Figure 6.4) 
 
Figure 6.4 Density plots (A and B) and histograms (C and D) demonstrating the down-regulation of 
CD4 (FITC) secondary to PMA and ionomycin stimulation (B and D) 
 
Flow cytometry figure of CD4(+) (FITC) co-stained with TNF-A (APC). Density plot A and histogram C 
represent control samples and density plot B and histogram D are following incubation with PMA and 
ionomycin. 
 
Following stimulation with PMA, the lymphocyte populations expressing cytokine consisted of 
predominantly CD8(+) and CD3(+) cells as demonstrated in Figure 6.5. 
  
  
CTRL PMA + 
ionomycin 
Loss of CD4 expression 
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Figure 6.5 Density plots of CD8(-)TNF(+) cells gated onto CD3TNF plot following incubation with PMA 
and ionomycin 
 
CD8(-) (vioblue)TNF(+) (APC) cells gated onto CD3(+) (FITC) TNF(+) (APC) density plot. This 
demonstrates that the majority of the cytokine expressing lymphocytes that do not express CD8 are 
CD3(+) (and likely to be CD8(-)CD3(+)CD4(+) cells). Lymphocytes were also co-stained with antibodies 
for CD19(+) and CD14(+) and did not show presence in the CD8(-)TNF(+) group. 
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6.12 Evaluation of PMA and ionomycin stimulation pre- and postoperatively on CD8 cells 
Cytokine expression was assessed following stimulation with PMA and ionomycin: 
A) Preoperatively (n=20)  
B) Postoperatively (n=9)  
Demographics of patients recruited into this study are summarised in Table 6.1. 
Table 6.1 Summary of patient demographics of the cytokine expression with PMA and ionomycin 
 Preoperative (n=20) 
Cohort 
Postoperative (n=9) 
Cohort 
Age (Years) 61 (54 – 72) 59(52-68) 
Gender (M/F) 12 / 8 4 / 5 
Absolute lymphocyte count (x 109/L) 1.76 (1.46-2.06) 2.36 (1.29-3.43) 
Relative lymphocyte count (%) 25.02 (21.20-28.84) 26.61(17.30-35.92) 
Type of surgery, n(%) 
          General 
          Gynaecology 
          Urology 
          Orthopaedic 
 
7 (35) 
2 (10) 
8 (40) 
3 (15) 
 
3(33) 
0 (0) 
1(11) 
5(56) 
Mean and 95% CI unless stated otherwise 
 
Effect of PMA and ionomycin on CD8 cell cytokine production 
PMA and ionomycin consistently increased CD8(+) intracellular cytokine production demonstrated by 
increased MFI (Figure 6.6) and percentage (Figure 6.7) of IL-2, TNF-α and IFN-γ production 
preoperatively and postoperatively. 
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Figure 6.6 Effect of PMA on MFI of CD8(+) cells expressing cytokine A) Preoperatively and B) Postoperatively 
A) Preoperative effect of PMA and ionomycin on CD8(+) MFI 
 
n=20; Control samples indication by 
“cytokine” and cells treated with PMA and 
ionomycin indicated by "Cytokine + PMA”. 
Results represent whole blood treated with 
PMA and ionomycin in addition to brefeldin 
alone (CTRL); Related samples Wilcoxen 
signed rank test. 
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B) Postoperative PMA and ionomycin on CD8(+) MFI 
 
n=9; Control samples indication by 
“cytokine” and cells treated with PMA and 
ionomycin indicated by "Cytokine + PMA”. 
Results represent whole blood treated with 
PMA and ionomycin in addition to brefeldin 
alone (CTRL); Related samples Wilcoxen 
signed rank test. 
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Figure 6.7 Effect of PMA on percentage of CD8(+) cells expressing cytokine A) Preoperatively and B) Postoperatively 
 
A) Preoperative 
 
 
 
  
n=20; all p<0.001; related samples Wilcoxen signed rank 
test;  CTRL = control. Shaded bars represent whole blood 
treated with PMA and ionomycin in addition to brefeldin 
alone (CTRL) 
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B) Postoperatively 
  
 
 
 
n=9; all p=0.008; CTRL = control.  PMA = PMA + ionomycin. 
Shaded bars represent whole blood treated with PMA and 
ionomycin in addition to brefeldin alone (CTRL) 
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6.13  Evaluation of perioperative changes in cytokine production of unstimulated (without PMA 
and ionomycin) CD4(+) and CD8(+) cells (n=12) 
Table 6.2 summarises the patients recruited into this study. 
 
Table 6.2 Summary of patient demographics in the paired pre- vs. postoperative cytokine 
expression cohort  
 
 Preoperative values of recruited patients 
(n=12) 
Age (Years) 59 (49-68) 
Gender (M/F) 7 / 5 
Absolute lymphocyte count (x 109/L) 2.32 (1.53-3.10) 
Relative lymphocyte count (%) 28.08 (20.70 – 35.47) 
Type of surgery, n(%) 
          General 
          Urology 
          Orthopaedic 
 
5 (42) 
2 (16) 
5 (42) 
Values in mean (95%CI) unless stated otherwise 
 
Unstimulated CD4(+) cytokine expression 
There was a postoperative increase in median (IQR) percentage of CD4(+) cells expressing IFN-γ 
(n=12; p=0.006; Figure 6.8).There was no difference in MFI of CD4(+) cells expressing cytokine 
postoperatively (IL-2 p=0.308; TNF-α p=0.182; IFN-γ p=0.110; related samples Wilcoxen signed rank 
test). 
 
Unstimulated CD8(+) cytokine expression 
There was an increase in median (IQR) percentage of CD8(+) cells expressing IFN-γ (Figure 6.8). There 
was an increase in MFI of CD8(+) cells expressing IL-2, TNF-α  and IFN-γ (Figure 6.9). 
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Figure 6.8 Perioperative percentage cytokine expression by CD4(+) (A-C) and CD8(+) (D-F) cells   
 
Perioperative changes (Pre = preoperative; Post = postoperative) in percentage of CD4+ (A-C) and CD8+ (D-F) cells expressing cytokine (n=12) 
P=0.14 
P=1.0 
P=0.94 P=0.07 
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Figure 6.9 Perioperative changes in cytokine production from unstimulated CD8(+) cells 
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6.14 Evaluation of perioperative changes in cytokine production from PMA and ionomycin 
stimulated CD8(+) cells (n=9)  
Compared to preoperative samples paired samples, when stimulated with PMA, a rise was 
noted postoperatively in MFI of CD8(+) cells expressing IL-2 and IFN-γ (Figure 6.10 A and C). 
There was no difference in median (IQR) percentage of CD8(+) cell expression of TNF-α or IFN-γ 
postoperatively with PMA stimulation, however an increase in median (IQR) percentage of 
CD8(+) cells producing IL-2 was also demonstrated (Figure 6.11). 
 
Figure 6.10 Perioperative changes in MFI (A-C) and percentage (D) of CD8+ cells stimulated 
with PMA and ionomycin expressing cytokines 
A) IL-2 
 
Shaded bar = postoperative; n=9; p=0.008
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B) TNF-α 
 
Shaded bar = postoperative; n=9; p=0.066
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C) IFN-γ  
 
Shaded bar = postoperative; n=9; p=0.021
   
156 
 
Figure 6.11 Perioperative changes in percentage CD8(+) cytokine expression with PMA and ionomycin stimulation 
 
 
P=0.04 P=0.07 P=0.17 
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6.15 CD4 cell (CD8 negative cell) response to PMA pre and postoperatively 
Percentage change in CD4(+) cells expressing cytokine did not vary perioperatively (IL-2 p=0.767; TNF-α 
p=0.515; IFN-γ p=0.173).  
 
MFI of CD4(+) cells (identified by CD8(-) cell population) increased with PMA stimulation for each 
cytokine (IFN-γ p=0.008; IL-2 p=0.008; TNF-α p=0.011; Figure 6.12).  
 
 
6.16 Relative Gain in MFI with PMA 
Relative gain (% increase in MFI) in MFI with PMA was not different pre- versus postoperatively for IL-2 
(p=0.859; n=9) or TNF-α (p=0.678; n=9), but was higher with PMA in postoperative samples for IFN-γ 
(Figure 6.13).   
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Figure 6.12 MFI of CD8(-) cells (CD4 cells) following PMA and ionomycin stimulation in the perioperative period 
  
P=0.008 P=0.011 P=0.008 
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Figure 6.13 Fold change in MFI of CD8(+) cells expressing IFN-γ caused by PMA compared in the perioperative period (related samples Wilcoxen signed rank test) 
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Discussion 
6.17 Discussion 
TH1 lymphokine production by stimulated and unstimulated CD8(+) cells increases postoperatively. 
Cytokine production by unstimulated CD4(+) cells on the other hand does not increase postoperatively.  
 
The main finding of this study is that perioperative differences are demonstrated between CD4(+) and 
CD8(+) cells. CD8(+) cells appear to have an increased ability compared to CD4(+) cells to be activated 
and produce cytokine following anaesthesia and surgical trauma. There was no demonstrable 
difference in CD8(+) FCCP mitochondrial membrane potential postoperatively compared to 
preoperative FCCP sample which is consistent with cytokine findings of this Chapter i.e. maintained 
ability to produce cytokine which may indicate less ETC dysfunction or relatively preserved glycolytic 
function of CD8(+) cells. The reduced cytokine production demonstrated by CD4(+) cells 
postoperatively may therefore be related to the reduced membrane potential seen with ETC 
dysfunction which may be due to increased propensity to apoptosis, either induced by FCCP, or 
occurring postoperatively. Figure 6.14 summarises potential mechanisms for increased CD8(+) cytokine 
production in relation to other findings in this thesis. 
 
Normal CD4:CD8 ratio is approximately 1:2. Surgery results in a reduction of CD4:CD8 ratio,(Dietz, 
Heimlich et al. 2000). Decreased CD4:CD8 ratio has also been related to increased incidence of 
postoperative sepsis following abdominal surgery in HIV infected patients.(Xia, Liu et al. 2012) This is in 
keeping with the hypothesis of more pronounced CD4(+) bioenergetic function impairment occurring 
compared to CD8(+) cells, predisposing CD4(+) cells to apoptosis (greater ETC dysfunction and 
increased mROS) postoperatively, and therefore decreasing CD4:CD8 ratio. This study also suggests 
that the ratio change following surgery may be accompanied by altered CD4 function. Since activation 
and cytokine production are energy dependent processes, the inability to increase TH1 cytokine 
production of postoperative CD4 cells may be related to altered lymphocyte metabolic and 
bioenergetic function (Chapter 4) along with CD4 mitochondrial membrane potential reduction 
postoperatively.  
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Figure 6.14 Potential mechanisms explaining increased CD8(+) cytokine production, related to other findings in this thesis. (Cells presumed to be more likely to 
be activated in the postoperative period) 
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Since cytokine production is dependent on glycolysis,(Chang, Curtis et al. 2013)  it was hypothesised 
that cytokine production would reduce postoperatively. This study demonstrates that when 
lymphocytes are interrogated postoperatively, a time when patients are often lymphopenic, they do 
not exhibit a decrease in TH1 cytokine production. These findings suggest that the lymphopenia 
induced by surgery may be part of a spectrum of change in lymphocyte function which when severe 
leads to the immune suppressed state described in acute sepsis.(Boomer, Shuherk-Shaffer et al. 2012) 
The “exhausted” and anergic immune phenotypes seen in sepsis have previously been associated with 
failure to secrete cytokines, reduced proliferation in response to antigen, increased expression of 
certain cell surface receptors (e.g. CD69) and decreased expression of the IL-7 receptor (cd127).(Yi, Cox 
et al. 2010)  
 
6.18 Comparison to other perioperative cytokine study findings 
Matsuda et al. demonstrated no significant change in percentage of CD4 cells expressing IFN-γ on day 3 
postoperatively following stimulation in 53 colorectal cancer surgical patients.(Matsuda, Furukawa et 
al. 2007) I found an increase in percentage of CD4 cells expressing IFN-G in unstimulated cells, which 
may be due to differences in experimental design. Firstly Matsuda did not report their findings in 
unstimulated cells (without PMA and ionomycin stimulation) and appeared not to demonstrate the 
downregulation of CD4 secondary to PMA and ionomycin that was apparent in my experiments. This 
may be due to their shorter incubation period of 4 hours compared to the 16 hours that I used with 
PMA and ionomycin. Their methodology does not however describe how CD4 expression was 
determined or how they overcame the downregulation. The increase in IFN-γ expression also seen in 
this study could be related to a longer incubation times in brefeldin A at 37oC (16 hours versus 4 hours) 
prior to intracellular staining and flow cytometry analysis.  Brefeldin has been shown to induce 
endoplasmic reticulum stress,(Islam, Hassan et al. 2006) activate apoptotic caspases.(Lee, Kim et al. 
2013) Brefeldin may have therefore influenced cytokine production by activating cells. Finally, 
Matsuda’s colorectal cancer population may demonstrate differences in cytokine production compared 
to the patients in this study since none of the patients recruited in this chapter were diagnosed with 
cancer. 
 
Ishikawa et al. reported an increase in percentage of CD4 cells expressing IFN-γ on day 2 post gastric 
and colorectal surgery but a decrease following hepatic resection.(Ishikawa, Nishioka et al. 2004) The 
discrepancy between these results may be due to the differences in background malignancies, the 
method of cell stimulation (PMA and ionomycin versus nil) and the use of a whole blood assay rather 
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than enzyme-linked immunosorbent assay (ELISA). Limitations of other previous studies which have 
evaluated cytokine production postoperatively include: failure to report the MFI (the absolute amount 
of cytokine present within each cell),(Berguer, Bravo et al. 1999, Stalder, Birsan et al. 2005, Matsuda, 
Furukawa et al. 2007) failure to assess accumulation of intracellular cytokine utilising protein transport 
inhibitor,(Stalder, Birsan et al. 2005) and presenting cytokine production from a combination of cell 
types.(Berguer, Bravo et al. 1999, Franke, Lante et al. 2009) 
 
6.19 Study strengths and limitations 
A limitation of this study was the downregulation of CD4 seen with PMA stimulation.(Kemp and 
Bruunsgaard 2001) CD8(-) cells (CD4 cells) were analysed following PMA stimulation, however relative 
gain of CD8 negative cells could not be calculated because without PMA stimulation, CD8(-) cytokine(+) 
populations were insufficient in number to analyse.(i.e. CD8-cytokine+ populations were more 
pronounced following PMA stimulation). Despite this, cytokine production in unstimulated CD4 and 
CD8 cells clearly show differing responses to surgery. 
 
The serial analysis of perioperative samples, enabling each patient to act as their own control, is a 
robust model that circumnavigates the significant challenges of appropriate control samples. Since 
patients were recruited from different surgical specialties, increased CD8 cytokine production appears 
to be independent of site of surgery. Whether patients had clinical signs of infection on the day of 
postoperative blood sampling was not factored into the data analysis, however this is unlikely given 
the fact that the team proceeded with elective surgery. Furthermore, the postoperative sample was 
chosen on day 3 following surgery because patients are usually still lymphopenic at this time point 
compared to preoperative values (Chapter 3). Furthermore due to the elimination half-life of the 
anaesthetic agents utilised in this study, anaesthetic drugs would have been eliminated by this 
postoperative day.(Smith, Scarth et al. 2011)  Further work is required to elucidate how intracellular 
cytokine production correlates with serum levels, how intracellular cytokine production changes until 
day of hospital discharge and its relationship to bioenergetic function and leukocyte counts (including 
CD4 and CD8 levels). Furthermore the relationship between intracellular cytokine production and 
development of signs of sepsis requires investigation. Cytokine production in relation to site and 
severity of surgery and pre-existing co-morbidities requires investigation. Further work is needed to 
elucidate whether bio-energetic changes exist in CD4(+) and CD8(+) cells postoperatively relate to 
differences in intracellular cytokine production. Finally, apoptosis assays of different lymphocyte 
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subsets would help to determine whether cells undergoing apoptosis are less likely to produce 
cytokine.     
Postoperative cytokine production may vary from baseline on a daily basis following surgery and it 
must be appreciated that I only evaluated production on day 3 following surgery.  In primates 
undergoing nephrectomy for example, intracellular production of cytokines by T (CD3) cells treated in a 
whole blood assay with PMA, ionomycin and concanavalin A, decreased on day 1 postoperatively 
compared to control animals not undergoing surgery (reduction from baseline of: 50% for IL-2, 29% for 
IFN-G and 22% for TNF-A).(Stalder, Birsan et al. 2005) Although this decrease was observed on 
postoperative day 1, in subsequent days the production of IL-2 and IFN-γ increased, reaching levels 
similar to those observed before surgery. This primate study did not however compare paired samples 
pre- and postoperatively from the same individual. 
 
6.20 Summary 
In summary intracellular cytokine production is lower in unstimulated CD4+ cells postoperatively. A 
decrease in lymphocyte glycolysis and increase in CD8(+) cytokine production seen postoperatively 
may be related to the stress response to surgery causing mitochondrial dysfunction leading to 
mitochondrial ROS production and activation of the inflammasome. The proposed relationship and 
mechanisms linking metabolic failure and activation of the inflammasome are explored further in the 
following chapter. 
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Chapter 7   
Stress induced hypometabolism in lymphocytes 
via activation of the inflammasome 
 
7.1 Introduction 
In this chapter I aim to explore a potential unifying mechanism, which would explain the postoperative 
immune phenotype demonstrated in this thesis so far: 
 Decreased oxidative phosphorylation 
 Decreased glycolysis 
 Increased mROS production in lymphocytes 
 Decreased mitochondrial membrane potential (CD4 cells) 
Increased TH1 lymphokine production (unstimulated CD8 cells) 
   
One possible unifying hypothesis which could explain the findings of reduced glycolysis, reduced 
mitochondrial membrane potential and increased mROS is through the activation of the NLRP 
inflammasome, outlined in Figure 7.1. 
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Figure 7.1 Figure demonstrating hypothesis of inflammasome activation secondary to postoperative mitochondrial dysfunction 
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7.2 Inflammasome  
Impairment of oxidative phosphorylation and glycolysis demonstrated in the postoperative period, 
results in reduced lymphocyte ATP production, which may impair lymphocyte immune response in the 
postoperative period.  
 
The inflammasome is a collection of multi-protein complexes, which mediate the processing and 
maturation of the inflammatory cytokines interleukin-1β (IL-1β) and IL-18. Interleukin 1 Beta (IL-1β) is 
an important mediator of the inflammatory response (associated with increased cytokine release), and 
is involved in a variety of cellular activities, including cell proliferation, differentiation, apoptosis and 
turnover of memory CD4(+) T cells.(Shive, Mudd et al. 2014)  
 
The constituents of the inflammasome vary depending on the activator initiating its assembly. It is 
consequently a critical checkpoint for the induction of other cytokines. (Contassot, Beer et al. 2012) It 
is responsible for detecting and responding to a large range of PAMPs (pathogen associated molecular 
patterns e.g. bacterial flagelli) and DAMPs (damage associated molecular patterns e.g. uric acid 
crystals).  
 
7.3 Caspase inhibits glycolysis 
In vivo, stimuli that fully activate caspase-1, inhibit glycolysis in wild-type cells compared with caspase-
1-deficient cells (Shao, Yeretssian et al. 2007) at several glycolytic checkpoints (Shao, Yeretssian et al. 
2007, Munoz-Planillo, Kuffa et al. 2013). Caspase-1 also regulates lymphocyte homeostasis through 
pyroptosis (a form of programmed cell death associated with antimicrobial responses during 
inflammation) as observed in Human Immunodeficiency Virus-associated CD4 depletion.(Gibbison, 
Angelini et al. 2013, Doitsh, Galloway et al. 2014) Figure 7.2 summarises a potential mechanism 
relating hypometabolism and inflammasome activation. Figure 7.3 summarises factors involved in the 
activation and regulation of the inflammasome. 
 
7.4 Caspase requires activation of inflammasome 
In 2004 Agostini et al. (Agostini, Martinon et al. 2004) demonstrated that nucleotide-binding 
oligomerisation domain (NOD) like receptor family, pyrin domain containing 3 (NLRP3), which is 
mutated in auto-inflammatory hereditary periodic fever syndromes, and homologous to NLRP1, forms 
an inflammasome complex comprising an adaptor protein (ASC), the caspase-recruitment and 
activation domain (CARD) containing protein cardinal and caspase-1. Caspase-1-dependent cell death is 
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initiated by infection, whereas apoptosis is induced by mitochondria. Both release stimulatory 
products into the cytosol to activate sensors that undergo oligomerisation to form an activation 
platform (inflammasome and apoptosome).(Labbe and Saleh 2008) Caspase-1 activation is therefore 
largely dependent on the inflammasome.(Schroder and Tschopp 2010) 
 
Activation of the inflammasome leads to the cleavage and activation of caspase-1 and subsequent 
cleavage of pro-IL-1β to its mature, active form, which is then released from the cell. Once released, IL-
1β binds to the IL-1R, leading to downstream signalling and a cascade of inflammation involving other 
proinflammatory cytokines. TLR triggering and autocrine IL-1R activation lead to pro-IL-1β 
transcription.(Man and Kanneganti 2015) Targets that may inhibit IL-1-mediated inflammation include 
specific inflammasome triggers, activation mechanisms, specific components of the inflammasome, 
caspase-1, IL-1β release, binding of IL-1β to the IL-1R, IL-1R signalling transduction, and downstream 
proinflammatory cytokines and superoxide ion (O2-).(Bulua, Simon et al. 2011) (Shao, Yeretssian et al. 
2007) 
 
7.5 Proposed ligands, which activate the inflammasome 
Inflammasome activation involves several hypothesised mechanisms, including potassium (K+) efflux 
secondary to ATP-gated channels,(Munoz-Planillo, Kuffa et al. 2013) reactive oxygen species (ROS), 
monosodium urate (MSU), and damage to cell membranes.(Schroder and Tschopp 2010) Both NLRP1 
and NLRP3 inflammasomes are present in human T-cells. Zhou et al. demonstrated that complex 1 
inhibition (rotenone) and complex III inhibition (antimycin) is associated with increased mROS 
production.(Zhou, Yazdi et al. 2011) Mitochondrial dysfunction (increased mROS as seen in Chapter 5) 
is therefore strongly implicated- although not obligatory(Munoz-Planillo, Kuffa et al. 2013)- for the 
activation of the NLRP inflammasome, through the generation of mitochondrial ROS.(Zhou, Yazdi et al. 
2011) Increased mROS production in leukaemic cell lines has been associated with activation of the 
NLRP3 inflammasome and increased IL-1B expression.(Zhou, Yazdi et al. 2011)  
 
Despite their anti-inflammatory uses, glucocorticoids activate the inflammasome. This has been 
demonstrated in activation of monocyte NLRP3 mRNA and protein in TH1P monocyte like cells.(Busillo, 
Azzam et al. 2011) A recent rat brain study demonstrated that low dose glucocorticoids cause a 
common inhibition of oxidative phosphorylation (State 3) and of complex V activity and modify proton-
flux through the mitochondrial inner membrane. Dexamethasone was also able to induce a specific 
inhibition of complex I activity and to decrease the superoxide anion radical generation. Based on data 
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from this rat study, inhibition of complex V and partial reversion of uncoupling appear to be common 
properties of glucocorticoids.(Morin, Zini et al. 2000) The theoretical consequence of such inhibitions 
could be the modulation of the mitochondrial function, oxygen consumption rate, ATP synthase 
activity and superoxide anion radical production, involved in many patho-physiological phenomena.  
 
Reduced glycolysis postoperatively results in activation of hypothalamic pituitary adrenocortical 
pathway stimulating production of glucocorticoid from the adrenal cortex. The prototypical 
neurohormonal response to surgery and trauma is characterised by substantial and prolonged 
elevations in circulating glucocorticoids.(Naito, Tamai et al. 1992) Glucocorticoids (dexamethasone) 
result in caspase-1 activation in murine models.(Chua, Chua et al. 2003) 
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Figure 7.2 Hypothesis of inflammasome activation following postoperative hypometabolic state 
 
HPA = hypothalamic pituitary adrenocortical pathway 
 
   
172 
 
Figure 7.3 Molecular mechanisms involved in activation of inflammasome 
 
= inhibition 
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Nucleotide-binding oligomerisation domain, leucine rich repeat containing X1 (NLRX1) within 
mitochondria modulates ROS generation. Mitochondrial ROS causes transcriptional induction of IL-1β 
and NLRP3 through mitogen-activated protein kinases (MAPKs), NF-KB (nuclear factor kappa-light-
chain-enhancer of activated B cells; a protein complex that controls transcription of DNA) and hypoxia-
inducible factor 1 (HIF-1), priming the cell for inflammasome activation. NLR is bound by heat shock 
protein 90 (HSP90; a chaperone protein that assists other proteins to fold properly, stabilises proteins 
against heat stress, and aids in protein degradation) and suppressor of G-two allele of SKP1 (SGT1; 
important gene in resisting pathogens) maintaining them in an active state, upon which 
oligomerisation with ASC (Apoptosis-associated speck-like protein containing a CARD) and caspase-1 
form a functional inflammasome leading to release of IL-1B and IL-18. Phagocytosis causes lysosomal 
rupture followed by release of cathepsin B into the cytosol and NLRP3 inflammasome activation. 
Microbial toxins and ATP ionotropic Purinergic Receptor P2X, Ligand-Gated Ion Channel, 7 (P2X7; 
purinergic receptor that functions as an ATP activated cation channel) lead to K+ efflux, which activates 
the NLRP3 inflammasome. High glucose concentrations activate NLRP3 through Thioredoxin-
interacting protein (TXNIP) binding.  
 
7.6 Hypothesis 
Glucocorticoids increase primary human lymphocyte mitochondrial ROS production, which causes 
activation of caspase-1 via the NLRP1 inflammasome.  
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Methods 
Five patients with normal preoperative lymphocyte counts with no co-morbidities undergoing elective 
urological procedures (VISION-UK) were recruited for this study. Isolated lymphocytes were incubated 
with dexamethasone 1μM for 60 minutes as these levels are close to human physiological levels 
postoperatively(Roth-Isigkeit and Schmucker 1997) while resulting in <10% lymphocyte apoptosis. 
mROS and caspase-1 expression were subsequently interrogated; mROS production was quantified 
using the previously described MitoSox assay in Chapter 2.; caspase-1 activity quantified using a 
FLICA™ Caspase 1 Assay Kit (ImmunoChemistry Technologies,ABD Serotec, Kidlington, UK).  
 
The in vitro caspase-1 assay employs the fluorescent inhibitor probe FAM-YVAD-FMK to label active 
caspase 1 enzyme in living cells or tissue samples. FLICA™ is cell permeant and non-cytotoxic. FLICA 
(Fluorescent Labeled Inhibitor of Caspases) probes are comprised of an inhibitor peptide sequence that 
binds to active caspase enzymes, a fluoromethyl ketone (FMK) moiety that results in an irreversible 
binding event with the enzyme, and a fluorescent tag (either carboxyfluorescein or sulforhodamine B) 
reporter. For a caspase 1 inhibitor, the multi-enzyme recognition sequence is tyrosine-valine-alanine-
aspartic acid (YVAD). The FLICA™ FAM-YVAD-FMK probe interacts with the enzymatic reactive center 
of activated caspase 1 via the YVAD recognition sequence, forming a covalent thioether adduct with 
the enzyme through the FMK moiety.  
 
50, 000 isolated lymphocytes were stained with FLICA reagent as per protocol (ImmunoChemistry 
Technologies, ABD Serotec, Kidlington, UK).  Reagent was constituted with 50µL DMSO to form the 
stock concentrate. The stock concentrate was diluted with 200µL PBS to form the working solution. 
10µL of the working solution was added directly to a 500µL aliquot of your cell culture for labeling. 
Cells and reagent were incubated for 30 minutes. Unbound FLICA™ FAM-YVAD-FMK reagent was 
washed twice using PBS. The remaining green fluorescent signal is a direct measure of caspase 
1 activity at the time the probe was added. The fluorescent signal was subsequently analyzed using 
flow cytometry. See Figure 7.4 below. 
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Figure 7.4 Method used to determine Caspase-1 activity in vitro
 
FITC MFI recorded from above histogram plots; MFI values taken from greater than 10,000 isolated 
lymphocytes. 
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Addition of nigericin was performed in order to demonstrate that dexamethasone resulted in caspase-
1 activation (a positive control - Figure 7.5). Caspase expression in isolated lymphocytes was also 
compared between cells incubated in dexamethasone and nigericin, an activator of the NLRP3 
inflammasome. (Figure 7.5). 
 
Figure 7.5 Nigericin utilised as a positive control for NLRP3 inflammasome activation 
 
 
n=5; Caspase expression increased in isolated lymphocytes treated with dexamethasone (1μM) 
compared to control sample  (p=0.04) and treated with Nigericin, a NLRP3 inflammasome activator; 
p=0.04); Error bars represent 95% CI 
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Immunoblots were performed using protein from 2.5 × 106 lymphocytes loaded per well of a 10% 
acrylamide gel from preoperative patients (n=3) with normal lymphocyte count and no co-morbidity. 
2.5 million lymphocytes were utilised for these experiments because this number resulted in a 
reproducible amount of protein, approximately 15 mcg per well. Immunoblots were performed with 
polyclonal goat anti-human IL-1 beta/IL-1F2 Antibody (1:1000; AF-201-NA; R and D Systems, Abingdon, 
UK). Cell lysates were probed with anti–β-actin antibodies (Santa Cruz Biotechnology, Inc.), which was 
utilised as a loading control. 
 
7.7 Statistical Analyses 
All results are expressed as absolute numbers and percentages (means 95%CI). Parametric methods 
and tests were used as indicated to analyze normally distributed data, while two-group nonparametric 
Wilcoxon signed-rank and Mann–Whitney U tests were used to analyze data deviating from a normal 
distribution. Statistical analyses were undertaken using SPSS IBM SPSS Version 20 (IBM Corporation, 
Somers, New York, USA). Reported p values are two-sided; a p value ≤0.05 was considered to indicate 
statistical significance.  
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Results 
 
Incubation with dexamethasone generated an increase in mitochondrial reactive oxygen species 
(Figure 7.6 A, B) and was associated with increased caspase-1 activity as assessed by FLICA assay 
(Figure 7.6 C).  
 
Figure 7.6 Mitochondrial ROS production in isolated lymphocytes (a, b) and caspase-1 activity (c) 
following incubation with dexamethasone 
 
a) 
 
 
 
>10,000 isolated lymphocytes interrogated per sample  
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b)  
 
n=5; p=0.007; incubation with 1μM dexamethasone; error bars indicate 95% CI 
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c) 
 
Dexamethasone results in increased caspase activity compared to control as demonstrated by   
increased FITC MFI (of FLICA caspase-1).  
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Immunoblot analysis following dexamethasone demonstrated an increase in IL-1β production. (Figure 
7.7) 
 
Figure 7.7 Immunoblot analysis demonstrating IL-1β production with dexamethasone 
 
 
I performed the above Western blot with Dr. John Whittle, β-actin utilised as loading control. 
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Discussion 
 
The mechanism underlying a global decrease in metabolic status postoperatively is consistent with 
increased activity of caspase-1, a pivotal executioner caspase that mediates the inflammatory response 
to a plethora of pathogen associated molecular patterns (PAMPs) and damage associated molecular 
patterns (DAMPs). Activation of a ubiquitous sensor of danger-molecules in T cells is consistent with 
the lack of clear association between preoperative lymphocyte count and clinical presentation or 
differences in parameters (Chapter 3). Therefore pre-existing lymphopenia does not necessarily result 
in identifiable morbidity preoperatively, however following surgical insult, the differences in Immune 
phenotype and outcomes secondary to inflammasome activation become unmasked. This data 
supports the hypothesis that impaired glycolysis occurs postoperatively secondary to a glucocorticoid 
driven activation of the inflammasome via increased caspase-1 activity. The impairment in glycolysis 
and activation of the inflammasome (demonstrated by increased IL-1β and increased caspase-1 
activity) also appear to be consistent with the postoperative increase in lymphokine production 
demonstrated in Chapter 6.  
 
Activation of the NLRP1 inflammasome appears to be the most likely pathway resulting in the 
postoperative phenotype demonstrated in this thesis. Splenocytes from NLRP3 deficient mice and wild 
type controls both undergo increased levels of apoptosis and caspase activity compared following 
dexamethasone exposure.  Splenocytes from NLRP3 deficient mice also express more NLRP1 protein 
following incubation with 1μM dexamethasone for 16 hours, indicating activation of caspase-1 via the 
NLRP1 inflammasome.(Edwards, Sultan et al. 2015)  Acute (postoperative) or chronic (preoperative 
lymphopenia) is associated with impaired lymphocyte functionality resulting from glucocorticoid 
activity and is associated with increased postoperative morbidity and mortality in these populations. 
 
Nigericin is an inflammasome activator and an inhibitor of lymphocyte proliferation.(Daniele, Holian et 
al. 1978) Inflammatory gene upregulation has been demonstrated in human lung cells by 
glucocorticoids and TNFα.(Lannan, Galliher-Beckley et al. 2012) Glucocorticoid related decrease in 
glycolysis and mitochondrial membrane potential of lymphocytes from patients with Chronic 
lymphocytic leukaemia (CLL),  appears to recreate the postoperative phenotype shown in this 
thesis.(Tung, Shi et al. 2013) Glucocorticoid activity is likely to be just one factor responsible for these 
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postoperative changes seen. For example programmed cell death 1 and its inhibitory receptor, have 
been associated with T cell exhaustion,(Boomer, To et al. 2011) neutrophil related T cell suppression 
has been described in human sepsis.(Pillay, Kamp et al. 2012) 
 
Taken together, the data from this thesis provides translational data supporting the role of impaired 
bioenergetic function in development of complex and multifactorial pathology. Clinical and immune 
function has also been directly associated with metabolic function. The fact that a substantial 
proportion of patients are lymphopenic prior to surgery, suggests that a population exists with an 
increased risk of developing critical illness. 
 
7.8 Mitochondria and inflammasome 
Reed and colleagues(Bruey, Bruey-Sedano et al. 2007) have also demonstrated that B-cell lymphoma-2 
(BCL-2) and BCL-XL genes, which inhibit apoptosis by controlling mitochondrial outer membrane 
permeabilisation (MOMP), block the NLRP1 inflammasome. Tschopp et al. extended the links between 
cell death and inflammation by postulating that mitochondria not only produce ATP, but are also vital 
for inflammation.(Tschopp 2011) Specifically, it was demonstrated that NLRP3 localises to the 
endoplasmic reticulum and translocates to the mitochondria upon stimulation, and that assembly of 
the NLRP3 inflammasome occurs in a MOMP-dependent manner.(Zhou, Yazdi et al. 2011) Consistently, 
inhibition of voltage-dependent anionic channels or overexpression of BCL-2, which blocks MOMP, 
dampens this response.  
 
Whether ROS is upstream or downstream of NLRP induction remains unclear. Bauernfeind et al. 
demonstrated that although NLRP3 inflammasome activation is unique among other known 
inflammasomes in its sensitivity to ROS inhibition, this phenomenon is attributable to the fact that 
NLRP3 strictly requires priming by a proinflammatory signal, a step that is blocked by ROS 
inhibitors.(Bauernfeind, Bartok et al. 2011) Although these data do not exclude a general role for ROS 
production in the process of NLRP3-triggered inflammation, they suggest that ROS is upstream of 
NLRP3 induction, but not activation.  
 
The stress response to surgery results in the release of corticotrophin from the pituitary stimulating 
cortisol secretion from the adrenal cortex.(Desborough 2000) Caspase-1 related inhibition of glycolysis 
(Shao, Yeretssian et al. 2007) may result in postoperative lymphocyte bioenergetic dysfunction. What 
   
184 
 
remains unclear is whether the metabolic changes demonstrated postoperatively (reduction in 
glycolysis and oxidative phosphorylation) are solely due to CD4 cell dysfunction. 
 
Data from my thesis suggests that the stress response to surgery rather than inducing individual 
complex inhibition in humans, may result in a more global impairment in ETC function. Therefore it is 
not clear whether glucocorticoids alone recreate the same postoperative bioenergetic phenotype in 
humans. I surmise that a ubiquitous stress-glucocorticoid response mechanism may promote 
postoperative lymphopenia by inducing bioenergetic impairment,(Stahn and Buttgereit 2008) 
increasing cytokine production and promoting apoptosis. This hypothesis would fit with the 
neurohormonal response to surgery and trauma, which is characterised by substantial and prolonged 
elevations in circulating glucocorticoids.(Naito, Tamai et al. 1992) This hypothesis would also explain 
the bioenergetic phenotype seen in postoperative lymphocytes, and also account for a failure to 
increase glycolysis in the face of lower oxidative phosphorylation.  
 
In summary, these findings suggest that perioperative glucocorticoid driven activation of the 
inflammasome may represent an under-recognised, pathologic mechanism that may result in a 
hypometabolic postoperative phenotype, possibly driven by caspase-1 mediated inhibition of 
glycolysis. This new paradigm suggests that manipulation of this inflammasome pathway through 
caspase-1 and inflammasome inhibitors such as VX-765 or parthenolide for example, may offer a novel 
strategy to reduce postoperative length of hospital stay and morbidity following the acute 
inflammatory challenges of surgery.   
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Discussion 
8.1 Thesis summary 
This is the first study to demonstrate a link between low AT and lymphopenia. Lymphopenia and low 
AT are independently associated with prolonged hospital stay following elective colorectal surgery. 
Immune dysfunction may therefore be a mediator (and low AT may be a marker) of poor perioperative 
outcomes. Postoperative alterations in lymphocyte count and NLR do not recover to baseline levels by 
day of hospital discharge following colorectal surgery.  
 
Significant bioenergetic and functional changes occur in lymphocytes postoperatively, which may 
explain why morbidity and mortality are increased following surgery. Ex-vivo analysis of lymphocytes 
demonstrates a decrease in glycolysis and oxidative phosphorylation consistent with global impairment 
of the ETC within lymphocytic mitochondria. Altered metabolic function postoperatively is also 
accompanied by a reduction in postoperative lymphocyte mitochondrial membrane potential, 
increased mitochondrial ROS production and increased lymphokine production. Since impaired 
bioenergetic and immune function occur postoperatively, these changes may have a greater 
clinical impact on patients who are lymphopenic preoperatively, which may explain the prolonged 
hospitalization demonstrated following surgical insult in this cohort. 
 
I hypothesised that the postoperative bioenergetic and immune functional changes demonstrated in 
lymphocytes may occur secondary to increases in glucocorticoids, associated with the stress 
response to surgery. These may subsequently result in activation of the inflammasome pathway. 
This hypothesis is supported by demonstration of increased caspase-1 activity (known to be associated 
with inhibition of glycolysis) and IL-1β expression (associated with activation of the inflammasome and 
increased cytokine production) following incubation of isolated lymphocytes with dexamethasone. 
 
This thesis provides translational data regarding postoperative changes in immune function, 
which potentially predispose patients to increased morbidity and mortality following surgery. I 
introduce the concept that metabolic abnormalities underlie the postoperative immune phenotype. 
These findings introduce new potential therapeutic targets, which may help to reduce hospital length 
of stay.      
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8.2 Summary of key findings 
Reduced aerobic capacity is associated with lymphopenia and preoperative lymphopenia is associated 
with prolonged hospital stay following major elective colorectal surgery 
Patients with more advanced heart failure, as reflected by low AT, demonstrate an increased number 
of neutrophils. This relative neutrophilia is accompanied by a decreased number of lymphocytes, 
characterised by higher proportions of terminally differentiated CD4(+) and CD8(+) T-subsets.(Moro-
Garcia, Echeverria et al. 2014) These data are consistent with molecular mechanisms driving a T-cell 
immunosenescent state.(Macaulay, Akbar et al. 2013)  
 
Importantly, treatment of cardiac failure with several commonly available evidence-based treatments 
(e.g. angiotensin-converting enzyme inhibitors(Gage, Fonarow et al. 2004), cardioselective beta 
blockade (Barnes and Ackland 2010) not only improves cardiovascular performance and reduces 
mortality, but also reverses the associated immune dysfunction. Experimental and clinical data suggest 
that established immune dysfunction is instrumental in promoting further cardiac failure, rather than 
merely being a marker of disease progression.(Topkara, Evans et al. 2011) Data from the perioperative 
literature supports this concept: patients with evidence for preoperative depletion of antibodies to 
endotoxin exhibit higher levels of pro-inflammatory cytokines and sustain more perioperative 
morbidity.(Bennett-Guerrero, Ayuso et al. 1997, Bennett-Guerrero, Panah et al. 2001, Moretti, 
Newman et al. 2006)  
 
Data from this thesis shows that a low preoperative AT measurement as assessed by CPET (<11 
mL/kg/min), is associated with lymphopenia and increased NLR. These factors have been 
independently demonstrated to be robust prognostic indicators following colorectal surgery. This data 
therefore supports the hypothesis that subclinical heart failure (as defined by poor aerobic capacity or 
AT <11 mL/kg/min) is associated with leucocyte markers of chronic systemic inflammation (lower 
lymphocyte count and higher NLR). This alteration in immune phenotype may be a significant factor 
explaining why patients with lymphopenia (who also have a lower AT) have prolonged hospital stay 
and increased medical and surgical complication rates following elective surgery. Therefore this thesis 
introduces a novel concept that immune dysregulation rather than being a marker of disease 
progression is considered to be a pivotal feature driving poor aerobic capacity,(Topkara, Evans et al. 
2011) and cardiac failure. Lymphopenia is therefore a biological marker, which highlights a group of 
patients at increased risk of adverse outcomes. This can be easily identified before major surgery in 
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most patients and points to underlying pathophysiological mechanisms, which may be amenable to 
therapeutic manipulation to improve perioperative outcome. 
 
Postoperative changes in relative lymphocyte count and NLR do not recover by day of hospital 
discharge 
I also present the largest prospective study evaluating trends in peripheral lymphocyte count and 
NLR conducted in a perioperative setting. The development of postoperative lymphopenia 
demonstrated in this colorectal cohort of patients is consistent with findings from previous 
studies. The recovery profile demonstrates that NLR and relative lymphocyte counts do not 
return to baseline levels by day of hospital discharge. This suggests that patients have a degree of 
ongoing inflammation (high NLR) and potentially impaired immune function following discharge 
from hospital, which may confer increased susceptibility to morbidity until levels return to 
baseline values. I have also shown that preoperative lymphopenia is an independent risk factor 
for prolonged length of hospital stay and development of complications following surgery in 2 
patient cohorts.  
 
Bioenergetic function of lymphocytes is impaired following elective orthopaedic surgery 
In patients with sepsis, cellular bioenergetic dysfunction has also been demonstrated in 
muscle(Brealey, Brand et al. 2002) and is proposed as a key mechanism of organ dysfunction in 
this setting. Cardiomyocytes and lymphocytes have previously been reported to have similar 
metabolic profiles in murine studies.(Cortez, Neves et al. 2012) Given that subclinical heart failure 
(low AT) has already been associated with lymphopenia and previous studies have described 
impaired bioenergetic function in cardiomyocytes from patients with heart failure, I next 
explored lymphocyte bioenergetics as a possible mechanism for impaired postoperative 
immunity. This could potentially explain why lymphopenic patients have an increased hospital 
length of stay.  
 
Bioenergetic analysis of lymphocyte function demonstrates that decreased oxidative 
phosphorylation and glycolysis occur in the postoperative phase at day 3 following elective 
orthopaedic surgery. Change in lymphocyte bioenergetic function may be a cause of or related to 
the increased propensity to apoptosis demonstrated in lymphopenic patients (as seen in the 
postoperative state).(Edwards, Sultan et al. 2015) The bioenergetic dysfunction observed in the 
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lymphocytes of these postoperative patients may represent a more global abnormality, resulting 
in reduced energy production and impaired organ function. 
Postoperative lymphocyte changes are consistent with mitochondrial dysfunction and activation 
of the inflammasome  
ETC dysfunction as demonstrated by reduced oxidative phosphorylation is also accompanied by 
other evidence of altered mitochondrial function postoperatively including an increase  in 
mitochondrial ROS production and decrease in mitochondrial membrane potential seen 
postoperatively in a variety of types of surgery. There is an increase in IL-1β, which is consistent 
with the hypothesis that there is activation of the NLRP inflammasome. There is also increased 
caspase-1 activity, which has previously been linked to inhibition of glycolysis . The trigger for this 
may be due to the increase in cortisol, which is seen postoperatively during the well-described 
stress response to surgery. The increase in circulating cortisol seen perioperatively may therefore 
result caspase related decrease in glycolysis and ETC dysfunction, which leads to the activation of 
the inflammasome and subsequent increase in lymphokine production. The precise mechanism 
however by which ETC function alters within lymphocytic mitochondrion postoperatively remains 
unclear. 
 
In active rheumatoid arthritis and SLE, increased lymphocyte mitochondrial oxidative 
phosphorylation is seen which can be ameliorated by high dose glucocorticoids,(Kuhnke, 
Burmester et al. 2003) presumably via their non-genomic effects reducing mitochondrial 
transmembrane potential and decreasing ATP availability.(Buttgereit, Burmester et al. 2000) 
These studies are consistent with findings from my thesis suggesting that  postoperative increases 
in glucocorticoid levels result in reduced mitochondrial membrane potential and bioenergetic 
function of lymphocytes. 
  
Given the presence of postoperative defects seen in lymphocytes, it is plausible that this group of 
immune cells plays an integral role in the development of postoperative morbidity resulting in 
prolonged hospital stay for patients with pre-existing lymphopenia. The ex-vivo postoperative 
functional impairment seen in lymphocytes may reflect in-vivo immune deficits of the adaptive 
immune response and the early control of inflammation and innate immunity, which may be more 
pronounced in patients with preoperative lymphopenia. 
  
   
190 
 
8.3 New aspects of work undertaken in this thesis  
This study establishes: 
 A relationship between low AT and lymphopenia. 
 Perioperative changes in leucocyte counts in patients undergoing colorectal surgery.  
 A relationship between preoperative lymphopenia and prolonged length of stay 
 The successful use of extracellular flux analysis to demonstrate reduced oxidative 
phosphorylation and glycolysis postoperatively in mitochondrial of lymphocytes. This study 
identifies extracellular flux analysis as a valid technique in assessing human disease states.   
 Perioperative changes in human lymphokine production utilising a whole blood assay. 
 Perioperative decreases in human lymphocyte mitochondrial membrane potential and 
increased mROS production in lymphocytes. 
 The changes demonstrated in membrane potential nd mROS production are reproducible 
through use of mitochondrial inhibitors. 
 That caspase-1 related inhibition of glycolysis may result in postoperative lymphocyte 
bioenergetic dysfunction. 
 Activation of the inflammasome (evidenced by increased IL-1β) in response to 
dexamethasone.   
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8.4 Strengths and Limitations 
Although there was an upward trend in lymphocyte count postoperatively, the time taken to 
return to baseline levels could not be fully elucidated from this study as patients were only 
followed up during their hospital stay. Furthermore the effect of preoperative phenotype 
(including cancer and preoperative lymphocyte count) and type of surgery on the recovery profile 
of lymphocyte and NLR warrants further investigation. 
 
The conclusions drawn from each chapter of this thesis should ideally be demonstrated o n 
individual patients during their perioperative course. By demonstrating a postoperative decrease 
in patient lymphocyte count, associated with decrease in postoperative bioenergetic function, 
increased lymphokine production, caspase-1 and IL-1β expression and cortisol levels, this would 
further support the overall hypothesis outlined in this thesis. However, practically this would be 
extremely difficult to undertake since the yield of lymphocytes required to perform many of the 
experiments involving isolated lymphocytes (extracellular flux analysis, mitochondrial membrane 
potential, mROS production, western blot analysis) would be significantly more than could 
otherwise be taken from a venepuncture of 15-20 mLs of patient whole blood. This would be 
particularly difficult to achieve in lymphopenic patients, especially postoperatively when the 
lymphocyte count would be expected to drop further. Similarly, though it would be interesting to 
repeat the experiments in this thesis on individual subsets of lymphocytes, the yield would make 
it difficult to perform this with the same lymphocyte numbers and therefore the power of the 
study would be compromised.  
 
One of the main methodological strengths of the experiments performed in this study was that 
individuals’ own samples were compared pre- and postoperatively, which reduced the number of 
confounding factors and allowed for elucidation of effects of perioperative management upon 
lymphocyte changes. While the most likely cause for the changes seen is surgery and tissue 
injury, the data from this study cannot exclude effects of pharmacological therapies administered 
during the perioperative period, particularly anaesthetic and analgesic agents.  Day 3 samples 
were chosen in the bioenergetic study in order to minimise the effects of anaesthetic agents on 
the results. While obtaining day 3 samples was practical following arthroplasty, (where the mean 
length of stay 5 is days) comparing day 3 lymphocytes to preoperative samples would have been 
more challenging for other surgical specialties due to the shorter length of hospital stay. 
Therefore for several other experiments (mitochondrial ROS and mitochondrial membrane 
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potential) day 2 postoperative samples were taken. Further work is required to determine the 
timeline of immune phenotype changes which occur from administration of anaesthetic agent, to 
start of surgical trauma, to each day following surgery to identify when peak changes occur and 
then identify recovery profiles in relation to preoperative patient phenotype and type of surgery  / 
size of surgical trauma. Furthermore comparisons of immune phenotype following general and 
regional anaesthesia are warranted in order to elucidate whether anaesthetic agents are 
contributing factors to bioenergetic and functional lymphocyte changes  seen postoperatively.  
 
It is not clear what difference in lymphocyte bioenergetic function, cytokine or mROS production 
correlates with significant clinical differences in the perioperative period. Further work is 
therefore required to associate these changes with clinical morbidity and mortality.  
 
Although a postoperative increases in ROS and decreases in mitochondrial membrane potential 
have been demonstrated, these are in separate samples to those in which cytokine production 
and altered oxidative phosphorylation and IL-1β secondary to stimulation with cortisol have been 
demonstrated and from different surgical specialties. It would therefore be prudent to 
demonstrate whether differences exist in lymphocyte bioenergetics and functional ity between 
surgical specialties and what degree of tissue trauma would be required to institute these 
changes. For example exploration of whether changes demonstrated following minor dental 
surgery are comparable to major general surgery is warranted. Additionally comparison of 
samples from patients with postoperative normal and lymphopenic counts would help determine 
whether these differences are more pronounced in the postoperative lymphopenic patients. 
These analyses were not performed due to the fact that most patients were found to be 
lymphopenic postoperatively.  
 
While results from this thesis introduce the concept of low AT being a marker rather than a 
mediator of perioperative poor outcome, further work is needed to explore this hypothesis. 
Postoperative samples should be interrogated for other immune signals , which have been 
associated with cardiac failure including endotoxin,(Niebauer, Volk et al. 1999) 
catecholamines(Tank and Lee Wong 2015) and BNP.(Miller, Saenger et al. 2016)  
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8.5 Supporting evidence for hypotheses outlined in this thesis 
Preoperative lymphopenia is associated with increased postoperative morbidity  and length of 
hospital stay 
Established preoperative lymphopenia (prevalence: 15-18%) is associated with excess postoperative 
morbidity (as assessed by postoperative morbidity scoring), including infections, and prolonged 
hospital stay as demonstrated in two cohorts of orthopaedic patients (n=417 and 328).(Edwards, 
Sultan et al. 2015) This data supports findings from colorectal patients in this thesis, which 
demonstrates prolonged hospital stay in patients with preoperative lymphopenia. 
 
Preoperative lymphopenia has a similar immune phenotype to postoperative lymphocytes 
Lymphocytes taken from lymphopenic patients demonstrate reduced proliferation, higher levels 
of apoptosis, reactive oxygen species production and cytokine production (all p<0.05), and lower 
levels of intracellular ATP, glycolytic capacity and mitochondrial oxygen consumption (all p<0.01)  
when compared to lymphocytes taken from patients with normal preoperative counts.(Edwards, 
Sultan et al. 2015) This is consistent with the decreased functionality demonstrated in 
postoperative lymphocytes, which were compared to individuals’ own preoperative samples. 
Lymphocytes from lymphopenic patients also therefore show decreased functionality associated 
with impaired bioenergetic capacity. This at-risk patient population can thus be identified 
preoperatively and may potentially benefit from immune-enhancing strategies. 
 
Systemic markers of inflammation and heart failure 
In patients with chronic systolic heart failure, the non-classical monocyte CD14(dim)CD16(+) 
subset is more prevalent and inversely associated with worsening cardiac performance.(Amir, 
Spivak et al. 2012) By contrast, reduced levels of the classical CD14(++)CD16(−) monocyte subset 
are reported in heart failure, compatible with remodelling roles for different 
subsets.(Apostolakis, Lip et al. 2010) CD14(+) monocyte subset analysis showed that the 
CD14(++)CD16(−) subset was reduced in patients with low cardiopulmonary reserve (colorectal 
patients; median AT = 10 (9-11) mL/kg/min; n=38) compared to age matched controls with higher 
mean AT undergoing arthroplasty (orthopaedic cohort, median AT >11 mL/kg/min; n=31).(Sultan, 
Edwards et al. 2014) These findings are in keeping with the hypothesis that low AT could be a 
marker rather than a mediator of poorer perioperative outcomes due to impaired immune 
function associated with subclinical heart failure.  
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Lymphocyte apoptosis postoperatively  
Lymphocytes taken from patients with preoperative lymphopenia demonstrate a similar bioenergetic 
profile to postoperative lymphocyte samples. The hypometabolic phenotype of lymphopenic patients, 
characterised by mitochondrial dysfunction leading to increased apoptosis through the intrinsic 
pathway, would explain the susceptibility of these patients to postoperative infection and therefore 
prolonged hospital stay.  Freshly isolated preoperative lymphocytes were incubated with common 
perioperative stressors at physiologically relevant doses. Lymphocytes obtained from postoperative 
patients expressed higher levels of the early apoptosis marker annexin V than matched preoperative 
samples.(Edwards, Sultan et al. 2015) 
 
Murine NLRP3 KO study 
Genetic ablation of the murine NLRP3 inflammasome fails to prevent glucocorticoid-induced 
splenocyte apoptosis and caspase-1 activity, but was associated with increased NLRP1 protein 
expression. (Edwards, Sultan et al. 2015) Given the fact that dexamethasone results in increased IL-1β 
production, these findings suggest that activation of the NLRP1 (not the NLRP3) inflammasome is 
responsible for the hypometabolic phenotype seen. Therefore cortisol may be a novel activator of the 
NLRP1 inflammasome perioperatively. Targeting the hypometabolic phenotype of postoperative 
lymphocytes offers a novel strategy to reduce postoperative infections and sepsis. Inflammasome 
inhibition utilising caspase-1 and inflammasome inhibitors such as VX-765 or parthenolide for example 
may affect postoperative lymphopenia and morbidity. 
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8.6 Hypometabolic functional states of lymphocytes 
Effector T cells play a vital role in adaptive immunity. While advances have been made in 
characterization of effector T cells in infectious disease models (particularly mouse models), the nature 
of these cells is not well understood in postoperative patients. The phenotype and functional profile of 
postoperative T cells is likely to be dramatically impacted by the different microenvironment. 
 
Successful activation of resting T-cells requires two signals.(Baxter and Hodgkin 2002) Firstly, this is 
produced by binding of MHC-II associated antigen on APCs to the TCR - CD3 complex. The second, co-
stimulatory signal is provided by binding of B7-1 (CD80) or B7-2 (CD86) on the APC to the T-cell CD28 
receptor, or by IL-2 ligation. The TCR signal is amplified through a protein tyrosine kinase cascade, 
involving a rise in intracellular calcium and activation of protein kinase C. The subsequent activation of 
transcription factors leads to movement of the cell from G0 to G1 in the cell cycle, IL-2 and other 
cytokine synthesis and RNA and protein production. These processes require a rapid increase in cellular 
metabolism.  
 
Interaction between co-stimulatory molecules CD80, CD86 and CD28 is crucial for appropriate T cell 
activation and immunoregulatory receptors such as CTLA-4 and PD-1 fine tune T cell activation (Figure 
1).(Crespo, Sun et al. 2013) Further research is needed to determine whether higher levels of 
immunoregulatory receptors (e.g. LAG-3, CD160, KLRG-1, Tim-3, CTLA-4 and CD57) are present in the 
postoperative microenvironment of T cells. Some of the T cell immunoregulatory receptors and their 
ligands are summarised in Figure 8.1. 
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Figure 8.1 T cell immunoregulatory receptors and their ligands 
 
 
Receptors in red; ligands in black; PDL1-2 = Programmed death ligand; PD-1 = Programmed cell death protein 1; MHC = major histocompatibility complex; HVEM = 
herpesvirus entry mediator; KLRG-1 = co-inhibitory receptor killer-cell lectin like receptor G1; Tim-3 = T cell immunoglobulin mucin-3; CTLA-4 = cytotoxic T-
lymphocyte-associated protein 4 (CD152); TCR = T cell receptor; LAG-3 = Lymphocyte activation gene-3; 2B4 = Natural Killer Cell Receptor 2B4 (CD244)  
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Several distinct states have been described in which reduced lymphocyte functionality may be seen 
(Table 8.1). Although there are similarities between these states they are thought to represent distinct 
lymphocyte phenotypes. The postoperative lymphocytes appear to demonstrate in part, an exhaustive 
phenotype as apoptosis and metabolism are decreased. The alteration in cytokine production in this 
states decreases, however the interaction between lymphocytes and the inflammasome is not taken 
into account in this simplified classification system. It is likely that anergy, exhaustion and senescence 
are all present in elderly surgical patients studied in this thesis. 
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Table 8.1 Terms describing T cell unresponsive, hyporesponsive or dysfunctional T cells 
Ignorance  T cell Unaware or ignorant of (self-) antigen due to physical sequestration or low 
level expression of antigen 
 
Tolerance Central Deletion of self-reactive thymocytes expressing TCR with too high affinity for self- 
antigen/MHC complexes 
 
Peripheral (self) To prevent auto-immunity, self-reactive T cells that escape negative selection are 
inactivated in the periphery by: deletion; suppression by T reg cells; induction of cell 
–intrinsic program mediating cell unresponsiveness 
 
Anergy In vitro Dysfunction of T cells from in vitro stimulation in absence of co-stimulatory signals. 
Decreased cytokine production, metabolism and apoptosis unchanged 
 
In vivo (adaptive 
tolerance) 
Dysfunction of T cells induced by sub-optimal in vivo stimulation 
Exhaustion  Persistent antigen and inflammation during chronic infection induces progressive 
loss of effector function in virus specific T cells. A state of functional 
hyporesponsiveness. Decreased cytokine production and increased apoptosis 
 
Senescence  Irreversible, permanent cell cycle arrest commonly reflected by telomere shortening. 
Decreased cytokine production and unchanged metabolism 
 
Quiescence  Reversibly arrested cell cycle state (G0 phase) 
 
 
As Figure 8.1 suggests there is an extremely complex network of immunoregulatory receptors and their 
ligands expressed on APCs which interact with infiltrating T cells.(Crespo, Sun et al. 2013) Some of the 
key features of the hyporesponsive states are and their interactions are outlined in Table 8.2. 
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Table 8.2 Features of key hyporesponsive states 
 Initiation Phenotype Regulation 
Anergy Reduced CD28 co-stimulation 
Increased co-inhibition 
Defective mTOR and 
Ras/MAPK signalling 
Ca2+ imbalance results in 
retention of active RAP-1 in 
cytosol 
 
Reduced IL-2  
Cell cycle arrest at 
G1/S phase 
Transcription factor 
(Erg2) 
Epigenetic factors 
(IKAROS and Sirt 1) 
result in histone 
modifications 
Exhaustion Increased PD-1 expression 
May also express inhibitory 
receptors (CD2444, BTLA, 
CTLA-4, CD160, LAG-3, Tim-3) 
 
Reduced IL-2, IFN-G, 
TNF-A 
Cell cycle arrest 
 
Senescence Reduced CD28 expression 
Increased Tim-3, CD57, KLRG-1  
Increased cell cycle controlling 
proteins (p16, p21, p53) 
Telomere shortening 
Cell cycle arrest in 
G1/S phase 
 
 
8.7 Anergy 
An excess of anergic T-cells is seen in trauma, where it is thought to be an indicator of pathological 
immune suppression and has also been associated with poorer outcomes.(Bandyopadhyay, De et al. 
2007) The phenotype of the lymphocytes from postoperative patients studied in this thesis is only 
partly consistent with anergy.  A failure to become activated when stimulated may lead to lower levels 
of both glycolytic and mitochondrial ATP production. However, anergic lymphocytes do not have 
increased apoptosis in vivo,(Walker and Abbas 2002), so widespread T-cell anergy is unlikely to explain 
the increase in apoptosis which occurs postoperatively.  
 
8.8 Exhaustion 
T cell exhaustion is a state of T cell dysfunction that arises during chronic infection and cancer. It is 
defined by poor effector function, sustained expression of inhibitory receptors and a transcriptional 
state distinct from that of functional effector or memory T cells.(Wherry 2011) Exhaustion prevents 
optimal control of infection and tumours. Both extrinsic negative regulatory pathways (such as 
immunoregulatory cytokines) and cell-intrinsic negative regulatory pathways (such as PD-1) have key 
roles in exhaustion. 
 
Hierarchical T cell exhaustion occurs during chronic infection. During initial infection, naive T cells are 
primed by antigen, co-stimulation and inflammation and differentiate into effector T cells. Clearance of 
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infection and antigen allows a subset of these functional effector T cells to further differentiate into 
highly polyfunctional memory (CD8) T cells able to coproduce many cytokines (such as IFN-γ, tumor 
necrosis factor (TNF) and IL-2), becoming cytolytic and proliferating vigorously. These cells also have 
considerable survival capacity and are maintained long term without antigen. During chronic infection, 
infection persists after the effector phase. As antigen and/or viral load increases, T cells progress 
through stages of dysfunction, losing effector functions and other properties in a hierarchical manner. 
T cell exhaustion is also accompanied by a progressive increase in the amount and diversity of 
inhibitory receptors expressed (including PD-1, LAG-3, 2B4, CD160, Tim-3, CTLA-4).(Crawford and 
Wherry 2009) In addition, altered inflammation and changes in immunoregulatory cytokines such as IL-
10 and/or TGF-β can have an increasingly important role. Ultimately, if the severity and/or duration of 
the infection is high and/or prolonged, virus-specific T cells can be completely eliminated, leading to 
loss of virus-specific T cell responses. The severity of T cell exhaustion is correlated with increasing 
inhibitory receptor expression, high viral (or antigen) load, loss of CD4+ T cell help and prolonged 
infection.(Wherry 2011) PD-1 may define and maintain T cell exhaustion, which is supported by 
evidence that PD1 blockade may rescue T cell effector function and result in improved effector 
responses such as cytokine expression, cell cycle progression and cytotoxicity.(Blackburn, Shin et al. 
2009, Jin, Anderson et al. 2010) 
  
The postoperative phenotype described in this thesis has several similarities with the exhaustion 
phenotype. Firstly, lymphocyte function is impaired in both groups. Secondly, lymphocyte apoptosis is 
increased in the advanced exhaustion phenotype, mediated by upregulation in Bim and 
downregulation of Bcl-2, consistent with the increases in intrinsic mitochondrial ROS observed.(Akbar 
and Henson 2011) Lastly, widespread transcriptional profiling of memory, effector and exhausted T-
cells has revealed metabolic abnormalities in exhausted lymphocytes, with downregulation of several 
genes involved in energy metabolism and the citric acid cycle.(Wherry, Ha et al. 2007) These 
transcriptional changes could potentially be responsible for reductions in glycolysis and oxidative 
phosphorylation in exhausted T-cells as seen in Chapter 4, however this requires further study. Despite 
these similarities, our patient cohort had an extremely low incidence of HIV, HBV and HCV from which 
most studies describing T cell exhaustion have described observations. 
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8.9 Senescence 
At a critical point telomere shortening due to repeated antigenic exposure triggers DNA damage which 
inhibits cell cycling. This results in large numbers of highly differentiated (CD27(-) CD28(-)) T-cells with 
reduced function and proliferative ability.(Akbar and Henson 2011) Senescence is associated with 
advanced age and CMV.  
 
The features of the postoperative lymphocytes may in part, fit with the senescent T-cell phenotype. 
Postoperative lymphocytes have a hypometabolic (and pro-apoptotic) phenotype with reduced 
glycolytic and/or mitochondrial oxidative phosphorylation. There is however no consensus on the 
apoptotic predisposition of senescent lymphocytes; long term cultures used to study senescent cells 
tend to be resistant to cell death, whereas more freshly isolated highly differentiated T-cells appear 
sensitive to apoptosis.(Plunkett, Franzese et al. 2007)  
  
In summary, whilst the phenotypes described in anergy, exhaustion and senescence do not fit precisely 
with the abnormalities found in postoperative lymphocytes, some similarities do exist. This is 
particularly the case for increased activity of co-inhibitory receptors such as PD-1 or dysfunction in 
other parts of the co-stimulatory pathway. The lymphocyte stimulation performed in the bioenergetic 
study within this thesis consisted of concanavalin A, which mimics TCR ligation by activating PKC, 
(Krauss and Brand 2000) without direct effects on the co-stimulatory pathway. Lymphocytes from 
preoperative samples demonstrated adequate co-stimulation by displaying glycolysis, whereas 
postoperative lymphocytes were unable to do this perhaps due to an abnormality in the co-stimulatory 
pathway (IL-2 or CD28 and CD80 / CD86). Inadequate co-stimulatory receptor activity (CD28 or IL-2) or 
increased co-inhibitory receptor activity (PD-1, CTLA-4) may be responsible for the altered metabolic 
profile demonstrated postoperatively. Surgery may also alter the ability of MHC class II molecules to 
bind with TCRs, or inhibit PKC activation following Concanavalin A activation.  
 
The two co-stimulatory pathways which may be implicated in the impaired postoperative bioenergetic 
function are the: 1) PI3K/Akt/mTOR pathway (CD28) and the 2) JAK/STAT/PIM pathway (IL-2). These 
are discussed as potential therapeutic targets in the next part of this discussion.  
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8.10 Future work and potential therapeutic targets 
Future bioenergetic studies and therapeutic targets 
It would be important to identify whether differences exist in postoperative inhibitory receptor 
expression (PD-1, CTLA-4, LAG-3), markers of senescence (differentiation markers CD27, CD28 and 
CD58, plus KLRG-1) in order to gain further understanding of the likely mechanism for lymphocyte 
hypometabolism.  
 
Since differences appear to exist between lymphokine production of CD4(+) and CD8(+) cells, it would 
be important to determine whether differences also exist between different subsets of lymphocytes in 
terms of bioenergetic function including: 
 Naive Th cells (CD3+ CD4+ CD45RA+ CD62L+) 
 Effector Th cells (CD3+ CD4+ CD69+) 
 Memory Th cells (CD3+ CD4+ CD45RO+) 
 As above for Tc cells (CD8 not CD4) 
 B-cells (CD3- CD19+) 
 NK cells (CD3- CD56+ CD16+) 
 
Given the fact that CD4 cells were unable to increase Th1 lymphokine production postoperatively, 
these cells may demonstrate reduced oxidative phosphorylation and glycolysis compared to CD8(+) 
cells. 
 
This thesis has identified an association between the postoperative state and reduced bioenergetic 
function of lymphocytes. What remains unclear is the precise molecular mechanism causing the 
altered mitochondrial function. The physiological levels of glucocorticoid, types of glucocorticoid, 
cellular pathways and receptors which are activated, warrant further investigation in order to identify 
potential therapeutic targets to maintain baseline lymphocyte function.  
 
An accumulating body of evidence highlights the diverse array of metabolic functions regulated by the 
steroid receptor co-activator (SRC), including systemic metabolite homeostasis, inflammation, and 
energy regulation.(Stashi, York et al. 2014) The cooperative and unique functions among the SRCs 
resulting in bioenergetic functional changes require investigation. Furthermore deciphering the 
fractional and synergistic contributions of the SRCs to metabolic homeostasis is crucial to 
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understanding fully the networks underlying metabolic transcriptional regulation in the perioperative 
period. Cytochrome c oxidase may be a therapeutic target of the glucocorticoid effect on the 
respiratory chain in order to limit its effect on postoperative change in oxidative phosphorylation 
based on data from rat kidneys.(Simon, Jolliet et al. 1998)  
 
By preventing reduction in oxidative phosphorylation and glycolysis seen in lymphocytes 
postoperatively with any given therapy, it would be prudent to also demonstrate a concomitant 
increase in lymphokine production showing that they are indeed related. Some important pathways 
involved in lymphocyte bioenergetics are outlines in the Table 8.3. The mediators identified in Table 
8.3 identify potential therapeutic targets for investigating whether postoperative changes in 
lymphocyte bioenergetic function can be modified.   
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Table 8.3 Key pathways controlling lymphocyte energy metabolism 
 
Stimulating factor Pathway Mediator Effects 
Co-stimulation  
(CD28 & 
CD80/CD86) 
PI3K 
AKT 
Links signal transduction to anabolic and 
glycolytic metabolism 
GLUT-1 receptor insertion at cell membrane, 
activates hexokinase, phosphofructokinase 
Inhibition of pro-apoptotic BAD 
mTOR 
Promotes protein synthesis if insufficient 
intracellular supply of amino acids 
Low ATP  
(High AMP: ATP) 
  AMPK 
Negative regulation of Akt / mTOR 
Inhibits growth and proliferation during nutrient 
deficiency / physiological stress  
Induces p53-mediated cell cycle arrest at the 
junction of G1 and S. 
IL-2  JAK and 
STAT 
pathways 
(via  
PIM1 / 
PIM2 
Functions overlap those of Akt and mTOR  
 
PI3K, phosphatidylinositol 3-kinase; Akt, protein kinase B; mTOR, mammalian target of rapamycin; 
AMPK, 5' AMP-activated protein kinase;  PIM1 /PIM2, proviral integration site 1 / 2 =oncogene, ; JAK, 
Janus kinase; STAT, signal transducer and activator of transcription; BAD, B-cell lymphoma-2-
antagonist-of-cell-death. 
 
Proto-oncogenes / tumour suppressors are also known to modulate energy metabolism. Many regulate 
glucose metabolism directly,(DeBerardinis and Thompson 2012) and activate the PI3K/Akt/mTOR 
metabolic signalling pathway, which is important for cell survival, metabolism and proliferation. 
Manipulation of these pathways can affect lymphocyte fate. For example, during T-cell activation, 
inhibition of mTOR can prevent proliferation and leads to formation of CD8 memory T-cells.(Pearce 
2010) Some key oncogenes, which are also potential therapeutic targets, are described in Table 8.4. 
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Table 8.4 Key oncogene effects on metabolism 
Oncogene Effects 
Akt Glucose uptake (via GLUT-1 transporter) 
Aerobic glycolysis 
Lipid synthesis (utilising mitochondrial citrate metabolised to Acetyl CoA) 
mTORC1 Protein synthesis 
Lipid synthesis  
Mitochondrial metabolism (anabolic precursors) 
Decreased autophagy 
Myc 
 
Glutamine uptake 
Glutaminase conversion of glutamine to glutamate (for mitochondria) 
 
In many cell systems, mTORC1 couples PI3K (phosphoinositide 3-kinase) and Akt (or protein kinase B) 
with the control of glucose uptake and glycolysis. However, this is not the case in activated CD8(+) T-
lymphocytes responding to the cytokine IL-2 where PI3K/Akt signalling is dispensable for the elevated 
levels of glycolysis that is characteristic of activated T-cells.(Finlay, Rosenzweig et al. 2012, Finlay 2013) 
mTORC1 is essential for glycolytic metabolism in CD8(+) T-cells, and this reflects the fact that mTORC1 
does not lie downstream of PI3K/PKB signalling in CD8(+) T-cells, as is the case in many other cell 
systems. Thus differences in cytokine production demonstrated between CD4(+) and CD8(+) cells 
postoperatively may be due to alterations in P13K/Akt/mTOR pathway activity.  
 
 mTORC1 activity is required for TCR-induced c-Myc expression and the switch to increased 
glycolysis.(Finlay, Rosenzweig et al. 2012) Accordingly, deletion of c-Myc in naive T-cells prevents TCR-
induced glucose uptake and glycolysis, (Wang, Dillon et al. 2011) A successful T-cell activation response 
involves expression Myc, an oncogene which plays a role in glutamine uptake, mitochondrial activity 
and mitochondrial biogenesis.(Altman and Dang 2012) A failure of adequate lymphocyte activation 
could therefore impair mitochondrial formation resulting in reduced postoperative respiratory 
capacity. This is described as an important factor in ongoing memory T-cell survival.(van der Windt, 
Everts et al. 2012) Evaluation of Myc and mTORC1 levels is needed in the perioperative period to 
determine whether these result in reduced glycolysis in lymphocytes postoperatively.  
 
mTORC1 also regulates glucose metabolism in CD8 lymphocytes through regulating the expression of 
the transcription factor HIF1α (hypoxia-inducible factor 1α). Strikingly, HIF1α functions to couple 
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mTORC1 with a diverse transcriptional programme that among other roles controls glucose 
metabolism.(Laplante and Sabatini 2012) Therefore changes in HIF1α levels in the perioperative period 
should be explored as a potential mechanism for altering bioenergetic function and may explain 
reductions in oxidative phosphorylation and glycolysis seen.  
 
In order to identify whether surgery alters these signalling pathways, which could result in the 
metabolic alterations demonstrated, further studies are also needed to assess and quantify Akt and 
mTor levels in lymphocytes following stimulation in the perioperative period. Additionally, assessment 
of the integrity of downstream TCR activation events after stimulation e.g. measuring IL-2 production 
in patient cells following mitogenic stimulation should be explored. The postoperative phenotype can 
be recreated in healthy control lymphocytes by performing co-stimulatory pathway blockade. The 
following pathways should be inhibited in order to demonstrate the likely cause of postoperative 
hypometabolism: 
 CD28 receptor antagonism 
 mTOR inhibition with rapamycin 
 AMPK activation (inhibits mTOR) with metformin 
 PD-1 / CTLA-4 agonism 
The PI3K/PKB/FOXO (forkhead box O) pathway also controls the expression of these key trafficking 
molecules. Defects in transcription or inhibition of the kinases involved in these pathways may be 
mechanistic in the metabolic and functional abnormalities seen in postoperative lymphocytes. (Finlay 
and Cantrell 2010) 
 
The Foxo family of transcription factors is a well-defined target of the Akt kinase. Aside from 
evolutionarily functions in nutrient sensing (via the P13K/Akt/mTOR pathway) and stress 
responses (via C-Jun N-terminal kinase), Foxo proteins also regulate the expression of target 
genes involved in the control of T cell homeostasis and tolerance.(Hedrick, Hess Michelini et al. 
2012) Some of the effects of Foxo1 stimulation include: 
 IL-7Rα expression – discussed further in the future cytokine target section. 
 Sphingosine-1-phosphate receptor 1 (S1P1) - involved in T-lymphocyte trafficking. 
Deficiency of S1P1 leads to T-cell lymphopenia in the peripheral lymphoid 
organs.(Matloubian, Lo et al. 2004) 
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 CCR7 – a chemokine receptor required for the migration of circulating 
lymphocytes to lymphoid organs.(Kerdiles, Beisner et al. 2009) 
 CD62L (L-selectin) – an adhesion molecule necessary for lymphocyte recirculation 
via adhesion to lymphoid tissue high endothelial venules and lymph node homing.  
Foxo1 deficiency leads to decreased lymphopenia-induced homeostatic proliferation due to 
reduced IL-7RαR expression, reduced egress of naive thymic T-cells due to S1P1 deficiency, and 
reduced lymph node lymphocyte numbers, with consequent total organism 
lymphopenia.(Gubbels Bupp, Edwards et al. 2009, Kerdiles, Beisner et al. 2009, Ouyang, Beckett 
et al. 2009) Therefore Foxo deficiency could be affected by the stress response to surgery and 
may be a contributing factor to peripheral lymphopenia.   
 
Further work should assess the impact of Foxo-1 dysregulation on the metabolic and functional 
profiles seen postoperatively. Useful things to identify perioperatively include: 
 Levels of lymphocyte S1P1 and CD127 (IL7) receptors 
 Effect of S1P1 and CD127 receptor agonists on lymphocyte metabolism 
 
Autophagy targets 
Autophagy is an intracellular catabolic process involving the generation of a double-membraned 
structure, sequestration of cytoplasmic components, and delivery of bound cellular matter to 
lysosomal compartments for degradation. This process is conserved in all eukaryotic cell types,  
and has been implicated in cellular survival during periods of cellular or cytotoxic 
stresses.(Kroemer, Marino et al. 2010, Levine, Mizushima et al. 2011) Autophagy can be divided 
into three main classes: 
1) Macroautophagy -de novo synthesis of autophagosomal membranes around bulk substrates 
to be degraded and the stepwise fusion of these autophagosomes with degradative vesicles 
to form autolysosomes.  
2) Selective autophagy, (subclass of macroautophagy) involves binding of substrates to adapter 
molecules for inclusion into the nascent autophagosome.  
3) Microautophagy involves the small-scale blebbing and sequestration of soluble components 
within the immediate microenvironment of previously formed autophagosomes generated 
during macroautophagy. 
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The role of autophagy and mitophagy in the postoperative phase is an under explored area.  
Autophagy provides an alternative source of nutrients scavenged from the cytoplasm, an 
alternative form of cellular degradation that augments the proteasomal system, and a major 
pathway for intracellular remodeling to reflect changes in the developmental or metabolic 
requirements of the cell.(Yorimitsu and Klionsky 2005) 
 
Autophagy genes including: Vps34, Atg3, Atg5, Atg7, Beclin-1, LC3, and p62 are expressed in both 
T and B lymphocytes.(McLeod, Jia et al. 2012) The expression of these genes in the perioperative 
period warrants further investigation in conjunction with clinical outcome. 
 
Methyl pyruvate can restore cytokine production by autophagy-deficient T cells,(Hubbard, Valdor 
et al. 2010) suggesting a function of autophagy in energy production and other essential 
processes in T lymphocytes. Much work remains to identify the soluble, cytoplasmic components 
that require autophagy for turnover and to determine whether their autophagy mediated 
turnover requires specific adapter proteins. The downstream targets of the T-cell receptor, which 
are responsible for activation-mediated autophagy, are unknown. The coordinated activity of 
NFAT, NFκB, or MAPK signals may be required. Furthermore, the contribution of autophagy to a 
robust T-cell proliferative response remains unclear. Further work is necessary to determine 
which targets are processed by autophagy and which are proteosomally degraded. Targeting 
autophagy may provide interesting therapies for T cells to overcome anergy induced by surgery. 
 
Future cytokine targets 
The data from this thesis examined Th1 cytokines and explored CD4 and CD8 subsets of 
lymphocytes. Limiting investigation to these 2 subsets of lymphocyte allowed me to demonstrate 
that cytokine production increased in CD8(+) cells more than CD4(+) cells. However, further 
investigation is required to elucidate not only how cytokine production from other subsets of 
lymphocytes changes postoperatively but also whether Th2 cytokine production is altered in 
different subsets postoperatively.  
 
In myeloid immune cells, PI3K and mTOR seem to constrain full immune cell activation by 
upregulation of the key anti-inflammatory cytokine interleukin 10 and inhibition of 
proinflammatory cytokines.(Weichhart and Saemann 2008) Decreased activity of these signalling 
pathways may be in part responsible for postoperative changes in TH1 cytokine production. 
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Manipulation of these pathways could therefore prove to be potential therapeutic targets to 
affect postoperative immune cell function via manipulation of cytokine production.  
IL-7 has several important roles in lymphocyte homeostasis: 
 naïve T-cell homeostatic proliferation 
 T-cell lymphopoesis in the bone marrow 
 anti-apoptotic actions via Bcl-2 upregulation 
 support of bioenergetic function through transcriptional regulation of the 
Glut-1 and hexokinase II genes or via the Akt pathway(Jacobs, Michalek et 
al. 2010) 
T-cell response to IL-7 is likely to be regulated by varying expression of IL-7 receptor α-chain (IL-
7Rα, or CD127) (Ouyang and Li 2011) The widespread pro-energetic and pro-survival activity of IL-
7 on lymphocytes means that reduced IL-7 activity due to reduced IL-7 lymphocyte exposure, or 
reduced IL-7Rα expression, may explain the postoperative lymphocyte phenotype. 
 
Cynomolgus monkeys receiving 10 days of exogenous IL-7 (rhIL-7) showed substantial, reversible 
increases in T-cell numbers involving a dramatic expansion of both naive and non-naive 
phenotype CD4(+) and CD8(+) subsets.(Fry, Moniuszko et al. 2003) The use of this therapy for 
humans in the perioperative phase has not been performed. Additionally, whether increases in T-
cell numbers postoperatively secondary to rhIL-7 result in improved outcome remains unclear.  
 
Pre-clinical and phase 1 human studies have demonstrated acceptable tolerabil ity of 
subcutaneous recombinant human IL-7 (rhIL-7) administered in subjects with refractory 
malignancy for its anti-tumour responses.(Sportes, Babb et al. 2010) The lymphocyte effects of IL-
7 include an increase in T-cell cycling, upregulation of bcl-2 and major sustained increases in CD4+ 
and CD8+ lymphocyte circulating numbers (thought to be due to increased production and 
peripheral proliferation). In a recent murine peritonitis model, rhIL-7 treatment started 90 
minutes after caecal ligation and puncture improved survival, reduced T-cell apoptosis, restored 
IFN-γ production and improved immune effector cell recruitment to the infected site .(Unsinger, 
McGlynn et al. 2010) This appears to be a promising potential treatment to improve immune 
function and reduce hospital length of stay secondary to morbidity for humans in the 
perioperative period.  
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To combat postoperative immunodepression, perioperative IL-2 administration has been tested in 
a phase II randomised trial (n = 39) to analyse efficacy on patients with radically operable gastric 
cancer.(Romano, Piacentini et al. 2004) In this study patients who received IL-2 had a significant 
increase in total and CD4(+) lymphocytes and these patients did not experience any anaesthesia-
related or surgical complications. The treatment group however did experience a greater 
incidence of fever than the control group. The wide range of side-effects resulting from IL-2 keeps 
it from widespread use at present. The prognostic impact of IL-2 treatment remains unclear.  
 
Future inflammasome and IL-1Beta studies and therapeutic targets 
During the past few decades, it has been widely recognised that Reduction-Oxidation (redox) 
responses occurring at the intra- and extra-cellular levels are one of most important biological 
phenomena and dysregulated redox responses are involved in the initiation and progression of 
multiple diseases. Thioredoxin1 (Trx1) and Thioredoxin2 (Trx2), mainly located in cytoplasm and 
mitochondria, respectively, are ubiquitously expressed in variety of cells and control cellular 
reactive oxygen species by reducing the disulfides into thiol groups. Thioredoxin interacting 
protein (Txnip/thioredoxin binding protein-2/vitamin D3 upregulated protein) directly binds to 
Trx1 and Trx2 (Trx) and inhibit the reducing activity of Trx through their disulfide 
exchange.(Yoshihara, Masaki et al. 2014) Recent studies have revealed that Trx1 and Txnip are 
involved in some critical redox-dependent signal pathways including NLRP-3 inflammasome 
activation in a redox-dependent manner.(Zhou, Tardivel et al. 2010) Therefore, Trx/Txnip, which 
exist in mitochondria are a redox-sensitive signalling complex regulating cellular redox status and 
has emerged as a key component in the link between redox regulation and the pathogenesis of 
diseases. This may be important in the regulating the increase in mROS seen in lymphocytes 
postoperatively and may therefore be an effective therapeutic target. While antioxidant 
treatment is associated with improvements in isolated aspects of lymphocyte function in animal 
and ex-vivo models these have not been explored adequately in clinically relevant 
studies.(Kurihara, Nagoshi et al. 2007, De la Fuente, Cruces et al. 2011) 
 
Much research over the past few decades has focused on determining the function of members 
of the cytosolic Nod-like receptor (NLR) family in terms of their triggers and the signal ling 
pathways that they control. As previously described in chapter 7, NLRP proteins play a role in 
sensing both microbial and danger signals and triggering the caspase-1 dependent 
inflammasome. The Nod subfamily characterised by proteins with a caspase-activating and 
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recruitment domain (CARD) or a so-called 'X' domain. Nod1, Nod2, NLRX1 and NLRC5 are all 
members of this subfamily and there has been recent work demonstrating the importance of 
these molecules in both pathogen sensing and regulation of innate and adaptive 
immunity.(Magalhaes, Sorbara et al. 2011) The changes in expression of these molecules within 
lymphocytes in response to perioperative increases in cortisol also require further investigation. 
 
Ginsenoside Rg1 protects cells by antagonizing neuronal apoptosis.(Wu, Pan et al. 2012) The 
phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signalling pathway may effectively 
reduce mitochondrial pathway-induced cell apoptosis.(Huang, Wu et al. 2014) Pre-treatment of rat 
chondrocytes with Rg1 has been shown to decrease the activity of IL-1β that reduces expression of 
Bcl-2 and level of phsophorylated-Akt, and increases Bax (Bcl-2-associated X protein) activity, 
Cytochrome c release, and caspase-3 activation. It also reverses the activity of IL-1β. These results 
indicate that Rg1 may protect chondrocytes from IL-1β-induced apoptosis via the 
phosphatidylinositol 3-kinase/protein kinase B signalling pathway, through preventing caspase-3 
release.(Huang, Wu et al. 2014) The protective effect of Rg1 on interleukin 1β (IL-1β)-induced 
lymphocyte apoptosis and the underlying molecular mechanisms has not been investigated. This 
could potentially be explored as a therapy to reduce postoperative lymphocyte apoptosis and 
inflammasome activation. 
 
Follistatin-like protein 1 (FSTL-1) is a secreted g protein produced mainly by cells of the mesenchymal 
lineage, such as cardiomyocytes and endotheliocytes.(Oshima, Ouchi et al. 2008) FSTL-1 inhibits 
apoptosis in cardiomyocytes but also may have a proinflammatory function. FSTL-1 is overexpressed in 
a number of inflammatory conditions characterised by elevated IL-1β. Whether its expression by 
lymphocytes changes postoperatively as has been shown in patients with septic shock (Chaly, Fu et al. 
2014) requires investigation. Similarly whether this contributes to postoperative lymphocyte apoptosis 
requires investigation.  
 
Future cohort studies 
Longitudinal population studies determining life expectancy, incidence of morbidity and cause of 
mortality, are required to determine long-term outcomes in asymptomatic non-surgical patients 
with lymphopenia. 
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8.11 Surgery as a model for cardiac failure, exercise and sepsis  
Cardiac failure 
The role of autonomic imbalance on lymphocyte distribution and peripheral number was highlighted 
by a study demonstrating marked lymphopenia - particularly of Th- and B-cells - in beta-blocker-naïve 
patients with cardiac failure, whereas beta-blocker treated patients had only a mild relative 
lymphopenia compared with healthy controls(von Haehling, Schefold et al. 2009). The close parallels 
between lymphocyte and cardiac responses to catecholamines have been highlighted by the elevation 
of GRK2 (G protein-coupled receptor kinase) expression and activity in lymphocytes in patients with 
heart failure, leading to failure of β-adrenoceptor mediated cAMP response. Abnormally high levels of 
kinase activity in lymphocytes are mirrored in cardiomyocytes, and have been strongly related to 
poorer ventricular ejection fraction and NYHA symptom severity.(Iaccarino, Ciccarelli et al. 2005) 
Apoptosis may also play a role in the lymphopenia of chronic cardiac failure,(Agnoletti, Boudjemline et 
al. 2004) which may be induced ex-vivo by circulating mediators such as catecholamines (Bergquist, 
Josefsson et al. 1997) or natriuretic peptides.(Shaw, Critchley et al. 2012) The effect of heart failure 
therapy on propensity to lymphocyte apoptosis has not been explored. Similarly, measurement of NT-
proBNP, endotoxin and kinase levels in relation in the postoperative period may provide additional 
support of the similarities between heart failure and the postoperative state.   
 
Exercise  
Exercise may be used as a model to recreate some of the physiological and neuroendocrine changes, 
which occur during surgery. Episodes of exercise cause a prompt increase in circulating lymphocytes - 
particularly memory T-cells and NK cells – the magnitude of which is related to exercise intensity and 
duration.(Mignini, Traini et al. 2008) Within an hour of ceasing exercise, lymphocyte numbers fall to 
levels lower than pre-exercise, a reduction, which may last for several hours and this particularly 
affects CD4+ and NK subsets. Redistribution of lymphocytes from the spleen to other sites of potential 
antigen encounter can be mimicked in murine models by catecholamines(Kradin, Rodberg et al. 2001) 
and abolished by pharmacological sympathetic blockade.(Kruger, Lechtermann et al. 2008). Exhaustive 
exercise induces lymphocyte apoptosis in approximately 60% and after 24 hours 86% still demonstrate 
an apoptotic pattern of DNA distribution, but the precise mechanism by which this occurs remains 
unclear.(Mars, Govender et al. 1998) A healthy volunteer study also demonstrated that exhaustive 
exercise induces apoptosis in peripheral blood lymphocytes whereas moderate exercise does 
not.(Mooren, Bloming et al. 2002)  
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Further work is required to elucidate the similarities between the postoperative and post-exercise 
states in terms of bioenergetic function and inflammasome activation.  
  
ROS generated temporarily during episodes of exercise have been shown to induce the transcription of 
antioxidant genes, such that chronic exercise improves cellular redox status.(Los, Droge et al. 1995) 
The effect of instituting an exercise programme prior to elective surgery and its effect on lymphocyte 
mitochondrial function and perioperative outcome is an area, which needs further research. 
 
Sepsis 
Failure of ATP production underlies organ dysfunction in critical illness. Using muscle biopsies from 
septic and healthy preoperative controls, severity of sepsis has been correlated with reduced ATP 
concentration, reduced complex I activity, increased nitric oxide production and reduced levels of 
glutathione.(Brealey, Brand et al. 2002) This failure of energy production in sepsis has been further 
demonstrated in immune cells. Reduced mitochondrial oxygen consumption due to ATP production 
(reduced state III respiration) has also been demonstrated in peripheral blood mononuclear cells from 
patients with septic shock.(Belikova, Lukaszewicz et al. 2007, Japiassu, Santiago et al. 2011) A further 
limitation common to studies in the septic patient population is the difficulty allowing for potential 
confounding factors in the association between defective energy production and worse clinical 
outcomes. In particular, the extent of pre-insult bioenergetic dysfunction is unknown, and the 
influence of common treatments, which may alter bioenergetic profiles such as glucocorticoids, 
antibiotics and insulin is hard to control for in these small studies. Further work is required to compare 
sepsis and the postoperative states. 
 
Since similarities appear to exist between lymphocytes taken from different diseases, comparison of 
immune phenotypes of each of these disease states (including sepsis, following exercise and 
postoperatively) would provide further insight into general and disease specific patterns, which may 
exist.  
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8.12 Conclusion 
Lymphopenia is common in the elective surgical population and is associated with other markers 
of increased perioperative risk such as low AT. Exploration of the postoperative immune and 
bioenergetic features of lymphocytes demonstrates a phenotype of reduced cellular function 
compared to preoperative baseline levels, which may have important implications for acquired 
lymphopenia, morbidity and recovery following surgery. 
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